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1 Introduction 
1.1 Fat metabolism and acetyl-CoA carboxylase (ACC) 
1.1.1 Fat deposition and mobilization  
 
Fat deposition and mobilization in the dairy cows are intriguing issues in the dairy industry. 
Chemically, fat generally refers to triester of glycerol and fatty acids. Functionally, fat is one 
of the major stores of energy and provides ATP for animals. Milk fat is an important energy 
source for an infant. To produce milk, its mother must store excessive fat than her own needs. 
This fat is required to be stored during dry standing. When an infant needs it, it is mobilized, 
transported via blood serum and secreted into milk. However, excessive mobilization might 
cause metabolic disorders (e. g. ketosis), especially within the first 2 weeks of lactation. Thus, 
the appropriate energy in diets is a key to avoid excessive mobilization of fat. It is valuable to 
know about fat metabolism for designing adequate diets. 
1.1.2 Biosynthesis of fatty acids and ACC 
The biosynthesis of fatty acids is a prominent metabolic process in most organisms. Because 
higher animals possess the limited capacity to store polysaccharides, if the ingested glucose 
exceeds immediate energy demands, the surplus will be stored as fat. Firstly, it is converted 
into pyruvate by glycolysis and then into acetyl-coenzyme A. Fatty acids are synthesized 
using acetyl-coenzyme A as a substrate and stored in adipose tissues and the mammary gland 
in triacylglycerol form. Besides serving as an energy storage form, the resulting fatty acids 
also participate in many important cellular functions, such as a transportable form of 
metabolic fuel, structural components of cell membranes, protective coating on the surface of 
the organism and cell signaling.  
In higher animals, the biosynthesis of saturated fatty acids from their ultimate precursor 
acetyl-coenzyme A (CoA) occurs in all tissues, but is especially prominent in the liver, 
adipose tissues and mammary glands. Biosynthesis fatty acid is opposite to fatty acid 
oxidation. The former occurs in the cytosol, whereas the latter occurs in the mitochondria. 
Fatty acid synthase catalyzes one acetyl residue and seven malonyl residues and subsequently 
undergos successive condensation steps to form a molecule of palmitic acid. Palmitic acid is 
further converted into various fatty acid forms. The formulation of reaction is:  
1 acetyl-CoA + 7 malonyl-CoA + 14 NADPH + 14 H+CH3(CH2)14COOH + 7 CO2 + 8 CoA 
+ 14 NADP+ +6 H2O (Lehninger, 1981).  
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In the biosynthesis course of palmitic acid, acetyl-CoA only provides one acetyl unit. The 
other seven units are required in the form of malonyl-CoA. Malonyl-CoA is generated by 
condensation of acetyl-CoA and HCO3-. Hence, acetyl-CoA, derived from carbohydrate or 
amino acid source, is the ultimate precursor (Figure 1) of all carbon atoms in a fatty acid 
chain. Acetyl-CoA carboxylase (ACC; EC 6.4.1.2), which catalyzes the synthesis of 
malonyl-CoA, is a key rate-limiting enzyme throughout fatty acid biosynthesis.  
Fatty acids
Carbohydrates
Acetyl-CoA
Malonyl-CoA
Fatty acids
Triacylglycerols and
other complex lipids
Acetyl-CoA 
carboxylase- alpha
Fatty acid synthase
Amino acids
Glycerol-P-acyltransferase
Acetyl-CoA
 
Figure 1 Acetyl-CoA is the key precursor in biosynthesis of lipids. 
 
1.1.3 Roles of ACC in fatty acid synthesis and oxidation
There are two ACC systems to control the amounts of fatty acids in cells. They are ACC- or 
ACC1 (ACACA) and ACC- or ACC2 (ACACB). Though both ACC- and ACC- catalyze 
the synthesis of malonyl-CoA, they play distinct roles in various cellular compartments. 
ACC- is necessary to form long chain fatty acids in the cytosol. ACC- knock out mice are 
lethal in embryonic period demonstrating that de novo fatty acids synthesis is essential for 
embryonic development (Abu-Elheiga et al., 2005). However, liver-specific ACC- knock out 
mice have no obvious health problems under normal feeding conditions. When compared with 
wild type mice, they exhibit lower ACC activity and lower malonyl-CoA levels. There was a 
significant decrease in de novo fatty acid synthesis and triglyceride accumulation in the liver 
(Mao et al., 2006).  
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Conversely, ACC- catalyzes acetyl-CoA to form malonyl-CoA in mitochondria. The 
resulting malonyl-CoA is the inhibitor of fatty acid oxidation. It decreases the transport of 
long-chain fatty acyl-CoA from the cytoplasm to the mitochondrial matrix, by inhibiting 
carnitine palmitoylacyltransferase I (CPT-I; EC 2.3.1.7) via an allosteric mechanism (Mcgarry 
et al., 1978a; Mcgarry et al., 1978b; Pripbuus et al., 1990). In ACC- knock out mice, 
increases in both fat and carbohydrate oxidation increase total energy expenditure, reduce fat 
deposits, result in lean body mass and prevents diet-induced obesity (Abu-Elheiga et al., 2003). 
Furthermore, ACC- knock out mice were protected from fat-induced peripheral and hepatic 
insulin resistance (Choi et al., 2007).  
Hence, ACC plays a pivotal role in fatty acids synthesis and oxidation. ACC- is thought more 
important in keeping a glucose homeostasis which is regulated systemically at the cellular 
level by energy charges (Cesquini et al., 2008). In this study, I focus on molecular regulation 
of bovine ACC-. 
1.1.4 Functional domains of the ACC-  
As stated above, ACC- catalyzes the conversion of acetyl-CoA into malonyl-CoA. However, 
it plays role not alone, but as a multifunctional enzyme complex. In prokaryotes and most 
plants, three conserved functional domains, biotin carboxylase (BC), biotin carboxyl-Carrier 
protein (BCCP) and carboxyl transferase (CT), are distributed in different proteins (Li and 
Cronan, Jr., 1992a; Li and Cronan, Jr., 1992b). However, in eukaryotes, they are harbored in 
one long peptide. The bovine ACC- multifunctional domains and binding sites for ATP, 
biotin and acyl-CoA are indicated in Figure 2. The overall reaction of biosynthesis of 
malonyl-CoA by ACC has two steps: Step1, BC catalyzes the carboxylation of biotin which is 
covalently bound to BCCP. This reaction is ATP-dependent; Step2, CT transfers the carboxyl 
from biotin to the acceptor, acetyl-CoA. The reactions are listed below (Lehninger, 1981):  
 
Step1: Biotin-BCCP+HCO3-+H++ATP carboxybiotin-BCCP+ADP+Pi 
 
Step2: carboxybiotin-BCCP+acetyl-CoAbiotin-BCCP+malonyl-CoA  
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5-13 14-16 17-18 119-39 40-52 52-54
ATP Biotin acyl-CoA
BC BCCP CT
EGGGGKGIR EVMKM SFSEIMQPWAQTVVVGRARLGGIPVGVVAV
313 321 786 1958 1987782
recombinant expression region
3122
 
Figure 2 Functional domains of bovine ACC-.
ACC- shown in the figure is the 265 kDa isoform derived from PI and PII of bovine ACC-. Numbers 
within boxes refer to exon numbers and functional domains are shown as grey filled boxes. The 
corresponding names are given below the exon boxes. The amino acid sequences and positions in the 
functional domains for ATP, biotin and acetyl-CoA (Kim, 1997) are listed above the exon boxes. BC, 
biotin carboxylase; BCCP, biotin carboxyl carrier protein; CT, carboxyltransferase. [The 
correspondence of the functional domain to the exact exon is referred to (Barber et al., 2005)].  
1.2 Regulation of ACC-?
In the above reactions, ACC- enzyme is regulated at different levels. These include the 
regulation of transcription initiation and subsequent mRNA splicing and stability. Together 
with the regulation at protein translation, these regulations belong to long-term regulation. 
Short-term regulation is also implicated in ACC-regulation, and is consisted ofallosteric or 
metabolic regulation and post-translational regulation of the enzyme. These processes will be 
discussed further in the following sections.  
1.2.1 Long-term regulation 
Liver, adipose tissues and mammary glands are the main sites for de novo fatty acid synthesis. 
In the liver, refeeding starved animals causes increased levels of the ACC- gene (ACC-) 
mRNA. Pregnancy and lactation dramatically readjust fatty acid synthesis to meet energy 
requirements, under these physiological conditions, this response of ACC- transcription is 
tissue-specific (Kim and Tae, 1994). Particularly in white adipose tissue and the mammary 
gland, great changes of lipid metabolism are the comprehensive results of complex factors 
including hormones and cytokines (Ros et al., 1990).  
Hormones, such as insulin, glucagon, triiodothyronine (T3), dexamethason, can regulate 
ACC- activity in a long-term fashion by adjusting the expression level of ACC-. These 
hormones are thought to regulate the ACC- transcription initiation via modulation of 
cytokines. This is the route by which different nutritional statuses regulate ACC- 
transcription.  
Insulin increases ACC- transcription initiation. Six hours after injection of insulin, the 
mRNA abundance of ACC- was increased from low level to normal in diabetic mice 
(Katsurada et al., 1990). T3 plays a similar role to insulin, whereas, glucagon decreases the 
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abundance of ACC- mRNA in avian hepatocytes (Yin et al., 2000).   
1.2.1.1 Multi-promoters regulate ACC- transcription initiation 
To control the transcription initiation ACC- gene, three promoters (PI, PII, PIII; Figure3) have 
been found in bovine with specific characteristics (Mao et al., 2001; Mao et al., 2002; Mao and 
Seyfert, 2002; Molenaar et al., 2003). PI is the main active promoter in the liver, adipose 
tissues and mammary glands; PII is the house keeping promoter; PIII is the abundantly 
expressed and induced promoter in the mammary gland (Mao et al., 2001; Mao et al., 2002; 
Mao and Seyfert, 2002).  
PI PII PIII
54 47316 133105bp:
65A4321exon: 5
253
ATG
4.3 1.9 3 15 4distance: [kbp]10.8
493
ATG
PIn?
41
1n?
ACC-TADA2L
 
Figure 3 The distribution of exons and bovine ACC- promoters 
PIn shown in this figure is the most 5´ promoter of the bovine ACC-, corresponding to PI of human 
ACC- (Mao et al., 2003), and PI of ovine and mouse ACC- (Travers et al., 2005). PI (Mao et al., 2001) 
refers to rodent and ruminant specific promoter (PIA) in the recent ACC reviews (Barber et al., 2005). 
PII refers to the house keeping promoter (Mao and Seyfert, 2002). PIII refers to the mammary gland 
specific promoter (Mao et al., 2002).The designation of all promoters of the bovine ACC- gene follows 
this figure.   
 
PI is a rodent and ruminant- specific promoter (Abu-Elheiga et al., 1995; Kim and Tae, 1994; 
Lopez-Casillas and Kim, 1991). It has strong activity in the liver, adipose tissues and 
mammary glands. Unlike rat and ovine PI, bovine PI has no TATA box, where the second ‘T’ is 
replaced by an ‘A’ base. This conserved sequence lies 3´ of the fourth transcription start site 
(Mao et al., 2001).  
PII is evolutionally conserved with the counterparts of human and rat. It has the common 
characteristics of a house keeping promoter: no TATA box, no CAAT box and is a GC-rich 
sequence. In vivo expression of PII reveals little tissue-specific restrictions. The 133 bp 
proximal promoter has a strong activity in different cell lines (Mao and Seyfert, 2002).  
PIII is primarily expressed and strongly induced (approximately 28-fold) in the lactating 
mammary gland (Mao et al., 2002). The transcripts of PIII in mammary epithelial cells (MEC) 
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of bovine and ovine have been identified by in situ hybridization (Barber et al., 2003; Mao et 
al., 2002). The long PIII promoter driving luciferase reporter was induced by prolactin and 
dexamethasone in stably transfected mouse MEC cells. Moreover, lactogenic induction was 
abolished if a binding site of unique signal transducer and activator of transcription (STAT) at 
position -797 to -786 was mutated by only two nucleotides (Mao et al., 2002). EMSA indicated 
STAT5A from mammary gland binds strongly to this region. Hence, STAT5 plays an important 
role in regulating the expression of ACC- in the milk producing cells of the mammary gland 
(Mao et al., 2002).  
PIn is a GC-rich and bidirectional promoter shared with the diversely oriented TADA2L gene, 
which encodes a component of chromatin-modifying complexes in ovine, mouse and human 
(Travers et al., 2005). PIn was originally identified in human adipose tissue (Ha et al., 1994) 
and was highly expressed in brain (Travers et al., 2005). The PIn of mouse or rat is located 43 
kb upstream of the second regulatory region. PIn is physically, the first promoter of the ACC- 
gene in ovine, mouse and human designated by the authors as ‘PI’ (Mao et al., 2003; Travers et 
al., 2005). To date, there are no reports of a bovine promoter PIn of ACC-. However, I 
hypothesized that bovine ACC- may harbour this conserved gene structure of PIn. Two 
reasons were provided. The first, the present bovine proximal PI has high identity with the 
second promoter of the ruminant and rodent; The second reason is that the most 5´ promoter PIn 
of human ACC- shows high identity with ovine PIn (The 1st promoter of ovine ACC-) 
(Barber et al., 2005), but has low identity with bovine PI. Hence bovine PI is distinct from PI of 
human and ovine ACC-. Hence, the present bovine PI may not physically be the first promoter 
at 5´ terminus of bovine ACC-. The first promoter of bovine ACC- is hereby named PIn as 
indicated in Figure 4. 
?
PIn PI
bovine
ovine
mouse
human
ACC-
 
Figure 4 PIn and PI comparisons of different species 
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1.2.1.2 Pre-mRNA splicing 
In ACC-, pre-mRNA splicing likely evolved as an important regulatory mechanism resulting 
in various mature RNA transcripts. The mature RNA may generate physically related but 
functionally distinct protein products from the same gene. The diverse 5´-UTRs derived from 
PI and PII can be synthesized into the ACC- protein using the start codon ATG which lies in 
exon5 (Mao et al., 2001; Mao et al., 2002; Mao and Seyfert, 2002). Transcripts derived from 
PIII can be translated into a smaller molecular weight bovine protein using the ATG in 
exon5A. However, alternative splicing of exon 28, which has been consistently described in 
pig and sheep (Barber et al., 2001; Gallardo et al., 2008), involves the presence/absence of an 
8-aa stretch with the ability to inhibit the phosphorylation of residue Ser-1200. Thus, 
pre-mRNA splicing, in addition to multi-promoters, contributes to regulate ACC- 
expression. In fact, in metazoans, the number of genes regulated by pre-mRNA splicing may 
be comparable to the number regulated by transcription initiation. Despite their obvious 
importance, alternative splicing mechanisms remain poorly understood (Carey and Smale, 
2000; Wang and Manley, 1997). 
1.2.1.3 Stability of mRNA  
The steady-state abundance of every mRNA is dependent on its rate of synthesis and rate of 
decay. The intrinsic stability of an mRNA has a profound influence on the abundance of the 
mRNA and the abundance of the encoded polypeptide. The stabilities of mRNAs in 
mammalian cells vary widely, with approximate half-lives ranging from 15 minutes to 10 
hours. Moreover, mRNA stabilities can be tightly regulated, and in some cases are regulated 
co-ordinately with transcription initiation (Carey and Smale, 2000). Pape and colleague 
investigated whether pre-mRNA decay is involved in the decrease of ACC- mRNA synthesis 
in the presence of tumor necrosis factor (TNF) (Pape and Kim, 1989). They found that the 
apparent half-lives of ACC-mRNAs (9 h) show no changes with and without induction of 
TNF. Hence, the regulation mechanism of ACC- mRNA stability is not yet understood. 
1.2.2 Short-term regulation 
The short-term regulation controls the ACC- enzymatic activity occurring within minutes, 
including allosteric activators, inhibitors and reversible phosphorylation. Hence, ACC- 
activity is a dynamic balance among the various allosteric effectors, specific protein kinase 
and phophatases (Barber et al., 2005).  
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1.2.2.1 Allosteric regulation 
Several allosteric effectors contribute to control ACC- activity. They are citrate, isocitrate, 
glutamate, guanine nucleotide, CoA and long-chain acyl-CoAs. The first four are allosteric 
activators, and the last two are allosteric inhibitors.  
Citrate and isocitrate are classic feed-forward activators of ACC- activity for the following 
reasons. First, citrate and isocitrate are intermediates in the tricarboxylic acid cycle (TCA 
cycle) and are precursor of the main substrate of ACC-, acetyl-CoA. They are found to 
activate ACC- in vitro and also stimulate lipogenesis in vivo (Abraham et al., 1960; Martin 
and Vagelos, 1962). Second, citrate activates the polymerization of an inactive enzyme into an 
active filamentous form composed of 10-20 protomers (Beaty and Lane, 1983a; Beaty and 
Lane, 1983b). Third, citrate diminishes ACC- phosphorylation in the hypothalamus, 
controlling food intake and coordinating a multiorgan network that controls glucose 
homeostasis and energy uptake through the adrenergic system (Cesquini et al., 2008). 
Glucagon and dibutyryl cAMP inhibit fatty acid synthesis by decreasing the concentration of 
citrate in chicken liver. In contrast, pyruvate or lactate activates fatty acid synthesis by 
increasing the concentration of citrate (Watkins et al., 1977). 
Glutamate is a structural analog of citrate. Hence, it can also act as an allosteric activator of 
ACC- (Boone et al., 2000b). Glutamate is a common product of amino acid, fatty acid and 
carbohydrate metabolism. Glutamate was also reported to induce ACC- activity through 
complementary action as a phosphatase activator (Boone et al., 2000a).  
Guanine nucleotides act as positive intracellular regulators for ACC- activity (Witters et al., 
1981). Photoaffinity labeling techniques indicated an intrinsic or associated GTP binding site 
on ACC- (Mick et al., 1998). However, the fact that isolated ACC can not be activated by 
guanine nucleotides suggests that this is a complex process, requiring an endogenous cell 
condition (Witters et al., 1981).  
CoA is an activator of ACC- activity (Yeh et al., 1981). ACC- has a CoA binding motif. 
The binding of CoA to ACC- may contribute to polymerize the ACC- enzyme. However, 
palmityl-CoA affects the binding of CoA to ACC-. CoA, together with bovine serum 
albumin like protein, can block the inhibition by palmityl-CoA. Hence, CoA, palmityl-CoA 
and bovine serum albumin like protein control ACC- activity in different physiological 
conditions (Yeh et al., 1981). 
Long-chain acyl-CoAs are classic feed-back inhibitors of ACC- activity. Palmityl-CoA, 
stearoyl-CoA and arachidyl-CoA are products of the lipogenic pathway (Faergeman and 
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Knudsen, 1997; Nikawa et al., 1979; Ogiwara et al., 1978). Long-chain acyl-CoAs were found 
to activate AMPKK, the kinase of AMPK, and to inhibit ACC- activity (Carling et al., 1987; 
Hardie and Carling, 1997). Acyl-CoA binding protein (ACBP) might act as the sensor to 
monitor the concentration of long-chain acyl-CoAs (Knudsen et al., 1993; Rasmussen et al., 
1993). 
1.2.2.2 Reversible phosphorylation 
Reversible phosphorylations of eight amino acid residues are relevant to the regulation of 
ACC- activity by protein kinase A (PKA) and 5´-AMP-activated protein kinase (AMPK) in
vitro and in vivo (Haystead et al., 1990). Interestingly, six (Ser-23, -25, -29, -77, -79, -95) of 
these residues cluster on the first 100 amino acid residues at the N-terminus of ACC-, while 
the remaining two (Ser-1200 and -1215) localize to the central region (Haystead et al., 1988; 
Munday et al., 1988).  
In vitro experiments indicated that AMPK phosphorylates Ser-79, -1200 and -1215 and 
inactivates ACC-. Ser-77 and Ser-1200 are phosphorylated by PKA and are accompanied 
with a moderate loss of ACC- activity (Davies et al., 1990). Prior phosphorylation of Ser77 
and Ser1200 by PKA prevents subsequent phosphorylation of Ser79 and Ser1200, but not 
Ser1215, by the AMPK. The fact that truncation of the first 200 amino acid residues reversed 
the phosphorylation of ACC- by PKA and AMPK implies that the key Ser residue for a 
regulatory response to these kinases resides in the N-terminus (Davies et al., 1990). In 
contrast, the phosphorylation of Ser-77 by PKA only results in a small effect on ACC- 
activity. Hence, the effects of AMPK on ACC- activity are mediated chiefly by 
phosphorylation of Ser-79. 
In vivo experiments in isolated adipocytes and hepatocytes manifested that glucagons and 
adrenaline activate the phosphorylation of Ser-79 and -1200, through PKA decreasing 
ACC-activity, but not AMPK. Combining with the evidence in vitro, hormones first activate 
PKA, and then activate AMPK, and results in the phosphorylation of Ser residues. Mutational 
experiments on rat ACC- cDNA in HeLa cells showed Ser-1200 was critical for the 
inactivation of ACC by PKA and that Ser-79 was essential for the inactivation of ACC activity 
by AMPK. Mutation of Ser-79 also prevented the phosphorylation of Ser-1200 by AMPK, but 
mutation of Ser-1200, not Ser-77, blocked the phosphorylation by PKA. 
Insulin activates ACC- in adipocytes, hepatocytes and intact liver by inactivating AMPK and 
decreasing the total phosphorylation of ACC-
However, insulin stimulates the 
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phosphorylation of Ser-29 (Haystead et al., 1988) which is mediated by casein kinase II in 
3T3 cells and hepatoma cells (Mabrouk et al., 1990). The insulin-activated ACC kinase may 
play an important role in the activation of ACC by insulin (Heesom et al., 1998). Similarly to 
insulin, epidermal growth factor (EGF), starvation or refeeding also affect the whole 
phosphate content of ACC-.  
1.3 PI is regulated by a bipartite repressor 
Previous work of our lab showed that a 1.3 kb PI (Figure 4) fragment drives the expression of 
reporter genes weakly in different model cells HC11, HepG2, and 3T3-L1 adipocyte. The 
deletion (-1330/-127) of the distal region stimulated reporter gene activity. The activity of 
bovine long ACC- PI promoter and the subsequently truncated PI (-1045/+84) was 
approximately as weak as the promoterless (~1-fold pGL3basic). However, the activity of the 
very short proximal 127 bp fragment of PI (-127/+84) was ~10 -fold of pGL3basic (Mao et al., 
2001). Hence, bovine PI is basically repressed, like its homolog in rat (O'Callaghan et al., 2001; 
Tae et al., 1994).  
+1-1330 -127
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-737
NdeI
-281
NdeI
-1045 -996
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C
ChoRE
USF
Genomic structure of PI from cattle
 
Figure 5 Candidate region for the repressive elements of PI 
 
Serial deletions of PI indicated that two separated regions be present to inhibit bovine PI 
activity. The distal repressive region resides within a well-preserved Art2 retroposon from 
position -1297 to position -762 (Mao et al., 2001). The counterpart distal repressive region of 
rat PI has been identified as a CA-28 microsatellite (Tae et al., 1994). Thus, sequence structure 
and evolutionary origin of the main repression element of PI in bovine are entirely different 
from its functional counterpart in rat. Further work found CA-28 together with the downstream 
CCAAT/enhancer binding protein (C/EBP) element represses the PI activity in rat (Tae et al., 
1994). Another report showed that the cotransfection of C/EBP expression vectors increased 
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rat ACC- PI activity (Tae et al., 1995). C/EBP inhibits the proliferation of liver cells, but 
activates adipocyte differentiation resulting in adipogenesis (Cao et al., 1991; Millward et al., 
2007; Rahman et al., 2007). Observation from C/EBP knockout mice demonstrated that lipid 
accumulation decreased and diet-induced obesity was inhibited (Millward et al., 2007; 
Rahman et al., 2007). Thus C/EBP factors are relevant to ACC- PI activity and subsequent fat 
metabolism. 
1.4 Transcription factors relevant to regulating ACC- PI activity 
1.4.1 Roles of CCAAT/Enhancer Binding Protein (C/EBP) 
The C/EBP factors are a large family transcription factors (Schrem et al., 2004), including six 
members ( and ). The N-terminus of those proteins is specific and comprises of 
the activation domain (AD) or repression domain (RD) (Figure 5).  
AD AD RD AD B ZIP
C/EBP
C/EBP
C/EBP
C/EBP
C/EBP
C/EBP
P42
LAP1
P32
P30
P14
LAP2
LIP
P27
P30
 
Figure 6 Schematic representation of the C/EBP family members.  
The leucine Zipper is shown in yellow with black vertical lines indicating the leucine residues. The basic 
region is red. AD is the activation domain. RD is the repression domain. [Adapted from Ramji and 
Pelagia, 2002] 
These proteins are highly conserved at their C-terminus, consisting of the DNA binding 
domain (B) and a leucine zipper domain (ZIP). Normally, C/EBP proteins work as 
homodimers or heterodimers via the leucine zipper domain dimerizing to regulate gene 
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transcription (Ramji and Foka, 2002). C/EBP and - are expressed early in the 
differentiation program, but are not immediately active. After a long lag, C/EBP and - 
become competent to bind to the C/EBP regulatory element in the C/EBP gene promoter, 
C/EBP being a transcriptional activator of numerous adipocyte genes (Cao et al., 1991; 
McKnight, 2001; Tang and Lane, 1999; Wu et al., 1998). Here, I focus on C/EBP and 
C/EBP due to limited information for C/EBP and .  
 
C/EBP(previously named as C/EBP) 
C/EBP plays an important regulatory role in energy metabolism in the liver (Crosson et al., 
1997). Disruption of the C/EBP gene in mice causes hypoglycaemia associated with 
impaired expression of gluconeogenic enzymes.  
Thyroid hormone positively regulates C/EBP expression 
Serial analyses of rat C/EBP promoters indicated that the TRE-1 element represents a 
functional T3 response element regulated by thyroid hormone (Menendez-Hurtado et al., 
2000). Moreover, some peptides of C/EBP were stimulated to autoregulate (Jurado et al., 
2002).  
Possible regulatory functions of alternative C/EBP translational products 
Based on the same mRNA, C/EBP can be translated into two isoforms: P42 and P30 (Figure 
5). A previous report showed the ratio of these two major proteins changes during 
differentiation of 3T3-preadipocyte and hepatocyte development (Lin et al., 1993). Hence, 
alteration of the ratio may be a regulatory event. 
The transactivation domain of C/EBP
It is reported that three domains in the N-terminus (corresponding to amino acid position 
1-107, 107-170 and 171 -245) contribute to regulate the transcriptional activity of the target 
gene (Pei and Shih, 1991). In vitro, the first two elements cooperatively mediate binding of 
C/EBP to TBP and TFIIB. This might eventually regulate the transcription of the target 
gene. 
Tissue-specific expression of C/EBP
The human C/EBP is differently expressed in tissues, expression levels in placenta being the 
highest of all other tested tissues. High expression was also found in the liver, lung, skeletal 
muscle, pancreas, small intestine, colon and in peripheral blood leukocytes. In brain, kidney, 
thymus, testis and ovary, C/EBP is also expressed, although to a lower extent (Antonson and 
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Xanthopoulos, 1995).  
C/EBP(also named as LAP, IL-6DBP, CRP2 or NF-IL6) 
Expression of C/EBP gene can be stimulated by glucocorticoid and glucagon in 
primacy-cultured rat hepatocytes (Matsuno et al., 1996). C/EBP has been linked to the 
metabolic and gene regulatory responses to diabetes and implicated as an essential factor 
underlying gulcocorticoid-dependent activation of insulin-like growth factor binding protein-1 
(IGFBP-1) and phosphoenolpyruvate carboxykinase (PEPCK) gene transcription in vivo. 
Isoforms of C/EBP were found to participate in gluconeogenesis via insulin and 
glucocorticoids (Ghosh et al., 2001).  
C/EBP isoforms are generated by alternative translation initiation and/or proteosomal 
regulation 
Four isoforms of C/EBP have been found. They are the full-length 39 -kDa C/EBP protein 
(LAP1), the 36-kDa Liver enriched transcriptional activator protein (LAP2), the 20-kDa Liver 
enriched transcriptional inhibitory protein (LIP) (Descombes et al., 1990; Descombes and 
Schibler, 1991) and the 14-kDa isoform (Schrem et al., 2004). Additionally different isoforms 
are generated by using various in frame starting ATGs. They may also be regulated by 
proteosomal cleavage (Burgess-Beusse et al., 1999). The cleavage activity is specific to 
prenatal and newborn livers, and is sensitive to chymostatin. The production of C/EBP 
protein isoforms in the neonatal mouse liver is regulated by C/EBP. In C/EBP knockout 
mice, the predominant C/EBP proteins are the larger 39-kDa and 36-kDa isoforms, whereas 
wild-type animals primarily possess the smaller 20-kDa and 14-kDa isoforms. These 
C/EBP-dependent differences are liver specific, present at day 18 of development, but 
absent from lung or adipose tissues, (Burgess-Beusse et al., 1999). 
Tissue-specific regulation of C/EBP
Sequence analysis and experimental evidence indicated that the rat C/EBP gene features two 
cAMP responsive elements (CRE) within its promoter. Subsequently, it was found that a 
C/EBP binding site overlaps with a CRE site. Moreover, in human hepatocellular liver 
carcinoma cells (HepG2), NF-B stimulated the autoregulation of C/EBP during 
inflammatory response (Niehof et al., 2001). Transcription factor C/EBP, CRE or NF-B may 
control C/EBP activity via interaction with their respective binding sites in different 
physiological conditions and tissues.  
Phosphorylation of C/EBP
Post-translational site-specific phosphorylation of C/EBP is an essential mechanism 
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regulating the transactivating potential of C/EBP factors (Buck et al., 1999; Buck and 
Chojkier, 2007; Mahoney et al., 1992; Trautwein et al., 1993a; Trautwein et al., 1993b; 
Trautwein et al., 1994). Several phosphorylated residues have been found in mouse 
C/EBPfactor. Phosphorylated Ser-239 stimulates C/EBP nuclear translocation. 
Phosphorylation of Thr-217 mediated by p90 ribosomal S kinase (RSK) contributes to the 
survival of stellate cells (Buck and Chojkier, 2007). Protein kinase C (PKC) phosphorylates 
Ser-105, -277 and -299, and PKA phosphorylates Ser-240. Only phosphorylation of Ser-105 is 
known to activate the expression of target gene at present. The others repress transactivating 
activity of the factor in PKC signalling pathway. 
1.4.2 Roles of Nuclear Factor-Y (NF-Y) 
Nuclear factor-Y (NF-Y, this study), also named as CCAAT binding factor (CBF), is 
composed of three subunits: NF-YA (CBF-B), NF-YB (CBF-A) and NF-YC (CBF-C) 
(Mantovani, 1999). Only after NF-YB and NF-YC form a dimer, can NF-YA recognize and 
bind to the complex resulting in a trimer. It is reported that NF-Y also recognizes the CCAAT 
binding motif. However, the protein structure and function are completely different from 
C/EBP factors (Celada et al., 1996; Romier et al., 2003). NF-Y represses or activates 
transcription during different physiological conditions thus acting as a bifunctional regulator 
(Bernadt et al., 2005). NF-Y can also recruit histone deacetylase (HDAC) to repress promoter 
activity (Peng et al., 2007). Compaction of DNA by NF-Y (Guerra et al., 2007) is another 
event that may conceivably contribute to the repression of transcription. Moreover, it is 
reported that NF-Y can cooperate with C/EBP to up-regulate transcription in adiponectin 
and amelogenin genes (Park et al., 2004; Xu et al., 2006).  
1.5 Goals of this study 
Studying the regulation of fat metabolism plays an essential role in the control of milk and 
meat quality of the agricultural industry. Since ACC is the rate-limiting enzyme in fatty acid 
synthesis, and its main active promoter PI is nutritionally regulated in the liver, adipose 
tissues and mammary glands of ruminant and rodent, it is of importance to understand the 
regulation mechanism controlling PI of bovine ACC--encoding gene. It was previously 
reported that PI is basically repressed. However, the underlining molecular mechanism keeps 
unknown. The goals of this thesis are: 
1) To characterize more 5´ promoter PIn expressing bovine ACC-. Sequence analyses 
manifest that the present bovine PI show identity to ovine and mouse PI, which is physically 
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the second promoter of ACC-. Travers and colleagues (2005) reported that PIn is physically 
the first promoter of ovine, mouse and human ACC-. Hence, bovine ACC- may harbour 
physically similar PIn at more 5´ region, initiating the transcription of ACC- in lipogenic 
tissues, such as the liver, adipose tissues and mammary glands. The identification and 
characterization of bovine PIn will act as a basis to confirm that PI is the major promoter in 
lipogenic tissues. 
2) To identify the cis-elements and the binding factors repressing PI activity. Results from 
the investigation of the PIn promoter confirmed that PI is the principally and nutritionally 
regulated promoter in lipogenic tissues. Previous work reported that PI is basically repressed 
by an upstream repressive element (Mao et al., 2001). O´Callaghan and colleagues found the 
distal repressive region of rat PI reduces the extent of the response to hormone, and they 
concluded that defining the repressors of PI is paramount to understanding the regulatory 
mechanism (O'Callaghan et al., 2001). Hence the elucidation of the repressive mechanism will 
contribute to understanding the regulation mechanism of fat metabolism.  
3) To identify the regulatory mechanism of the basal PI activity. Previous work manifested 
that the basal PI promoter has strong activity in model cells HC11, HepRI and 3T3-L1 
adipocyte. Based on the primary results of this study, C/EBP and NF-Y activate both the long 
and proximal PI. Hence, it is necessary to investigate how these factors regulate basal PI 
activity. Identification of the basal control cis-elements and the binding factors is the basis to 
finally resolve the regulation mechanism, and hence know how the repressors and activators 
synergistically modulate PI.  
4) To characterize the molecular mechanism controlling ACC- PI activity. After discovering 
the cis-elements and the relevant factors in both the repression and activation region, I cast 
interests to how these factors cooperate to control the PI promoter activity in model 
cells-HC11. It is necessary to examine the effects of these factors separately or collaboratively 
to control PI promoter. These works will be the basis by which I finally delineate the 
molecular mechanism controlling PI expression and regulation. 
5) To discern the relationship of the relevant endogenous factors to ACC- PI activity. After 
identification of the master control unit of PI, the interest is to know how the relevant factors 
in vivo cooperate to regulate PI promoter and control fat metabolism. Therefore I aim to probe 
the mRNA levels of the relevant transcriptional factors in different lipogenic tissues.  
Finally, to develop a method for the measurement of ACC- expression by an avidin-biotin 
complex indirect sandwich ELISA (ABC-ELISA). The present measurements of bovine 
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ACC- mass are mostly dependent on the measurement of mRNA level, enzyme activity 
analysis. The enzyme activity assay is easily affected by the measuring conditions. Firstly, the 
different isoenzymes (ACC- and ACC-) can not be easily discriminated in crude protein 
sample or after purification procedures. Secondly, the loss of phosphorylation of ACC will 
make the apparent enzyme mass more than the real value due to the activation by 
dephosphorylation of ACC-. The measurement by quantitative real-time PCR is in the 
mRNA level. It can not tell more information about the regulation of ACC- in the protein 
level and post-translational level. ABC-ELISA will produce specific, accurate and sensitive 
information of the regulation of ACC- enzyme. Hence, two antibodies for ACC- from 
rabbit and goat, and the recombinant antigen will be raised in the study to establish the 
ABC-ELISA.  
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2 Materials and Methods 
2.1 Materials 
2.1.1 Bacterial strains 
Strains Genotype Source 
E. coli XL1-Blue 
SupE44, hsdR17, recA1, endA1, gyrA96, thi,relA1, lac- 
[F’, proAB+, laclqYM15, ::Tn10(Tetr)] 
Stratagene 
E. coli BL-21 E. coli B F– dcm ompT hsdS (rB– mB–) gal (DE3) Stratagene 
2.1.2 Reagents and antibodies 
Table 1 Reagents 
Reagents  Source  
Restriction enzymes MBI Fermentas  
DNA polymerase I Large (Klenow) Fragment Promega 
Superscript II Reverse Transcriptase Invitrogen  
T4 DNA ligase Invitrogen  
RNase A Serva  
RNase T1 Sigma-Aldrich  
Proteinase K Serva  
Synthetic oligonucleotides Sigma-Genosys  
dNTPs Roche  
Poly(dIdC) Roche  
32P-dCTP Amersham Pharmacia  
Anti-Digoxigenin-AP, Fab fragments Roche  
Roti®-Block (10 ×) ROTH  
TRIzol Invitrogen  
Sephadex G-25 Amersham Pharmacia  
CNBr-activated Sepharose 4B Amersham Pharmacia  
Protein A agarose Sigma-Aldrich  
DANSYL Chlorid Sigma-Aldrich  
AHT (anhydrotetracycline) IBA  
Folin-cicocalteu’s phenol MERCK  
Freund’s adjuvant complete  Sigma-Aldrich  
Freund’s adjuvant incomplete  Sigma-Aldrich  
Insulin  Sigma-Aldrich  
Trypan blue  Sigma-Aldrich  
G418 sulfate  Serva  
RPMI 1640 medium  Biochrom AG  
Dulbecco’s MEM (DMEM)  Biochrom AG  
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Hank’s salt solution  Biochrom AG  
Trypsin/EDTA solution  Biochrom AG  
Fetal calf serum (FCS)  Biochrom AG  
Antibiotic antimycotic solution (100×) Sigma-Aldrich  
FuGENE 6 Transfection Reagent Roche 
Lipofectamine™2000 Reagent Invitrogen 
Ni-NTA sepharose (50 % suspension) IBA 
Strep-tag Protein Ladder (lyophilized) IBA 
BenchMark™ Pre-Stained Protein Ladder Invitrogen 
Ultra-Sensitive ABC Peroxidase Rabbit IgG Staining Kit Pierce 
 
Table 2 Antibodies 
 Antibody origin No. Source 
1 anti-CBFB (NF-YA, H-209)  Rabbit  sc-10779× Santa Cruz 
2 anti-CEBP Goat  sc-9315× Santa Cruz 
3 anti-His tag [His-probe (H-15)] Rabbit  sc-803 Santa Cruz 
4 anti-C/EBP ( 198) Rabbit  sc-746× Santa Cruz 
5 anti-p-C/EBP (Thr217) Rabbit  sc-16993× Santa Cruz 
6 anti-C/EBP (C-19) Rabbit sc-150 Santa Cruz 
7 anti-FLAG ® M1 Monoclonal Antibody Mouse F3040 Sigma 
8 mono anti-actin Mouse A2547 Sigma 
9 anti-(bovine) ACC-  Rabbit  X7 This study 
10 anti-(bovine) ACC- Goat  G7 This study 
11 anti-mouse IgG (Fab specific) HRP Goat  A3682 Sigma 
12 anti-Rabbit IgG AP Goat  A-3687 Sigma 
13 anti-mouse IgG AP Goat  A-2429 Sigma 
14 Anti-Goat IgG (whole molecule)–AP  rabbit A4187 Sigma 
15 Strep-Tactin AP conjugate ?  2-1503-001 IBA 
16 anti-Goat IgG HRP Rabbit  3140 Pierce 
2.1.3  Plasmid vectors 
Table 3 Plasmid vectors 
Plasmids Source 
pBR328 Our lab 
pGEM-T easy Promega 
pGEM-T Promega 
pGL3-basic Promega 
phRL-TK Promega 
pASK-IBA43+ IBA 
pPR-IBA101 IBA 
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pFlag.cmv-1 Sigma 
pcDNA3.1+ Invitrogen 
pEGFP-N1 Dr. Wei Yang 
pAsRed2-L1 As above 
pCMV-CHOP Prof. Dr. Gerald Thiel, University of the Saarland Medical Center 
pCMV-flag-C2/CEBP As above 
pCMV-Flag-C/EBPN As above 
A-C/EBP As above 
SREBPIA Dr. Jianqiang Mao 
TRB As above 
2.2 Preparation of DNA 
2.2.1 Mini-preparation of plasmid DNA 
1) Inoculate 3 ml of LB medium containing appropriate antibiotics with a single bacterial 
colony. Incubate at 37 °C overnight with vigorous shaking. 
2) Harvest the bacterial cells from 1.5 ml of the overnight culture by centrifugation at 
13,000 rpm for 30 sec. Discard the supernatant. 
3) Resuspend the bacterial pellet in 100l of ice-cold Solution I. Incubate on ice for 5 min. 
4) Add 200l of freshly made Solution II, and mix by gently inverting the tube 6 times. Let 
stand on ice for 5 min. 
5) Add 150l of ice-cold Solution III and mix the contents by inverting the tube 6 times. 
Let stand on ice for 10 min. 
6) Centrifuge at 13,000 rpm for 5 min at room temperature. The cell DNA and bacterial 
debris should form a tight pellet on the bottom of the tube. 
7) Transfer 450l of the supernatant into a fresh tube.  
8) Add 450l of isopropanol to the tube. Mix well and let stand at room temperature for 15 
min. 
9) Recover the DNA by centrifugation at 13,000 rpm for 5 min at room temperature. 
10) Discard the supernatant. Wash the pellet with 70 % ethanol at room temperature. Discard 
as much ethanol as possible, and then dry the DNA pellet briefly in vacuum desiccator. 
11) Dissolve the DNA pellets in 40l of TE (pH8.0, containing 20g/ml RNase A) and store 
the DNA at –20°C. 
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Solution I 50 mM Glucose, 25 mM Tris-Cl pH8.0, 10 mM EDTA (autoclaved) 
Solution II 0.2 NaOH, 1 % SDS (Prepare and use freshly) 
Solution III 60 ml of 5 M KAC, 11.5 ml of HAC, 28.5 ml of H2O (autoclaved)  
TE 10 mM Tris-Cl pH8.0, 1 mM EDTA pH8.0 (autoclaved) 
2.2.2 Midi-preparation of plasmid DNA 
1) Harvest the bacterial cells from 50 ml of the overnight culture by centrifugation at 4000 
rpm for 10 min. Discard the supernatant. 
2) Resuspend the bacterial pellet in 10 ml of TE (10 mM Tris-HCl, 1 mM EDTA, pH 8.0). 
3) Collect the bacterial cells by centrifugation at 4000 rpm for 10 min. 
4) Resuspend the washed bacterial pellet (from step 3) in 2 ml of Solution I. Let stand on ice 
for 5 min. 
5) Add 4 ml of freshly made Solution II, and mix gently by inverting the tube 4-6 times. Let 
stand on ice for 5 min. 
6) Add 3 ml of Solution III, and mix the contents by inverting the tube for 6 times. Let stand 
on ice for 10 min. 
7) Centrifuge the bacterial lysate at 4000 rpm for 15 min at 4°C. 
8) Filter the supernatant through four layers of cheesecloth in a 50 ml centrifuge tube. Add 
0.6 volume of isopropanol, mix well and let stand at room temperature for 15 min. 
9) Recover the DNA by centrifugation at 4000 rpm for 15 min at room temperature. 
10) Decant the supernatant and rinse the pellet with 70 % ethanol. 
11) Air-dry the pellet and dissolve the DNA pellet in 1.4 ml TE (pH8.0). The nucleic acids 
are purified further by the following steps. 
12) Add 5l of RNase A (10 mg/ml) and 0.3l of RNase T1 (100 U/l), incubate for 5 min 
at 37°C.  
13) Add 2.5l of Proteinase K (20 mg/ml) and 1.88l of 20 % SDS, incubate for 30 min at 
37°C. 
14) Extract with 1.4 ml of phenol/chloroform/isoamylalcohol (25:24:1). 
15) Centrifuge at 13,000 rpm for 5 min at room temperature. 
16) Extract with 1.4 ml of chloroform/isoamylalcohol (24:1). 
17) Centrifuge at 13,000 rpm for 5 min at room temperature. 
18) Add one-tenth volume of 3 M NaOAC (pH 5.2) and 1 volume of isopropanol, mix well. 
19) Centrifuge at 13,000 rpm for 5 min. 
20) Wash the pellet with 70 % ethanol. Air-dry the pellet and dissolve the DNA in 200l of 
TE buffer (pH8.0). The purified DNA is ready for sequencing and transient transfection. 
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2.2.3 Preparation of genomic DNA 
1) One gram of tissue is ground into powder with or after freezing with liquid nitrogen in a 
motar. 
2) Add 250 mg of tissue powder into 3 ml of proteinase K buffer (containing 0.5 mg/ml 
proteinase K and 1 % SDS). 
3) Mix gently and incubate overnight at 56 °C. 
4) Cool down to room temperature, and add an equal volume of phenol into above solution. 
Mix gently by inverting the tube for 10 min. 
5) Remove the upper aqueous phase to a new tube. Add one-tenth volume of 3 M NaOAC 
(pH 5.2), mix and add 1 volume of isopropanol and mix gently but thoroughly. 
6) Centrifuge at 3000 g for 10 min at 4°C. 
7) Wash the DNA pellet once with 70 % ethanol. Remove as much of the 70% ethanol as 
possible, using an aspirator. Store the pellet of DNA in an open tube at room temperature 
until the last visible traces of ethanol have evaporated. Note: Do not allow the pellet of 
DNA to dry completely; desiccated DNA is very difficult to dissolve. 
8) Add appropriate amount of 1 mM Tris-HCl (pH 8.0). Place the tube on a rocking platform 
and gently rock the solution for 12-24 hours at 4°C until the DNA has completely 
dissolved. Store the DNA solution at 4°C. 
Buffer 150 mM EDTA, 50 mM Tris-HCl (pH 8.0), 100 mM NaCl 
Proteinase K solution Add the following sequentially: 400 ml of buffer, 6 mM DTT, 0.5 mg/ml proteinase K, 1 % SDS 
2.2.4 Preparation of BAC DNA 
1) Inoculate 10 ml of LB medium containing 125g/ml Chlorampenicol with a single 
bacterial colony. Incubate at 37 °C overnight with vigorous shaking. 
2) Inoculate 500 ml of LB medium containing 125g/ml Chlorampenicol appropriate 
antibiotics with 5 ml of the overnight culture. Incubate at 37 °C overnight with vigorous 
shaking. 
3) Harvest the bacterial cells by centrifugation at 6000 g for 15 min at 4 °C. Discard the 
supernatant. 
4) Homogeneously resuspend the bacterial pellet in 10 ml Buffer P1. 
5) Add 10 ml of Buffer P2, mix thoroughly by vigorously inverting 4-6 times, and incubate 
at room temperature for 5 min. 
6) Add 10 ml of Buffer P3, mix thoroughly by vigorously inverting 4-6 times, and let stand 
on ice for 20 min. 
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7) Centrifuge at 4000 rpm for 10 min at 4 °C and filter the supernatant.  
8) Equilibrate a QIAGEN-tip by applying 10 ml of Buffer QBT and allow column to empty 
by gravity flow. 
9) Apply the supernatant to the QIAGEN-tip and allow it to enter into the resin by gravity 
flow. 
10) Wash the QIAGEN-tip with 2×30 ml Buffer QC. Allow Buffer QC to move through the 
QIAGEN-tip by gravity flow. 
11) Elute DNA with 15 ml of Buffer QF pre-warmed to 65 °C into clean 50 ml vessel. 
12) Precipitate DNA by adding 10.5 ml of isopropanol to the eluted DNA. Centrifuge at 
15000 g for 30 min at 4 °C. Carefully decant the supernatant. 
13) Wash the DNA pellet with 5 ml of 70 % ethanol and centrifuge at 15,000 g for 10 min. 
Carefully discard the supernatant. 
14) Air-dry the pellet for 5-10 min and dissolve DNA in a suitable volume of H2O. 
Buffer P1 50 mM Tris-Cl, pH8.0; 10 mM EDTA, 100g/ml Rnase A 2-8 °C 
Buffer P2 0.2 M NaOH, 1 % SDS 15-25 °C 
Buffer P3 3.0 M KAC pH5.5 15-25 °C 
Buffer QBT 750 mM NaCl, 50 mM MOPS pH7.0, 15 % isopropanol, 0.15 % Triton x-100 15-25 °C
Buffer QC 1 M NaCl, 50 mM MOPS pH7.0, 15 % isopropanol 15-25 °C 
Buffer QF 1.25 M NaCl, 50 mM MOPS pH8.5, 15 % isopropanol 15-25 °C 
TE 10 mM Tris-Cl, pH8.0; 1 mM EDTA 
2.3 Preparation of RNA 
2.3.1 Preparation of RNA from cells and tissues 
1) a. Add 1 ml of TRIzol reagent to 100 mg of tissue and homogenize with Ultra-Turrax T25 
for 10 s. 
2) b. Aspirate the medium and then lyse cells directly in a culture dish by adding 1 ml of 
TRIzol reagent to a 3.5 cm diameter dish. Pipette the cell lysate up and down several 
times. 
3) Incubate the homogenized samples for 5 min at room temperature. 
4) Add 0.2 ml of chloroform per 1 ml of TRIzol reagent. Shake tubes vigorously for 15 s 
and incubate for 2-3 min at room temperature. 
5) Centrifuge at 11,500 rpm (Eppendorf 5417R) for 15 min at 4°C. 
6) Transfer the aqueous phase to a fresh tube. Precipitate the RNA from the aqueous phase 
by mixing with 1 volume of isopropanol. 
7) Incubate for 10 min at room temperature, and centrifuge at 11,500 rpm for 10 min at 4°C. 
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8) Discard the supernatant and wash the RNA pellet once with 70 % ethanol, adding 1 ml of 
70 % ethanol per 1 ml of TRIzol reagent used for the initial homogenization. 
9) Centrifuge at 11,500 rpm for 5 min at 4°C.  
10) Briefly air-dry the pellet and dissolve RNA in DEPC-treated water.  
11) Stored at -70 °C.  
2.3.2 Electrophoresis of RNA through agarose gels containing formaldehyde 
Separation of RNAs according to size is the first stage in quality analysis. The method 
described in this protocol uses formaldehyde to denature the RNA, ethidium bromide to stain 
it, and electrophoresis through agarose gels containing formamide to separate the resulting 
formaldehyde-RNA-ethidium adducts. 
1) Dissolve 0.72 g of agarose in 43.3 ml of DEPC-treated water.  
2) Cool to 70 °C, and add 10.7 ml of 37 % formaldehyde and 6 ml of 10× MOPS buffer. 
Mix thoroughly and pour onto gel apparatus.  
3) Add 1/5 volume of 5× RNA loading buffer to RNA sample, heat to 65°C for 5 min, and 
chill on ice.  
4) Load the sample onto the gel, and run at a voltage of 5 V/cm in 1× MOPS buffer.  
 
10× MOPS buffer  400 mM MOPS, 100 mM NaOAC, 10 mM EDTA  
RNA loading buffer  15 % Glycerin, 0.4 % Bromophenol blue, 0.4 % Xylencyanol, 1mM EDTA  
5× Loading buffer  10l Formamid, 3.5l Formaldehyde, 1l 10× MOPS buffer, 2l RNA loading buffer, 0.1l EtBr  
2.4 Cloning of DNA 
2.4.1 Digestion by restriction enzyme 
To construct a recombinant vector, 5-10g empty plasmid DNA is digested with 10 unit of 
restriction enzyme in a 100l digestion system. Incubate overnight at 37°C and analyze the 
digestion efficiency by agarose gel electrophoresis. To prepare the insertion DNA fragment, 
digest 500 ng-2g of the original DNA with 5 units of restriction enzyme depending on the 
length of the original material in 50l. For restriction enzyme analysis of the recombinant 
vector, 100 ng of plasmid DNA and 1 unit of restriction enzyme of each are enough for one 
digestion for a unique restriction site for 30-60 min at optimal temperature. If it is the 
insertion fragment that should be checked, 20 ng of the smallest band has to be visible. So the 
DNA amount used for digestion should be adjusted accordingly. 
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2.4.2 Detection of DNA in Agarose Gels 
These sites of DNA fragment that were assessed by comparing the residual restriction enzyme 
digests towards either of two `DNA ladders´ (Table 4).  
Table 4 DNA molecular weight ladder 
DNA/HindIII (bp) pBR328/HinfI+../BglI (bp) 
23,130 2,176 
9,416 1,766 
6,682 1,230 
4,361 1,033 
2,322 653 
2,027 517 
564 453 
 394 
 298 
 234 
 220 
 154 
2.4.3 Purification of DNA fragment from gel 
Load the PCR reaction mixture of RE digestion mixture on a 0.8-2 % agarose gel using 1× 
TBE as running buffer. Run gel until the DNA band of interest could be separated from 
adjacent contaminating fragments. Purify the excised gel according to the manufacturers’ 
protocol. Add appropriate amount of elution buffer to the upper reservoir of the filter tube. 
Centrifuge for 1 min at maximum speed then store the eluted DNA at +2 to +8°C for short 
time or -20°C for later analysis. 
2.4.4 Blunting with Klenow enzyme 
DNA Polymerase I Large (Klenow) Fragment consists of a single polypeptide chain (68 kDa) 
that lacks the 5´3´ exonuclease activity of intact E. coli DNA polymerase I but retains its 
5´3´ polymerase, 3´5´ exonuclease and strand displacement activities. The 5´3´ 
polymerase activity of the Klenow Fragment can be used to fill in 5´-protruding ends with 
dNTPs; The 3´5´ exonuclease activity can be used to generate blunt ends from a 3´-overhang.  
DNA fragment x l
10× Klenow buffer 5 l 
Klenow enzyme (5 U/l) 0.5 l
dNTPs (10 mM each) 1 l
Add water to total volume 50 l
Incubate the reaction for 30 min at 37 °C, then stop the reaction by heating the mixture for 10 
min at 75°C. 
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2.4.5 Ligation 
For the highest ligation efficiency, the molar ratio of vector: insertion should be optimized. In 
most cases, a 1:3 molar ratio works well. Set up the following reaction.  
Insertion DNA fragment x l
Vector DNA fragment yl 
2× ligation buffer 5 l 
T4 DNA ligase (1 U/l)  0.5 l
Add water to total volume 10 l
Incubate the reaction for 1-2 h at room temperature or overnight at 4 °C. Following the 
ligation reaction, transform the ligated DNA into competent cells.  
2.4.6 Transformation of DNA into E. coli 
Preparation of competent E. coli cells and transformation are performed as described 
(Sambrook et al., 1989). 
Preparation of competent cells 
1) Plate E. coli XL1-1 blue on Tetracycline plate (LB+15g/ml Tet). 
2) Inoculate 3 colonies into 5 ml of SOB-medium, grow overnight at 37 °C. 
3) In the morning, inoculate 5 ml hereof into 50 ml (at 1:10) of PSI medium in 1 L flask. 
4) Grow until OD600=0.45-0.55 (need 2 h). 
5) Transfer into a 50 ml Falcon tube, and let stand on ice for 15 min. 
6) Spin down for 15 min at 3000 rpm. Discard the supernatant and invert. Dry with paper 
towel. 
7) Carefully resuspend in 15 ml of RF1 medium (ice cold), and let stand on ice for 10 min. 
8) Spin down for 15 min at 3000 rpm, remove supernatant, invert dry with paper towel. 
9) Resuspend pellet in 4 ml of RF2 medium (ice cold). Let stand on ice for 15 min. 
10) Snap freeze 80 l (or 40 l) aliquots in liquid N2. 
11) Store at -70 °C. 
SOB-Medium 2 % Bacto-tryton, 0.5 % Bacto-yeast extract, 20 mM of NaCl, 2.5 mM KCl, 10 mM MgSO4, 10 mM MgCl 
PSI-Medium 2 % Bacto-tryton, 0.5 % Bacto-yeast extract, 10 mM of NaCl, 5 mM KCl, 20 mM MgSO4 
RF1  100 mM RbCl, 50 mM MnCl2, 30 mM KAC pH7.5, 15 % Glycerol. adjust pH value to 5.8, sterile by filtration.  
RF2 100 mM MOPS (pH 6.8), 10 mM RbCl, 75 mM CaCl2, 15 % Glycerol. pH 6.8 adjusted by NaOH, sterile by filtration. 
 
Transformation 
12) Add ligated DNA into the tube containing 40 l of competent cells. Mix the contents of 
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the tubes by swirling gently. Let to stand on ice for 30 min. 
13) Incubate the tube at 42 °C in a water bath for 90 s.  
14) Chill the tubes on ice for 1-2 min. Add 0.4 ml of LB medium to each tube. Incubate the 
culture at 37 °C for 45 min with gentle shaking.  
15) Transfer the appropriate volume of transformed competent cells onto LB/X-gal/Amp 
plates.  
16) Leave the plates at room temperature until the liquid has been absorbed. Invert the plates 
and incubate overnight at 37 °C.  
2.4.7 Screening of the recombinant clones  
-complementation  
-complementation occurs when two inactive fragments of E. coli -galactosidase associate 
to form a functional enzyme. Many plasmid vectors such as pGEM-T easy and -T vector carry 
a short segment of DNA containing the coding information for the first 146 amino acids of 
-galactosidase. Vectors of this type are used in host cells that express the carboxy-terminal 
portion of the enzyme. Although neither the host nor the plasmid-encoded fragments of 
-galactosidase are themselves active, they can associate to form an enzymatically active 
protein. Lac+ bacteria that result from -complementation are easily recognized because they 
form blue colonies in the presence of the chromogenic substrate X-gal. However, insertion of 
a fragment of foreign DNA into the polycloning site of the plasmid almost invariably results 
in production of an aminoterminal fragment that is no longer capable of -complementation. 
Bacteria carrying recombinant plasmids therefore form white colonies. 
Normally, 20 mg of X-gal and 40 l of IPTG are added into 500 ml of LB medium with agar. 
Substitutively, 40l of 40 mg/ml X-gal and 7l of 0.5 M IPTG were added to 100-200l 
transformed cells for one plate. Plate on LB agar and incubate overnight under 37°C.  
Fast extraction  
In order to quickly identify the positives transformants with about 1 kb insertion in 3-5 kb 
vector, fast extraction is used to screen the correct transformants. The bacteria cells were 
lysed with phenol, and at the same time RNA was decomposed by adding Rnase A. Plasmid 
DNA can be visualized by EB staining on an agarose gel.  
1) Inoculate 3 ml LB medium containing appropriate antibiotics with a single bacterial 
colony. Incubate at 37 °C overnight with vigorous shaking. 
2) Transfer 100-500l of overnight bacterial cultural cells into a 1.5 ml of centrifuge tube.  
3) Spin down for 30 s at max speed. 
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4) Discard the supernatant and add 50l of TE buffer, 50l of phenol into the pellet. Add 
2l of Rnase A and 2l of 10× DNA loading buffer in the cover of 1.5 ml centrifuge 
tube.  
5) Vortex well. Gently spin down the Rnase A and add 10× loading buffer into the tube 
bottom and mix well. Spin down for 6 min at maximal speed at room temperature.  
6) Load 5-10l of supernatant onto agarose gel. 
Colony PCR 
1) Inoculate 3 ml LB medium containing appropriate antibiotics with a single bacterial 
colony. Incubate at 37 °C overnight with vigorous shaking. 
2) Transfer 50l of overnight bacterial culture and spin for 30 s at max speed to collect the 
cell pellet. Discard the supernatant.  
3) Add 50l of water into the pellet. Boil for 5 min. 
4) Spin at max speed for 5 min. 1l of the supernatant will be used as template for normal 
PCR. 
Sequencing 
250 ng of DNA in 8l of water is necessary for the construct of pGEM-T easy or pGEM-T 
vector series. T7 and SP6 primers are used for sequencing. For others constructs, specific 
primers from our lab are used for sequencing. The primers for different vectors are listed in 
Table 5. 
Table 5 Sequencing primers used in this study 
vectors Sequencing primers 
pGEM-T easy  
(or T vecter) SP6 T7 
pGL3 basic BASENDf (S92) 5_Lucr (S72) 
pAskIBA43+ pAIBA3f (S497) IBA_r (S1576) 
pFlag.cmv-1 pFLAG-f (S1221)  
pcDNA3.1 pcDNA3.1_f (S1557) pcDNA3.1_r (S1558) 
2.5 Polymerase Chain Reaction (PCR) 
Polymerase chain reaction (PCR) is a common and indispensable technique in molecular 
research. In principle, PCR has three reactions: denaturation, annealing and chain extentions. 
The detailed procedure is adjusted for various requirements such as Touch-Down, 
high-fidelity and GC-rich templates.  
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2.5.1 Primer design 
Basically, the primers are designed by Primer Premier 5.0 (PremierBiosoft). And make the 
annealing temperature about 64-66 °C resulting in real annealing temperature will be 60 °C. 
The Tm of oligonucleotides is calculated according to the following formula (Thein et al., 
1986): Tm=2°C × (A+T) + 4°C × (G+C).  
2.5.2 Standard PCR 
All the PCR reactions are carried out in 0.5 ml PCR tubes. The thermocycler is a 
trio-thermoblock (Biometra). High quality water is always used for all the PCR applications. 
For normal PCR, FastStart Taq DNA polymerase is used. The specific polymerase for specific 
PCR is desribed in the following section. Generally for subcloning, the reaction is prepared in 
a total 50 l volume as the following: 
1 water 42 l 
2 10 × incubation buffer 5l  
3 dNTPs (10 mM each) 1 l  
4 Forward primer (50 M) 0.5 l 
5 Reverse primer (50 M) 0.5 l 
6 Template (10-40 ng of DNA) 1 l 
7 Taq DNA polymerase 0.1 l 
Total volume 50  l  
 
Place the tubes in the thermocycler and start cycling immediately using the following 
Touchdown program (Don et al., 1991): 
 Temperature Time Cycles 
Initial denaturation 95°C  3 min 1 
Denaturation 95°C  30 sec 
Annealing 70°C (-1°C per cycle) 30 sec 
Elongation 72°C 1-3 min 
10 
Denaturation 95°C  30 sec 
Annealing 60°C 30 sec 
Elongation 72°C 1-3 min 
30-35 
Final elongation 72°C 7 min 1 
2.5.3 High-fidelity PCR 
For cloning of protein expression and point mutation, Expand High-Fidelity PCR System kit 
(Roche) is used for PCR. Due to the inherent 3´-5´- exonuclease or “proofreading” activity 
of Taq DNA polymerase, the fidelity of DNA synthesis with this is higher than that of the 
normal Taq DNA polymerase. Usually, prepare two reaction mixes in microfuge tubes on ice: 
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Mix1 Mix2 
PCR grade water xl PCR grade water 19.25l 
dNTPs 1l 5× buffer vial 2 5l 
Primer1 0.3l Enzyme system 0.75l 
Pimer2 0.3l   
DNA template xl  
Total volume 35l Total volume 25l 
 
Combine Mix 1 and Mix 2 in a PCR tube, and mix. Place samples in the preheated 
thermocycler, and start cycling using Touch-Down program. 
2.5.4 GC-rich PCR 
Amplification of GC-rich nucleic acids as well as uniform amplification of a mixture of 
DNAs with varying GC content is still problematic. Several reagents have been used to 
disrupt base pairing of isostabilize DNA like DMSO, formamide, glycerol, TMAC, Betaine 
and 7-deaza dGTP. The GC-RICH PCR System (Roche) is composed of a unique enzyme 
blend of thermostable enzyme with a proofreading activity. This polymerase mixture by itself 
outperforms Taq DNA polymerase in respect to yields, fidelity and specificity beside the 
possibility to amplify fragments up to 5 kb in length. The GC-RICH reaction buffer in 
combination with the separately included GC-RICH solution allows one to amplify very 
efficiently difficult templates such as GC-rich targets. The GC-solution works perfectly 
together with adjusting DMSO to amplify high GC content DNA target. 
Mix1 Mix2 
PCR grade water 22.5l PCR grade water 4.5l 
dNTPs 0.5l 5× buffer vial 2 10l 
Primer1 0.5l Enzyme system 0.5l 
Primer2 0.5l   
DNA template 0.5l  
GC-RICH solution vial3 5l  
DMSO 100% 5l  
Total volume 35l Total volume 15l 
 
Pipette together on ice Mix1 and Mix2 in a thin-walled PCR tube and mix well by pipetting 
up and down. Run Touch-Down program. 
2.5.5 Reverse transcription PCR (RT-PCR) 
First-Strand cDNA is synthesized using SuperScript II (Invitrogen). The following 20l 
reaction volume can be used for 10 pg-5g of total RNA or 10 pg-500 ng of mRNA. 
1) Add the following components to a nuclease-free microcentrifuge tube: 1l of oligo 
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(dT)20 (50M); or 200-500 ng of oligo(dT)12-18; or 50-250 ng of random primers; or 2 
pmol of gene-specific primer and 5g of total RNA and 1l 10 mM dNTP Mix (10 mM 
each), add distilled water to 13l. 
2) Heat mixture to 65°C for 5 min, and incubate on ice for at least 1 min. Collect the 
contents of the tube by brief centrifugation and add 4l of 5× First-Strand Buffer, 1l of 
0.1 M DTT, 1l of RNaseOUT and 1l of SuperScript II RT (200 U/l).  
   Note: When using less than 50 ng of starting RNA, the addition of RNaseOUT is 
essential. 
3) Mix by pipetting gently up and down. If using random primers, incubate tube at 25°C for 
5 min. Incubate at 42°C for 30-60 min. Increase the reaction temperature to 42°C for 
gene-specific primer. The reaction temperature may also be increased to 55°C for difficult 
templates or templates with high secondary structure. 
4) Inactivate the reaction by heating at 70°C for 15 min. 
Note: Amplification of some PCR targets (those >1 kb) may require the removal of RNA 
complementary to the cDNA. To remove RNA complementary to the cDNA, add 1l (2 U) of 
E. coli RNase H and incubate at 37°C for 20 min. 
5) The cDNA is purified with High PCR Pure Kit and eluted with 50 l of water. 
Subsequent PCR amplification is performed using this purified cDNA as the template to 
obtain the specific gene sequence.  
2.5.6 Rapid amplification of cDNA ends (RACE) 
The GeneRacer™ (Invitrogen) method is based on RNA ligase-mediated and oligo-capping 
rapid amplification of cDNA ends (RACE) methods, and results in the selective ligation of an 
RNA oligonucleotide to the 5?-ends of decapped mRNA using T4 RNA ligase. The kit 
ensures the amplification of only full-length transcripts via elimination of truncated messages 
from the amplification process. The truncated mRNA and non-mRNA is eliminated by 
dephosporylation with calf intestinal phosphatase (CIP) to remove the 5´phosphates. Hence 
these RNA can not be ligated with RNA oligo. Whereas, the full-length RNA only can be 
ligated after decapping with tobacco acid pyrophosphatase (TAP) to remove the 5´cap 
structure from them. This treatment leaves a 5´phosphate required for ligation to the 
GeneRacer? RNA Oligo.Upstream primers are derived from the RNA oligonucleotide and the 
downstream primers are devised based on the target sequence for 5´RACE.  
For amplification of 3´ RACE, the first-strand cDNA is reversely transcribed with GeneRacer
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?. The upstream primers are derived from the target sequence, but the downstream primers are 
designed to the Oligo (dT)18 primer. Using nested PCR, specific and productive target 
sequence can be amplified.  
2.5.7 Genomic Walking 
GenomeWalker System (Clontech) is a PCR based method that facilitates cloning of unknown 
genomic regions upstream or downstream from a known DNA sequence. The first step is to 
construct genome Walker “libraries” – separate aliquots of DNA are digested to complete with 
different restriction enzymes (DraI, EcoRV, PvuII, ScaI and StuI) that leave blunt ends and 
then are ligated to the Genome Walker Adaptor. Two steps of PCR are used to amplify the 
DNA sequence of interest; the first or primary PCR uses the outer adaptor primer (AP1) and 
an outer gene-specific primer1 (GSP1). The primary PCR mixture is then diluted and used as 
a template for a second or “nested” PCR with the nested adaptor primer (AP2) and a nested, 
more 5´ located the GSP1, gene-specific primer2  (GSP2). The amplified product can then 
be cloned and further analyzed. The following procedure has been used for amplification of 
DNA sequence from BAC DNA.  
1) Digestion of BAC DNA: Set up five blunt-end digestions. For each reaction, combine the 
following in a separate 0.5 ml tube and then incubate at 37°C for 3 h.  
2l BAC DNA (50 ng/l) 
0.2l Restriction enzyme (10 U/l) 
1.0l 10 × RE buffer 
6.8l H2O 
10l Total volume 
2) Purification of digested DNA: Add 90l water to each reaction tube, and extract with 
100l of phenol, and then 100l of chloroform. Precipitate with isopropanol and 
dissolve the DNA pellet in 10l of water. 
3) Ligation of digested Genomic DNA to Genome Walker Adaptors: For each library 
construction, set up a total of five ligation reactions. From each tube, transfer 4l of 
digested, purified DNA to a fresh 0.5 ml tube. To each, add the following. Incubate 
overnight at 4 °C. To stop the reactions, incubate at 70 °C for 5 min. To each tube add 
72l of H2O. 
1.9l Genome Walker Adaptor (25M) 
1.6l 5× ligation buffer 
0.5l T4 DNA ligase (1U/l ) 
4) Procedure for PCR-based DNA walking in Genome Walker Libraries: Expand TM Long 
Template PCR System (Boehringer Mannheim) has been chosen for the amplification of 
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appropriate PCR product from the Genome Walker libraries. For primary PCR (primer: 
AP1/GSP1), use 1l of each library. The reaction is prepared and carried out as the 
following.  
Master Mix 1 (25l ) Master Mix 2 (25l ) 
H2O 20.25l H2O 19.25l 
dNTPs  
(10 mM each) 1.75l 
Expand PCR buffer 
 (10×, 17.5 mM MgCl2) 
5l 
AP1 1l Enzyme Mix (3.5 U/l) 0.75l  
GSP1 1l   
DNA library  1l   
 
5) If there are any bands or smearing obtained, continue the secondary PCR (primer: 
AP2/GSP2) with Touch-Down program, using 1l of a 50-fold dilution of the primary 
PCR products as the primary PCR. 
2.5.8 PCR- mediated site-directed mutagenesis 
Site-directed mutagenesis is produced by Fusion PCR which named also overlapping PCR. 
Generally, three steps of PCR are performed to introduce a point mutation, or to delete or to 
insert a short DNA fragment in the target region by overlapping PCR fragment. Due to that 
the PCR product can be checked in each step ensuring that, this technique is safe and quick to 
mutate (including point mutation, deletion and insertion) a target sequence by normal PCR. 
The first step is to design suitable primers, especially the mutation primer pairs, insuring 
enough overlapping temperature. In the following example, four nucleotides GCAA will be 
mutated into TAGT (relative to the forward sequence) by fusion PCR. P1 and P2 primer pairs 
are derived based on the vector; P3 and P4 primer pairs are devised for mutation. P3 and P4 
primer pairs are overlapped (18 bp) and the mutation sequences are included. Three PCR 
reactions are performed to result in the final mutation sequence. The procedure is described in 
the following:  
mut P4
mut P3
P1
P2
GTGTCATTAGTGAGGCAGCCAAGTTTTGG
Template AAGATACTGGAGGTGTCATGCAAGAGGCAGCCAAGTTTTGGTGTTCTATGACCTCCACAGTACGTTCTCCGTCGGTTCAAAACCAC
TCTATGACCTCCACAGTAATCACTCCGTC 
 
1) Amplify with the template and P1 and P3 primers to obtain product 1. Amplify with P2 
and P4 to retrieve product 2. These two reactions can be completed in the same PCR 
program but in different vials. The standard Touch-Down PCR program, and purify 
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product 1 and product 2 with Kit. 
2) Mix equal molar of Prod1 and Prod2 in PCR system, and run the same PCR program for 
only 5 cycles.  
3) After the additional extension time is over, complement the reaction with P1, P2 and run 
another 30 cycles.  
4) The aim product (Prod3) can be detected by agarose gel electrophoresis.  
5) Excise the aim band and clean with kit, and the product can be cloned into pGEM-T easy 
vector or digested for ligation if enough products were obtained.  
2.5.9 Quantitative Real-Time PCR 
Real-Time PCR is a rapid and sensitive way to measure the transcription level of genes. In 
this study all real-time PCRs were carried out with LighterCycler system (Roche). SYBR
 
Green® I Dye is used in real-time PCR because it can bind to the dsDNA and emit fluorescent 
signal. This signal is captured by the combined microvolume fluorimeter and analyzed by 
computer. The cycle number is defined as Cot in which the fluorescence signal exceeds 
certain threshold intensity. The melting curve analysis of the PCR products is performed to 
evaluate the specificity of the PCR products.  
In this study, 1-5g of total RNA is first primed in reverse with oligo (dT)20 and a gene 
specific primer. Normally, -actin is used to normalize transcription data. After the 
first-strand synthesis, products are purified with the High Pure PCR Product Purification Kit. 
Real-time PCR are carried out with the LightCycler FastStart DNA Master SYBR Green I Kit, 
which includes the fluorescent dye and the reagents for PCR. A dilution series (101-106
 
copies) 
of appropriate cDNA subclones are included in each run and serve to calculate the copy 
numbers of transcripts.  
Normal reactions are carried out in 10l. The reaction containes 5l of DNA template, 2.6l 
of water, 0.2l of forward primer (25M), 0.2l of reverse primer (25M) and 2l of 
master (prepared by adding 14l of tube a into one tube of b). For GC-rich gene transcripts, 
the reaction system is composed of 3l of template, 2.6l of water, 0.2l of forward primer 
(25M), 0.2l of reverse primer (25M), 1l of 5× GC-solution (Roche), 1l of 100 % 
DMSO and 2l of master. The basic amplification profile is as desribed: 
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 Temperature: °C Time Slope: °C/s Cycles 
Pre-incubation 95 10 min 20 1 
95 15 s 20 
60 5 s 20 
72 20 s 20 Amplification 
85 5 s 20 
40 
95 0 s 20 
65 15 s 20 Melting 
95 0s 0.1 
1 
Cooling 40 60 20 1 
2.6 Cell culture and transfection 
2.6.1 Cell line 
The cell line and relevant cell media used in the study are as described:  
 Cell line Growth Medium 
HC11 murine mammary epithelial cell 
RPMI1640 supplemented with 10 % FCS, 5g/ml insulin, 1 ng/ml 
murine epidermal growth factor (EGF), and 50g/ml gentamicin 
HEK293 human embryonic kidney cell 
DMEM supplemented with 10 % FCS, 1 mM sodium-pyruvate and 
50g/ml gentamicin 
HepG2 human hepatocellular liver carcinoma cell 
Minimum essential medium (Eagle) with 2 mM L-glutamine and 
Earle's BSS adjusted to contain 1.5 g/l sodium bicarbonate, 0.1 mM 
non-essential amino acids, and 1.0 mM sodium pyruvate, 90 %; FCS, 
10 %  
pbMEC 
primary bovine 
mammary epithelial 
cells 
RPMI1640 supplemented with 0.1 mM L-methionine, 0.4 mM 
L-lysine, 0.01 mM sodium pyruvate, 10 % FCS, and the hormones 
prolactin, hydrocortisone, and insulin all at 1g/ml. pbMEC cells were 
always cultured in the dishes coated with Collagen R (Serva) 
3T3-L1 murine 3T3-L1 pre-adipocyte cell line 
Growth medium: DMEM with 4 mM L-glutamine adjusted to contain 
1.5 g/L sodium bicarbonate, 10 % FCS 
2.6.2 Transient transfection 
1) The day before transfection, seed ~3×105 cells in growth medium without antibiotics to 
result in 60-80 % confluence in the next day for transfection. Change cell numbers and 
total DNA amount proportionally according to Table 6 for different cell plate.  
Table 6 Growth area of culture plates 
Culture vessel Growth Area (cm2) Relative Area (fold) 
96-well 0.32 0.2 
24-well 1.88 1 
12-well 3.83 2 
6-well 9.4 5 
35 mm 8.0 4.2 
60 mm 21 11 
100 mm 55 29 
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2) Prepare DNA in 100l of serum-free medium (RPMI or DMEM). For transfection with 
Fugene6, add 3l of Fugene6 reagents into the DNA tube. Gently mix and collect the 
reagent mix to the bottom by short time spinning. Incubate for 20 min at room 
temperature and add into the 6-well-plate. For transfection with lipofactamine, prepare 
lipofactamine in 100l of medium (serum-free) and incubate for 5 min at room 
temperature.  
3) Add lipofactamine-medium mix into the diluted DNA tube and incubate for 20 min at 
room temperature, and add into the 6-well-plate with optimal confluent growing cells. 
4) 24 h later after transfection, split the cells into 3 wells of 24-well-plate and continue to 
incubate for another 24 h.  
5) 48 h later after transfection, the reporter gene activity is assayed with Dual-Luciferase® 
Reporter Assay system (Promega). 
2.6.3 Luciferase activity assays 
The Dual-Luciferase® Reporter Assay system (Promega) is used to assay the activities of 
firefly and renilla luciferases sequentially in the same assay tube. The former activity is 
measured first by adding 100l of luciferase assay reagent II to generate a stabilized signal. 
Their activities are quenched by adding 100l of Stop & Glo® Reagent (0.25× SG), and the 
renilla activities are measured simultaneously. 
 Water Original reagent Substrate 
0.25× LARII 3 ml LAR: 1 ml  
0.25× SG 3 ml SG buffer: 1 ml 16.6l 
2.7  Preparation and purification of antigen and antibodies  
The molecular weight of native ACC- is about 265 kDa or 259 kDa. ACC- has conserved 
domains such as ATP binding domain, Biotin binding domain and acyl-CoA binding domain 
(Figure 2). The technique to raise antibodies relied on the full-length purified ACC will be 
laborious and non-specific. In order to handle easily to raise anti-bovine ACC-, the 
recombinant strategy is performed in the study. I truncate and recombinantly express the 
specific N-terminus bovine ACC- with His-tag at the N-terminus in E.coli. Subsequently, the 
recombinant ACC-is purified by Ni-NTA sepharose for antigen. 
2.7.1 Protein expression and preparation (for inclusion bodies) 
1) Inoculate 5 ml of LB medium containing 100g/ml ampicillin with a fresh colony 
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harboring the expression plasmid. Incubate overnight at 37°C with vigorous shaking. 
2) Inoculate 250 ml of LB medium containing 150g/ml ampicillin with 5 ml of the 
overnight culture. Incubate for 3~4 h at 37°C in a shaking incubator until the cells reach 
mid-log growth (A550=0.45-0.55). 
3) Transfer 1 ml of the un-induced culture to a tube, which acts as a negative control in 
future analysis. 
4) Induce the remained culture by adding 25l of 2 mg/ml anhydrotetracycline (AHT) 
solution and continue incubation at 37°C for 3~5 h.  
5) Harvest the cells by centrifugation at 6500 rpm (rotor JA20) for 15 min at 4 °C. 
6) Wash the cell pellet with 20 ml of 1× His-Buffer. 
7) Resuspend the pellet in 10 ml of Equilibration Buffer (8 M urea is for solublization of 
inclusion body) and sonicate for 5 min in 15 ml centrifuge tube on ice-cold water bath. 
8) Centrifuge at 3750 rpm for 15 min at 4°C and collect the supernatant. 
1×His-Buffer 50 mM sodium phosphate, pH 8.0, 0.3 M sodium chloride 
Equilibration Buffer 0.1 M sodium phosphate pH 8.0, 8 M urea; 
 
2.7.2 Affinity purification via Ni-NTA sepharose 
Ni-NTA sepharose provides a powerful and versatile technique for isolating recombinant, 
6×His-tagged proteins. Protein purification is based on the high affinity and specificity of 
unique Ni-NTA (nickel-nitrilotriacetic acid) resin for proteins with a 6×His tag. The 
interaction between the metal ion and target His-tagged proteins is steady in denaturing 
conditions (8 M urea, pH8.0), but is decreased by the decreasing of pH value. Hence, His-tag 
affinity purification provides an efficient and specific purification for recombinant inclusion 
bodies. The procedures are as follows: 
1) Prepare 1 ml (1×) of Ni-NTA affinity column and equilibrate with 5× Equilibration buffer. 
2) Load clear supernatant sample onto the column, wash with 3× Equilibration buffer. 
3) Wash with 3× volume of Wash buffer. 
4) Elute the target proteins with 3× volume of Elution buffer.  
5) Dialyze against water and condensed against PEG20000. 
6) Collect the dialyzed inclusion body (target protein) by centrifugation and dissolve in 
appropriated buffer. 
Equilibration buffer 0.1 M sodium phosphate pH8.0, 8 M urea; 
Wash buffer 0.1 M sodium phosphate pH6.3, 8 M urea; 
Elution buffer 0.1 M sodium phosphate, pH 4.5, 8 M urea; 
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2.7.3 Measurement of protein concentration 
Bradford method is used to measure protein concentration in the research. 1-20l of serial 
dilutions of BSA is used as standard proteins. Assay reagent is diluted by mixing 0.2 ml of 
Bio-Rad protein reagent with 0.8 ml of water. The protein is added into the diluted Assay 
reagent. A595 is measured after 5 min. The absorption of the standard protein is used to 
calculate the protein concentration of the sample. 
2.7.4 SDS-PAGE electrophoresis 
1) Recipe of the separating gel and the stacking gel. 
 10 % Separating gel 5 % Stacking gel 
H2O 3.5 ml 2.2 ml 
40 % Acrylamide 2.5 ml 0.5 ml 
2 % N,N’-methylene-bis-acrylamide 1.4 ml 0.27 ml 
1.5 M Tris  2.5 ml (pH8.8) 1 ml (pH 6.8) 
20 % SDS 50l 20l 
20 % APS (ammonium persulfate) 50l 20l 
TEMED 8l 4l 
Total volume 10 ml 4 ml 
2) Assemble the electrophoresis device Mini-PROTEAN 3 cell (Bio-Rad). Pipette 3.3 ml of 
the separating gel, and seal immediately with H2O. After the polymerization is completed, 
discard the overlay water and add the stacking gel, and then insert a comb.  
3) Prepare samples using 2× Loading buffer. Heat to 95 °C for 5 min to denature the 
proteins. 
4) Loading up to 20l each of the samples into the wells. Run the gel at a voltage of 80 V 
for 10 min in the Running buffer, and followed at 200 V for 35 min.  
5) For Laemmli gel, submerge the gel in staining buffer for 20 min with gentle shaking. 
Wash the gel with H2O and incubate the gel in Destaining buffer for 1-4 h or overnight 
with gentle shaking. To make a permanent record, dry the gel in gel drier machine at 75 
°C for 45 min. 
10× Running buffer 25 mM Tris base, 250 mM Glycine, 0.1 % SDS (Tris: 32g; Glycine: 188g; SDS: 10g; total=1L) 
2× Loading buffer 100 mM Tris-Cl pH6.8, 4 % SDS, 0.2 % bromophenol blue, 20 % glycerol, 5 % 2-mercaptoethanol 
Staining buffer 40 % Methanol, 10 % Galcial acetic acid, 0.1 % Coomassie brilliant bule R-250 
Destaining buffer 10 % Methanol, 7 % Galcial acetic acid 
2.7.5 Antigen preparation 
The purified protein is then coupled with the fluorogenic reagent Dansyl chloride, which 
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emits green light after activation by UV. This facilitates the purification of the antigen from 
SDS-PAGE gels (without previous staining) which always includes denaturation. This in turn 
hinders subsequent elution of proteins. 
1) Concentrate the purified protein to 2 ml by dialyzing against PEG20000. Measure the 
final concentration and determine the protein contents. Aliquot 100g of concentrated 
protein to be dansylated. 
2) Precipitate the 100g of protein by adding 3× volume of ice-cold acetone. Incubate for 
30 min at -20 °C, and centrifuge at 14000 rpm for 15 min at 4 °C. 
3) Dry the pellet and dissolve in 100l of 2 % SDS solution. 
4) Add 25l of Dansylation buffer and 2l of 10 % DANSYL chloride in acetone. Mix 
vigorously.  
5) Boil for 3 min, and then add 1l of 2-mercaptoethanol and boil for another 1 min. 
6) Separate unreacted products via the sephadex G-25 column equilibrated with 
Tris-Glycine buffer by collecting the fast fraction (orange fluorescence). 
7) Unit the dansylated protein solution with the residual sample (from Step 1), and add 
2–mercaptoethanl to 2.5 %. Boil for 3 min. 
8) Dialyze against Tris-Glycine buffer for 3 h. 
9) Add 1 volume of 2× protein Loading buffer, mix and boil for 3 min. 
10) Separate the samples on SDS-PAGE gel. Check the green fluorescence bands with UV 
light and excise the desired band as the antigen. Store at -20 °C for future use. 
Dansylation buffer 0.4 M Na2HPO4 pH8.2, 10 % SDS 
Tris-Glycine buffer 2 ml of 5× SDS-running buffer, 0.5 ml of 20 % SDS, 97.5 ml H2O 
2.7.6 Immunization 
1) Prior to injection, pre-bleed the rabbit in order to get a pre-immunization control serum. 
2) Crunch the gel slice containing 100-200g of antigen by pressing it through 2 syringe 
several times. For the first injection, mix the crunched antigen with complete Freund’s 
adjuvant, while for boost injection, mix antigen with incomplete Freund’s adjuvant.  
3) Two muscular injections on the thigh were done every 4 weeks. 
4) Bleed 7-10 days after the third injection, and then bleed every 7-10 days after each boost 
injection for three times. Each time collect 20-40 ml of blood form one rabbit, 50-100 ml 
from one goat. 
5) Place the collected blood at 4 °C overnight to clot. Clean the supernatant (serum) by 
centrifugation at 300 g for 10 min. 
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6) Incubation at 56 °C for 30 min to inactivate complement. Store at -20 °C for future 
purification.  
2.7.7 Antibody purification 
General procedures: Follow Pharmacia booklet ´Affinity Chromatograph´ about CN-Br 
activated Sepharose. 
Preparations of antigen  
1) Dissolve ~40 mg of crude extract (containing >10 % of desired protein; eventually 
pre-extract with ~4 M urea) in ~3 ml of 2 % SDS in 1/10 coupling buffer. 
2) Press through syringe (yellow needle) several times to completely resuspend the pellet. 
3) Heat to 100 °C for 3 min. 
4) Spin at 13 000 rpm (Epp Centrifuge) to remove clear supernatant.  
5) Salt up by adding 300l of 5M NaCl and 300l of 1 M NaHCO3. 
6) Fill up the final volume to 8 ml with coupling buffer. 
7) This will be the ligand for next step. 
Coupling the ligand to CN-Br activated Sepharose 
1) Take 1 g of CN-Br activated Sepharose powder (yields 3 ml of swollen gel). 
2) Wash and re-swell on a sintered glass filter; take 200 ml ice-cold (!) 1 mM HCl, apply in 
several aliquots, resuspend on filter and suck off (take ~15 min minutes). This is the 
ready activated Sepharose gel.  
3) Mix ligand immediately with activated gel, swirl slowly for 1 h in an Erlemeyer flask at 
room temperature. 
4) Wash away excess ligand with coupling buffer. 
5) Block unreacted groups for 1 h at room temperature with 0.1M Tris pH 8.0. 
6) Wash with 5 fold volume of 1 % triton X-100, 8 M urea and 2 % SDS and water 
sequentially. 
7) Wash again with coupling buffer followed by 0.1M HAC pH 4, 0.5 M NaCl and binding 
buffer. 
Purification of polyclonal antibodies 
1) Pour column and store in binding buffer (may wish to add NaAzide: Na3N3). 
2) Load clear serum supernatant into the column. 
3) After the serum is loaded, wash the medium with binding buffer until the base line is 
stable.  
4) Subsequently the specific antibody is eluted off using 8 ml of Elution buffer from affinity 
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column into 2 ml of Neutralization buffer.  
5) Dialyze the eluted antibody solution against 3×500 ml of 1× PBS for 48h. Concentrate 
the antibody by dialyzing against PEG 20000. After determining the concentrations of the 
affinity purified antibody (usually the final concentration is 1~2g/l), store aliquots at 
–20°C.  
Binding buffer Tris buffer (0.05 M Tris pH 7.8, 0.15 M NaCl, 0.1 % NaAzid) 
Elution buffer 1 M Propionic acid (pH 2.3)  
Neutralisation buffer 1 M Tris (unbuffered = pH 11.2) 
2.8 Immunological methods 
2.8.1 Western blot 
1) After SDS-PAGE electrophoresis, incubate the gel in Transfer solution for 5 min with 
gentle shaking. 
2) Prepare a sandwich device using one layer of PROTRAN nitrocellulose membrane 
(Whatman® Schleitcher & Schull). Electrotransfer for 1 h for 30-65 kDa protein in 10 % 
SDS-PAGE with 200 mA current. If for 265 kDa native ACC-, blot for 3 h in 5 % 
SDS-PAGE with 200 mA current. Pre-stained marker was used to test the transfer 
efficiency.  
3) Block the transferred membrane with Blocking buffer for 1 h with shaking at room 
temperature or overnight at 4 °C.  
4) Wash the membrane 3 times with 20 ml of Washing buffer, each 5 min. 
5) Incubate the membrane with primary antibody diluted (normally 0.1g/ml) in Washing 
buffer for 1 h at room temperature with gentle shaking. 
6) Wash as in step 4. 
7) Incubate the membrane with secondary antibody diluted (1:10,000) in Washing buffer for 
1 h with shaking. 
8) Wash as in step 4 
9) Equilibrate the membrane in Detection III solution for 5 min with gentle shaking. 
10) Develop the membrane in freshly prepared substrate solution (NBT/BCIP) in a sealed bag 
in dark. No shaking during development. 
11) When the intensities of desired bands are achieved, stop the colour reaction by rinsing the 
membrane with TE buffer. 
10× PBS 1.37 M NaCl, 78.10 mM Na2PO4, 26.80 mM KCl, 14.70 mM KH2PO4 
Transfer buffer 10 mM Tris pH8.2, 2 mM EDTA, 50 m M NaCl, 0.1 mM DTT 
Transfer buffer-wet 1 L: 50 ml of 1 M Tris pH8.5, 200 ml methanol, 15 g of Glycine 
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Blocking buffer 1× Roti-Block in 1× PBS pH8.2 
Washing buffer 1× Roti-Block, 1× PBS pH8.2, 0.2 % Triton X-100, 0.1 % SDS 
2.8.2 Protein-protein interaction by immuno-precipitation 
The immuno-precipitation was performed as described (Xu et al., 2006). 
1) Add 1 ml of ice-cold 1× PBS to cells and collect to a 1.5 ml tube. Spin at max for 1 min 
at 4 °C to collect cells again.  
2) Discard the supernatant and add 0.4 ml of IP buffer into the cell pellet.  
3) Lyse the cells by passing six times through a 22-gauge needle and centrifuge at 3000 rpm 
for 15 min at 4°C. Aliquot 100l for SDS-PAGE analysis.  
4) Add 0.5 ml of IP buffer into the rest cell lysate. Pre-clean with 40l of Protein A-agarose 
(Upstate Biotechnology, Lake Placid, NY, USA) for 2 h at 4°C.  
5) Add 2g of antibody into the 300l of pre-cleaned cell lysate and incubate overnight at 
4°C in 0.5 ml centrifuge tube.  
6) Add 20l of Protein A-agarose and incubated for 2 h at 4°C. 
7) Centrifuge at 5000 rpm for 1 min at 4°C. 
8) Wash with 0.3 ml of ice-cold 1× PBS 3 times. 
9) Centrifuge at 5000 rpm for 1 min at 4°C.  
10) Add equal volume of 2× LP buffer, boil for 5 min and spin for 1 min at 5000 rpm. Load 
to gel or stored at -70°C 
IP buffer (1 ml) 0.9 ml of 1× PBS; 100l of 10 % NP-40; 10l of 100 mM PMSF; 5l of cocktail inhibitor (Sigma); 5l of 200 mM NaVO3  
2.8.3 Indirect sandwich ELISA for bovine ACC- 
The Ultra-sensitive ABC Peroxidase Staining Kits use the avidin-biotin complex (ABC) 
method to amplify signal intensity (Hsu et al., 1981). The multiple binding sites between the 
tetravalent avidin and biotinylated antibodies (bound to the antigen) are ideal for improving 
sensitivity by increasing the number of enzyme molecules at the target. This method uses a 
biotinylated horseradish peroxidase (HRP) that is pre-incubated with avidin at a specific ratio, 
forming large complexes. An aliquot of this solution is then added to the biotinylated antibody 
that is already bound to the target. The result is a greater concentration of enzyme (three 
enzyme molecules to one avidin molecule) at the antigenic site and, therefore, an increase in 
signal intensity and sensitivity in ELISA. This signal amplification method may also be used 
for immunohistochemistry, Western blotting, in situ hybridization and electron microscopy 
procedures.  
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1) Coat plate with 100l of coating buffer (antibodies) o/n at 4 °C. 
2) Rinse each well with 150l of washing buffer 
3) Add antigen in 100l of washing buffer. 
4) Rinse 3 times with 150l of washing buffer. 
5) Add primary antibodies in 100l of washing buffer at RT for 1 h. 
6) Rinse 3 times 150l of washing buffer. 
For normal method, continue step 7-9), then continue step13-end 
7) Add secondary antibodies in 100l of washing buffer at RT for 1 h. 
8) Rinse 3 times with 150l of washing buffer. 
9) Rinse with 150l of water. 
For ABC method, continue from step6 then step10-end 
10) Add 100l of Biotinylated Secondary Antibody to each well and incubate plate for 30 
minutes at room temperature. Note: The ABC Reagent may be prepared during this 
incubation step (see Materials Required Section).  
11) Rinse each well three times with 200l of Wash Buffer. Add 200l of Wash Buffer to 
each well and incubate at room temperature for 5 min. 
12) Empty plate and tap residual liquid on a paper towel. Add 100l of the ABC Reagent to 
each well and incubate at room temperature for 30 min at room temperature.  
13) Immediately before use mix equal volumes of the TMB solution and the Peroxide 
Solution.  
14) Add 100l of TMB Substrate solution to each microplate well. 
15) Incubate plate at RT for 15-30 min or until the desired color develops.  
16) Stop reaction with 100l 2 M sulfuric acid or 8 M acetic acid with 1 M sulfuric acid. 
17) Measure the absorbance of each well at 450 nm. 
Coating buffer 1.59 g Na2CO3; 2.93 g NaHCO3; 0.2 g NaAzid and 1 L water, pH9.6. 
Washing buffer 1× PBS pH8.2; 0.2 % Triton X-100; 0.1 % SDS; 0.5 % BSA (1× Roti-block) 
anti-goat IgG HRP Conjugated (1: 5 k-100 k for ELISA) (horseradish peroxidase) 
Substrate buffer Prepare before use with TMB solution and peroxide solution 
TMB solution 3, 3, ‘5, 5’-tetramentylbenzidine solution: 0.4 g/L 
Peroxide solution contains 0.02 % hydrogen peroxide in citric acid buffer 
Stop buffer 2 M sulphuric acid  
for ABC method 
Biotinylated Secondary 
Antibody 
Add 3 drops (135l) of Blocking Serum and 1 drop (45l) of the 
Biotinylated Secondary Antibody from the Ultra-Sensitive ABC Staining 
Kit to 10 ml of PBS.  
ABC Reagent Prepare reagent 30 minutes before use (see Step 6). Add 4 drops (180l) of Reagent A to 10 ml of PBS followed by 4 drops (180l) of Reagent B. 
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Immediately mix solution and allow 30 minutes for the complex to form.  
 
2.9 Southern blot 
The Southern blot hybridization is used to locate and identify a specific DNA segment within 
a complex mixture of molecules. DNA (genome or other source) is digested with restriction 
enzymes and separated by gel electrophoresis according to size. The separate DNA molecules 
are transferred from the agarose gel onto a nitrocellulose membrane or Hybond–N nylon 
membrane. The blot is then incubated with a labelled single–stranded probe of the target DNA. 
This probe will hybridize with its complementary DNA sequence and form a double-stranded 
DNA molecule. The probe must be labelled before hybridization either radioactively or 
non-radioactively (e.g., DIG-labelled). 
 Gel blotting 
1) Digest the DNA sample with restriction enzymes and separate the DNA fragments on an 
agarose gel. 
2) Submerge the gel in 0.25 M HCl for 10 min with gentle shaking. 
3) Denature the dsDNA molecules to form a single stranded (ss) DNA molecule by 
immersing the agarose into Denaturation solution for 30 min. 
4) Rinse the gel once with H2O and submerge it in the Neutralization solution for 30 min. 
5) Set up a sandwich device to transfer the DNA fragments from the gel onto Hybond –N 
nylon membrane (Amersham Pharmacia) by the capillary action in 20×SSC buffer. 
Transfer overnight to ensure the sufficient transfer of DNA. 
6) After transfer, submerge the membrane in 6×SSC for 5 sec. Air dry briefly and fix the 
DNA to nylon membrane by UV crosslink for 3 min. 
Denaturation solution 0.5 N NaOH, 1.5 M NaCl 
Neutralization solution 1 M Tris-Cl pH7.5, 1.5 M NaCl 
20×SSC buffer 3 M NaCl, 0.3 M Sodium citrate, pH7.0 
 Probe labeling 
The DIG Oligonucleotide 3´–End labelling Kit is used to non-radioactively label the probe in 
this application. Oligonucleotide probes are enzymatically labelled at their 3´–end with 
terminal transferase by the incorporation of a single digoxigenix-labelled dideoxyuridine- 
triphosphate (DIG-dd UTP). 
1) Add the following components on ice: 
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Probe (100 pmol) xl  
5× Reaction buffer 4l 
CoCl2 solution 4l 
DIG-ddUTP solution 1l 
Terminal transferase (2.5 U /l) 1l 
H2O xl 
Total volume 20l 
2) Mix and incubate at 37°C for 30 min. Place on ice. 
3) Stop the reaction by adding 2l of 0. 2 M EDTA (pH8.0). 
 Hybridization 
1) Prewarm the Prehybridization buffer and add it to a heat sealable bag with the blot 
membrane. Seal the bag. Incubate for 1-2 h with gentle shaking in 60 °C bath. 
2) Replace the solution with about 0.2 ml/cm2 membrane prehybridization buffer containing 
the 100 pmol DIG-labelled probe. Incubate the blot overnight in 60 °C water bath with 
gentle agitation. 
3) Wash the blot twice for 5 min in 2× SSC, 0.1 % SDS at RT. 
4) Wash the blot twice for 15 min in 0.1× SSC, 0.1 % SDS at 60 °C with shaking. 
Prehybridization buffer 5× SSC, 0.1 % SDS, 1 % Blocking reagent (Roche) 
 Immunological detection 
The DIG-labelled probes can be detected by the antibody conjugated to the enzyme alkaline 
phosphatase (AP), which catalyzes the deposition of dyes at the site of the enzyme in the 
presence of nitroblue tetrazollium salt (NBT) and 5-bromo-4-chloro-3-indolyl phosphate 
(BCIP). 
1) After hybridization and stringency washing, rinse the membrane briefly with Detection I 
solution. 
2) Incubate for 30 min with Detection II solution. 
3) Dilute Anti-DIG-AP Fab fragments to 150 mU/ml (1:5000) in Detection II solution and 
incubate the membrane for 30-60 min with diluted antibody solution. 
4) Wash twice for 15 min with Detection I solution with gentle shaking. 
5) Equilibrate the membrane in Detection III solution. 
6) Incubate the membrane with freshly prepared Colour solution in a sealed bag in the dark. 
Do not shake during colour development. 
7) When desired intensities of the band are achieved, stop the colour reaction by rinsing the 
membrane with TE buffer. 
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Detection I solution 0.1 M Tris-Cl pH7.5, 0.15 M NaCl 
Detection II solution Dection I solution with 1 % Blocking reagent 
Detection III solution 0.1 M Tris-Cl pH9.5, 50 mM MgCl2, 0.1 M NaCl 
Color solution 337.5g/ml NBT, 175g/ml BCIP in Detection III solution 
2.10 Eletrophoretical Mobility Shift Assay 
Eletrophoretical mobility shift assay (EMSA) is used to identify transcriptional factor that 
bound to the target DNA element. Normally the DNA probe is labelled with -32P-ATP at the 
end by T4 polynucleotide kinase or -32P-NTP by DNA polymerase large fragment (Klenow). 
The protein-DNA complex is visible by the labelled probe.  
The specificity of the shifted band can be resolved based on two different criteria. One can 
use a molar excess of the unlabelled double stranded oligonucleotide to compete with the 
labelled for the binding proteins. The sequence specific radioactively labelled band will 
eventually disappear proving sequence identity. The site specific band will be not be affected 
by mutational unlabelled double stranded oligonucleotide. Alternatively, or augmenting the 
competition analysis, one can apply an antibody know to bind to the transcription factor of 
interest. If the antibody recognizes and binds to the factor having bound to the radioactive 
probe, then the molecular weight increases. The shifted band appears as heavier and new is 
called ``supershifted´´. This assay verifies the identity of the DNA binding factor. Using 
sensitive scanning system, this technique can also quantity the candidate factors. 
 Step1: Probe labeling 
The probe labelling can be done either by end labelling using T4 polynucleotide kinase or 
using filling-in of 5´-overhangs with the Klenow enzyme. In our lab, the latter method is 
preferred due to its greater reproducibility and better labelling efficiency.  
1) Combine 5l of 50M long forward primer (-25 mer) with 10l of 50M short reverse 
primer (10 mer) into 30l of H2O. Mix well. The primers used for EMSA in the study are 
listed in the following table. 
No. Probe long short No. Probe long short 
1 EA 1396 1395 15 Eccmu 1420 1418 
2 NFY_CBF 1369 1371 16 C/EBP3mu 1346 1244 
3 Ecc 1419 1418 17 SP1mu 1422 1421 
4 C/EBP3 1245 1244 18 GLI 1375 1374 
5 SP1 1226 1421 19 Fast 1373 1372 
6 EAm6 1401 1395 20 STAT 1450 1451 
7 EAm1 1397 1395 21 STATmu 1452 1451 
8 EAm3 1398 1395 22 C/EBP3mu2 1575 1574 
9 EAm4 1399 1395 23 ECcmu3 1572 1418 
10 EAm5 1400 1395 24 NFY5 1633 1634 
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11 EAm6 1401 1395 25 CEBP_con 1487 1486 
12 EAm7 1402 1395 26 CEBP_conmu 1489 1488 
13 EAm8 1403 1395 27 LDLR 1510 1511 
14 EAm9 1404 1395 28 C/EBP2 1243 1242 
2) Boil the mixture in a water bath for 10 min and immediately chill on ice. 
3) Transfer 1l of mixture to a new tube containing 99l H2O, and set up the following two 
reactions in a total volume of 50l to synthesize cold and hot probe:  
Table 7 Labeling of hot probe 
Cold probe reaction Hot probe reaction 
36l  Original primers mix 36l  diluted primers mix 
5l 10× Klenow buffer 5l 10× Klenow buffer 
1l dNTPs 1l dNTPs (A G T) 
1l Klenow enzyme 1l dCTP(32P) 
7l H2O 1l Klenow enzyme 
  6l H2O 
50l Total volume 50l Total volume 
4) Incubate at 30°C for 1 h. 75 °C 10 min and then place the tubes on ice. 
5) Proceed to purify with the Mini Quick Spin Column. Briefly, prepare the spin column by 
evenly resuspending the matrix and subsequently removing excess buffer. Spin for 1 min 
at 1000 g. Slowly and carefully, apply the samples to the center of the column bed, and 
finally collect the purified probe by centrifugation of 1000 g 4 min. The molecular 
concentration of labelled probe is 40 fmol/l, while that of unlabelled probe, which is 
used in competition reaction, is 4 pmol/l. 
 Step2: EMSA reaction 
DNA-protein binding reactions are normally conducted in a total volume of 20l and always 
work on ice except indicted elsewhere. To set up the binding reactions, add the components in 
the order given below.  
Binding reaction (l) Competition Standard Supershift 
dd H2O X X X 
Poly-dIdC (1g/l) 1 1 1 
2× binding buffer 10 10 10 
Nuclear extract (2-10g) X X X 
Hot probe (40 fmol/l) 1 1 1 
Cold or mutant probe (4 pmol/l) 1   
antibody (2g/l)   0.5-1 
Total volume 20 20 20 
After the addition of all components, spin the reaction tubes briefly in a microfuge, to bring 
all fluid down to the bottom of the tube. Incubate 20 min at RT. But the supershift reaction 
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should be kept for 10 min under RT before adding the hot probe. Then load all the samples on 
the 4 %-6 % non-denaturing PAGE gel.  
2× binding buffer 
 
10 mM MgCl2; 0.2 mM EDTA pH8; 2 mM DTT; 0.1 M NaCl; 20 % Glycerol; 
20 mM HEPES pH7.9, 0.4 mM PMSF. 
Step3: Electrophoresis and autoradiography detection 
Prepare a 4-6 % non-denaturing PAGE (0.5× TBE) gel for running the EMSA samples 
according to the following protocols. 
4 % 5 % 6 % PAGE gel 
0.5 ml 0.5 ml 0.5 ml 10×TBE 
1 ml 1.25 ml 1.5 ml 40 % Acrylamide 
0.5 ml 0.62 ml 0.75 ml 2 % N,N’-methylene-bis-acrylamide 
7.9 ml 7.52 ml 6.9 ml H2O 
100l 100l 60l 20 % APS (ammonium persulfate) 
10l 10l 15l TEMED 
10 ml Total volume 
Pre-run the gel for 1 h in 0.5× TBE at a voltage of 5 V/cm. Load the EMSA samples into the 
wells of the gel. Run the gel for around 2 hours. Transfer the gel to a double layer of 
Whatman paper and dry the gel on a gel dryer for 45 min at 75 °C with vacuum. Put the dried 
gel in the cassette with screen on top for overnight exposure. Screens are qualitatively and 
quantitatively analyzed with a Storm 840 PhosphoImager (Molecular Dynamics). 
2.11 Chromatin Immunoprecipitation 
Chromatin Immunoprecipitation (ChIP) is a powerful tool for the study of protein-DNA 
interactions in vivo (Weinmann et al., 2002; Weinmann et al., 2001). In this method, protein is 
fixed on DNA in vivo. After the chromatin is sheared either by sonication or by enzymatic 
digestion, the protein-DNA complex could be captured by immunoprecipitation using 
antibodies. Subsequently, the DNA is purified by digestion of the protein with proteinase K 
and the copies of target DNA can be quantified by real-time PCR. Using specific antibodies 
against different transcriptional factors, the native recruitment of relevant factors is known 
from copies of DNA. ChIP assays were performed according to manufacturer's protocol 
(Upstate Biotechnology, Lake Placid, NY, USA).  
 Step 1: Prepare cell lysate 
1) Cells are washed with 1× PBS.  
2) Add 40l of 0.5 M DSG freshly made (fc is 2 mM) in 10 ml of PBS/Mg2+, pH8.0. Cells 
are fixed with DSG for 45 min at room temperature by gentle rotation. 
3) Aspirate the PBS/Mg2+ from plate and wash the cells with 1×PBS pH8.0 twice. 
4) Add 10 ml of PBS/Mg2+ pH8.0 containing 270l of 37 % formaldehyde and incubate at 
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room temperature for 10min with rotating. 
5) Add 1 ml of 1.25 M Glycine (10×) to quench formaldehyde.  
6) Wash cells three times with ice cold 1× PBS pH8.0 and transfer the plates on the ice. Add 
1 ml of ice-cold 1× cold PBS pH8.0 containing 0.5 % Protease Inhibitor Cocktail II 
(Sigma) and 1 mM PMSF to scrape the cells into a new tube.  
7) Collect cells by centrifugation at 1000 rpm for 5 min at 4 °C.  
8) Add 0.35 ml of SDS lysis buffer (Upstate) containing 0.5 % Protease Inhibitor Cocktail II 
and 1 mM PMSF to tube, suspend cell pellet. 
9) Let stand on ice for 10 min. 
1× PBS pH8.0 Adjust 1× PBS pH7.5 to 8.0 with 137.5l of 5 M NaOH 
1× PBS/Mg2+ Add 5l of 2 M MgCl2 into 10 ml of the above 1× PBS pH8.0 
0.5 M DSG Add 6.5 mg of DSG in 40l of 100 % dimethyl sulfoxide 
 
 Step 2: Sonication to Shear DNA 
1) Shear chromatin with Branson sonifier (setting 2, 40 %) for 20 s. 
2) Transfer 40l aliquot for agarose gel analysis. 
3)  Add 1.6l of 5 M NaCl and 1l of 20 % SDS, 0.4l of 20 mg/ml Protease K, 65°C for 
1h.  
4) Extract with equal volume of phenol. Transfer the supernatant and add one-tenth of 3 M 
NaAC pH5.2. Add 1 volume of isopropanol to precipitate DNA.  
5) Rinse with 70 % ethanol and air dry at room temperature.   
6) Dissolve the DNA in TE buffer and analyze by 2 % agarose gel.  
7) If desired, spin lysate at 14,000 rpm at 4°C for 10 min to remove insoluble material. 
8) Sheared crosslinked chromatin can be stored at -80 °C. 
 Step 3: Immunoprecipitation (IP) of Crosslinked Protein/DNA 
1) Add 900l of Dilution buffer containing 0.5 % Protease Inhibitor Cocktail II and 1 mM 
PMSF into the tube containing 100l of chromatin (one IP). 
2) Add 25l of Protein A agarose (Upstate) for each IP, incubate for 2 h at 4 °C with 
rotation. 
3) Supplement 3g of rabbit normal IgG and continue to incubate for another 1 h. 
4) Pellet agarose by brief centrifugation 3000-5000 g for 1 min. 
5) Collect the supernatant. Transfer 100l of the supernatant as 10 % Input and save at 4°C. 
6) Add 4g of the target antibody to the rest supernatant fraction. Incubate overnight at 4°C 
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with rotation. 
7) Add 50l of Protein A agarose and incubate for 3 hour at 4 °C with rotation. 
8) Pellet Protein A agarose by brief centrifugation (3000-5000 g for 1 min) and discard the 
supernatant fraction. 
9) Wash the Protein A agarose-antibody-chromatin complex by resuspending the beads in 1 
ml of the cold buffers in the order listed below and incubating for 5 min on a rotating 
platform followed by brief centrifugation (3000-5000 g for 1 min). Remove the 
supernatant fraction: 
a. Low Salt Immune Complex Wash Buffer, one wash 
b. High Salt Immune Complex Wash Buffer, one wash 
c. LiCl Immune Complex Wash Buffer, one wash 
d. TE Buffer, two washes 
 Step 4: Elution of Protein/DNA Complexes for analyses 
1) Elute twice with Elution buffer and incubate for 15 min at room temperature. Combine all 
elutes (~300l). 
2) Add 12l of 5 M NaCl and 6l of 0.5 M EDTA pH8.0, 15l of 1 M Tris-Cl pH6.5 and 
3l of 20 mg/ml Proteinase K and incubate at 65°C for 4-5 h or overnight to reverse the 
DNA-Protein crosslinks. After this step the sample can be stored at -20°C and continued 
the next day. 
3) Extract with phenol/chloroform. Transfer the upper aqueous layer. 
4) Add one-tenth of 3 M NaAC pH5.2, and add glycogen 0.2 μg/μl. Mix well.  
5) Add 1 volume of isopropanol and let stand at -20 °C > 20 min. Pellet the target DNA by 
centrifugation for 5 min at 13,000 rpm at room temperature. Rinse with 70 % ethanol.  
Air-dry and dissolved into 36 μl H2O. 
6) Run quantitative real-time PCR to measure the copy number of the candidate region of 
target genes 
Elution buffer (1 ml) 50l of  20 % SDS, 100l of 1M NaHCO3 and 850l of dH2O 
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3 Results 
3.1 Developing basic knowledge and tools to the PI repressor 
Our lab’s previous work demonstrated that the bovine ACC- gene is located on bovine 
chromosome 19. The full length bovine ACC- cDNA comprises 7381 bp (Sequence ID 
AJ132890). Seven different transcripts have been found to be transcribed by the three 
promoters (PI, PII, PIII). The transcripts derived from PI and PII can be translated into the 
ACC- 265-kDa isoform. In mammary gland PIII abundantly transcribes mRNA for 
translation to the ACC-259-kDa isoform. Among the three promoters, PI promoter is 
abundantly expressed and nutritionally regulated in the mammary gland, adipose and liver 
tissues. Due to the importance of PI in fatty acid synthesis, research on PI will shed light on 
the regulation mechanism of fat metabolism.  
It has been reported that another promoter PIn locates more 5´ than PI as a bifunctional and 
GC-rich promoter expressing ACC- abundantly in brain among sheep, mouse and human 
(Travers et al., 2005). The presence of a similar promoter possibly exists in the bovine ACC- 
gene. If so, this promoter may contribute to ACC- expression, warranting its investigation in 
bovine lipogenic tissues. In the study, bovine PIn was isolated and identified as a 
brain-specific promoter, barely contributes to the ACC expression in the lipogenic tissues 
(appendix A). Hence, PI, but not PIn, is the key promoter for ACC expression in these tissues. 
 
Sequence analysis demonstrated that PI (Sequence ID AJ276223): a TATA-box is absent and 
multi-transcription start sites exist. The proximal promoter has strong activity when the 
repression region is deleted in reporter gene analysis, but the long promoter has retained 
marginal activity compared to pGL3basic. Thus, PI promoter is basically repressed by a distal 
repression region. Interestingly, a repression region was also found in rat PI promoter. The 
repression region hampers the response of PI to induction by hormone (O'Callaghan et al., 
2001). Hence, the regulation of PI promoter can be better understood after the elucidation of 
the repression mechanism. 
Further analysis manifested that the repression region is from position -1045 to -127. 
Restriction analysis divides the region into three possible elements: A, B and C. Removing 
element A or element B and C relieves the repression of PI. Hence, the repression region is 
bipartite, similar as the counterpart of the rat repressive element. Tae et al. 1994 discovered 
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that the upstream repressive element is a CA-28 microsatellite, unlike the bovine upstream 
element, which is included in a retroposon. The rat downstream repressive element of PI is a 
C/EBP binding site. Mutation of the C/EBP binding site relieves the repression of PI. Unlike 
bovine PI, a TATA box is present in rat PI promoter, which suggests that the bovine PI 
repression mechanism maybe different from mouse PI. The fine mapping of the exact 
elements and the cis-elements within these elements remain unknown.  
To unravel the responsible elements controlling PI activity, computer-aided database analyses 
were performed on bovine PI. Results indicated that a great many putative binding sites of 
transcription factors were present both in the distal and proximal regions (Figure 7). Hence, 
fine mapping of the repressive elements and the repressors is a necessary and efficient means 
to define the molecular mechanism of PI regulation.  
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Figure 7 Putative attachment sites for transcription factors in bovine ACC- PI 
The corresponding putative factors are shown above the promoter. The positions are indicated below the 
promoter. Repressive and proximal regions are determined based on previous studies. The repressive region lies 
between position -1045 to -127 and the proximal region extends from -127 to +84. +1 indicates the transcription 
start site. Element A, -B & -C are candidate repression elements. 
GLI: Glioma associated oncogene; NF-Y/CBF: Nuclear Factor-Y/The CCAAT-Binding Factor (or CP1); C/EBP: 
CCAAT/Enhancer Binding Protein;  
 
Species-specific transcriptional factors are indispensable to study gene regulation. Functional 
studies have been well documented in human and mouse models. However, no many tools are 
available to study bovine gene regulation. Hence, it is necessary to clone and construct the 
expression vectors of the relevant transcription factors. In the current study, this includes the 
C/EBP and NF-Y factor families (appendix B).  
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3.2 PI is nutritionally regulated in different tissues and physiological conditions?
In mammals, liver, adipose and mammary gland are main sites of de novo fatty acid synthesis. 
Previous data showed that ACC- PI is the prominent promoter which contributes to bovine 
total ACC- transcription in these tissues (Mao et al., 2001). It was reported that PI activity 
was regulated in adipose and liver tissues during starvation and refeeding in the rats (Kim and 
Tae, 1994). The present study concentrated on probing the regulation of bovine ACC- PI. 
Hence, PI derived mRNA copies were measured by real-time PCR during different 
physiological conditions in bovine liver and adipose tissues.  
3.2.1 ACC- PI is repressed in vivo by starvation 
Liver biopsies were taken from four dry standing cows. The cows were subsequently starved 
for 43 h, and liver biopsy was repeated for each cow. Then the cows were refed with their 
normal diet and 29 h later liver biopsies were taken once again.  
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Figure 8 Expression patterns of bovine ACC- in the liver and adipose tissues during different 
nutritional conditions by real-time PCR 
A) Transcripts of genes or derived promoters in the liver during nutritional regulation.  
B) PI expression by feeding changes and calving in adipose tissue.  
 
For A, mean (error bars, SEM., n=4) of mRNA level of normally fed cows (with maximal PI activity) is set to 1. 
The different symbols represent various genes. Both ACC- total (all promoters) and PI transcripts decreased 
significantly after starving (p<0.01), but only ACC- PI transcripts increased significantly when refed for 29 h 
(p<0.01). For B, total RNA was from the subcutaneous adipose biopsy on day –10 (ten days before calving), day 
+ 1(the first day after calving) and +10 (the tenth day after calving). Mean (error bars, SEM., n=8) of ACC- PI 
mRNA level on day +1 is set to 1. The black round () and empty triangle symbols () represent the diets 
enhanced with starch and fat respectively before calving.  * represents p<0.05, ** represents p<0.01. 
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In the liver as indicated in Figure 8A, the transcripts derived from ACC- PI and all 
promoters were decreased significantly and synchronously after starvation for 43 h. The 
concentration of mRNA copies derived from ACC- PI in the fed condition was 16 fold that 
found after starvation. The concentration of all ACC- transcripts increased in tendency as 
well after refeeding, but the increase was statistically not significant. In contrast, the 
concentration of ACC PII derived transcripts decreased only slightly by 19 % not significantly. 
The concentration of transcripts encoding Fibrinogen did not change during the experiments. 
These were assessed as references for liver function. The measurements of PI derived 
transcripts thus reconfirm that PI activity in the liver is indeed nutritionally regulated.  
 
3.2.2 Starch-enriched diet enhances, but lactation silences ACC- transcription in 
adipose tissue 
In order to evaluate the nutritional regulation of PI activity in adipose tissue, a different 
experimental setting had to be chosen. Groups of eight cows each were fed with two different 
diets for 3 months before calving. The diets consisted of either the ordinary diets 
(carbohydrate-enriched) or were enriched with fat components. Adipose tissue was collected 
from a skin area on the back behind the withers, 10 days before calving and subsequently at 
day1 and 10 after calving.  
The same assay technique was used to measure ACC- PI activity in adipose (Figure 8B). 
When the mean level of ACC- PI derived transcripts after calving (at day +1) was set to 1, 
the concentration of ACC- PI derived transcripts of starch-enriched group was remarkably 
higher (368 -fold) than that of fat-enriched group (43 -fold). Ten days after calving (until day 
+10), the concentration of PI derived transcripts did not change significantly in either group. 
These data demonstrate that the onset of lactation after calving silences the ACC- PI 
transcription in bovine adipose tissue. Specifically they show that the starch-enriched diet 
elevated ACC- PI activity ~9 fold compared to the fat-enriched group before calving 
(p=0.057, n=8). Hence, bovine ACC- PI transcription is nutritionally and physiologically 
regulated in adipose tissue. 
Results 
54 
3.3 Delineation of the repression elements and factors in the distal region of PI 
Previous work indicated that the activity of long PI promoter is repressed (Mao et al., 2001). 
Hitherto, the knowledge about the molecular nature of the repressor is limited, except that it is 
overlapped with a retroposon.  
3.3.1 Elements contributing to PI repression 
3.3.1.1 Delineation of cis-relevant DNA-sequence element of the PI repressor 
In order to delineate and finely map the PI elements contributing to the PI repressor, PI 
reporter constructs (Figure 9) were established harboring serial deletion of the wild type 
promoter. All vectors were constructed by restriction digestion or PCR.  
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Figure 9 Structure of PI and its deletion series in reporter constructs 
The wild type promoter region was cloned into the multi cloning site of pGL3basic. The derived constructs were 
either shortened with restriction enzyme or recloned by PCR. Bold lines indicate the sequence elements included 
into the respective construct. 
 
To delete element B (EB), PCR was carried out with Ac_pI_f 9 and PI_eb_r using Nde as a 
template. The amplified product was inserted into KpnI/NdeI (-281) of Nde and resulted in 
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B. EC was deleted by three steps:C1, C2 and C3. Three substituent forward primers 
PI_ec_1f, PI_ec_2f and PI_ec_3f respectively (introduced a NdeI site) and the same reverse 
primer 5_lucr were used for PCRs to amplify the insertion fragments.Nde was also used for 
the templates. The amplified fragments were inserted into the NdeI(-737)/HindIII site of EB. 
The other vectors were constructed by according restriction enzyme as indicated in the 
scheme. All clones were confirmed by digestion or colony PCR, followed by sequencing. 
3.3.1.2 Element A and C, but not B, repress PI activity 
Serial constructs were transiently transfected into HC11 cells. The long promoter -1045 was 
close (repressed) and the proximal promoter (-127) was open (data not shown), just as 
previously reported (Mao et al., 2001). Therefore, the repression region resides between 
position -1045 and position -127 including elements (E)A, EB and EC as indicated Figure 10. 
When EA was deleted, the activity [A (-996/+84)] was ~2.9 -fold of that of the wild type 
promoter (Figure 10). Thus, PI was derepressed by deletion of EA.  
0
1
2
3
-1045 A
Fo
ld
 o
f w
ild
 ty
pe
HC11
HepG2
** **
Nde B Stu
A.
** **
0
1
2
3
*
-1045 C1 C2 C3
B.
HC11
 
Figure 10 Mapping of the repressive elements of PI promoter by deletion in HC-11 and HepG2 
cells
The map of the reporter constructs as described in Figure 9. Reporter construct and pRL-TK vectors were 
transient cotransfected into HC11 cells. The transfection efficiency was normalized with pRL-TK activity. The 
activity of wild type promoter (-1045) was set as 1.0. Empty column represents the data from HC11 cells and 
filled column indicates the data from HepG2. Error bars: SEM. Data indicated were the summary of at least three 
independent experiments. * p<0.05, ** p<0.01. 
 
Similarly, PI was fully active in the clone Stu (~2.7 -fold of wild type) in which the region 
-828/-127 comprising EB and EC had been deleted. However, the deletion of position -737 to 
position -281 between two NdeI sites in Nde reporter, together with EB (-828/-281) deletion 
in the B reporter kept the deleted PI close, indicating that EB does not contribute to PI 
repression (Figure 10A). Similar results were found using human hepatocellular liver 
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carcinoma (HepG2) cells, but the effect is moderate. Hence, the repressor is associated with 
two elements: EA and EC. EB does not contribute to repression. To confirm the role of EC, 
EC was deleted by three steps in further experiments (Figure 10B). The deletion C3 
derepressed the PI activity. This result indicated that the region had been deleted in C3 
contributes to PI repression.  
To examine if the repression elements and repressor can also control heterogonous promoters, 
the PI driver (from -127 to +84) in -1045 was replaced with the mini-TK promoter and a 
reporter construct (-1045TK) was established. TK-promoter is the thymidine kinase promoter 
from herpes simplex virus. Subsequently, the EB and EC were deleted based resulting in 
StuTK. These two constructs were transfected into HC11 cells. Results indicated that when 
the repressive elements were disrupted by deleting EB and EC, the deleted promoter was open 
(data not shown). Hence, PI repressive elements and repressor can also repress the 
heterologous TK-promoter. 
3.3.2 Identification of transcription factors binding to EA and EC 
3.3.2.1 Delineation of the factors binding to EA 
Since element EA comprises 50 base pairs of DNA segment, it is still a large region for fine 
analysis of the potential transcriptional factors. Narrowing the key region of EA relevant to PI 
repression facilitates the eventual search for the relevant binding factors.  
3.3.2.1.1 The left side of EA is relevant for PI repression in HC11 
EA extends from position -1045 to -996. In order to narrow down the key repressive region of 
EA, EA was split by two deletions: A-L and A-R (Figure 11). In A-L, the left part (5´) of 
EA from position -1045 to -1019 was deleted based on the clone -1045. Amplification was 
performed with the forward primer PI_A_f4 and the reverse primer 5_lucr. The PCR product 
was blunted and inserted into the KpnI(blunted with Klenow)/HindIII of clone -1045. 
InA-R, right part (3´) was deleted by PCR-mediated mutagenesis. The mutational primer 
pairs (P2 and P3) were PI_ec_CEBP_B_fm and PI_ec_CEBP_B_rm, and P1 and P4 were 
BASENDf and 5_lucr respectively. Results indicated that the deletion of the left side (in A-L, 
-1045/-1019) resulted in derepression, similar to the deletion of the entire EA (Figure 11) in 
my previous experiments. In contrast, the deletion of the right side of element A (A-R, 
-1019/-996) did not result in derepression. Hence, the left side of element A conveys 
repression of PI activity (Figure 11).  
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Figure 11 The fine mapping of element A repressing the PI activity 
L or R: the left or right side of EA. Data indicated were from assays measured in triplicate. Error bars: SEM. **: 
p <0.01. 
3.3.2.1.2 NF-Y and GLI may bind to EA 
Computer analysis demonstrated that the left side of element A contains putative attachment 
sites for the factor NF-Y, Glioma associated oncogene (GLI), signal transducers and activators 
of transcription (STAT) and FAST (Figure 12A). To identify which of these transcription 
factors do indeed bind here, EMSAs were performed using the labelled element left side 
(EA-L) as a probe. Two main DNA-protein complexes (named C1 and C2) were formed using 
nuclear extracts from HC11 cells, pbMEC and mammary gland (Figure 12B). C1 could be 
competitively inhibited by the unlabelled GLI consensus competitor (Figure 12D: Lane 3). 
When the core sequence GGG in oligonucleotide of EA-L was mutated into ttt (named m3), 
the unlabelled mutation probe could not compete for C1 (Figure 12D: Lane 9). This indicates 
that GLI can bind to EA through the original sequence of m3.  
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Figure 12 Comprehensive EMSA analyses of the factors binding to element EA 
A) Diagram summarizing the sequences used as probes in EMSA assays; the putative binding sites for 
transcription factors are depicted. `m´ represents is the alteration of wild type promoter sequence (wt) introduced 
into the wt sequence, as used for the EMSA-analyses.  
B) EMSA analyses of the putative factors interacting with the left side of element A with nuclear extracts from 
mouse HC11, bovine pbMEC (primary bovine mammary epithelial cells) and MG (mammary gland). FP: free 
probe. C: competition of self. Cy: Competition of consensus NF-Y binding motif. Ca: Competition of 
consensus STAT6 binding motif (GTATTTCCCAGAAAAGGAAC). S: shift. SS: supershift with anti-NF-YA. 
32P-EA-L is the left side of EA. C1: DNA-protein complex 1; C2: complex 2.  
C) NF-Y binding to its consensus binding motif. 32P-NF-Y-con is the consensus NF-Y binding motif. `S´ 
represents the DNA-protein complex formed with nuclear extract from mouse HC11 cells. `SS´ represents the 
supershift band. 
D) Competition analyses indicated that NF-Y and GLI bind to the contiguous sites of EA-L. Cf: Competition of 
FAST (GCTGCCCTAAAATGTGTATTC-CATGGAAAT). Cg: Competition of GLI 
(TCGACTCCCGAAGACCACCCACAATGATGGTTC (Yoon et al., 2002)). SS is the lane with antibody. m1-9 
are unlabelled mutational series of EA-L for mutation competition. 
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Results also indicated that in the presence of 100 fold molar excess unlabelled NF-Y 
consensus probe, C2 is efficiently competitively inhibited using nuclear extracts from HC11 
(Figure 12 B: Lane 3, D: Lane 1). Addition of anti-NFY antibodies always supershifted C2, no 
matter if nuclear extracts from mouse or bovine mammary epithelial cells or from udder were 
used (Figure 12B, lane 6, 8, 10). The unrelated rabbit anti-C/EBP did not affect C2 (Figure 
12D, lane 7). Taken together, the data show unambiguously that NF-Y binds to the left side of 
EA. Supporting these data, the mutated probes (m5, 6 and 7) did not affect C2 in mutational 
competition analyses (Figure 12D: Lane 11, 12, 13). Figure 12 also suggests both FAST and 
STAT can not bind to EA-L. The data together show that element A may eventually be bound 
by the factors GLI and NF-Y.  
3.3.2.1.3 Mutation of the CCAAT binding motif of NF-Y relieves repression 
In order to further unravel the functional role of NF-Y interaction with the reverted CCAAT 
element in EA-L, the core NF-Y binding sequence was mutated from ATTGG to AgacG by 
PCR mediated site-directed mutagenesis. It was reported that the CCAAT nucleotides 
mutations dramatically decreased NF-Y binding (Dorn et al., 1987). For the PCR, P2 and P3 
for EA-m6 were replaced by the primers PI_eA_m6f and PI_eA_m6r. The resultant mutant 
reporter construct (EA-m6) was transiently transfected into HC11 cells.  
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Figure 13 Derepression of PI promoter activity by mutation of the NF-Y binding site in the left 
side of element EA 
The results were the average of four independent experiments. Error bars: SEM. ** represents p<0.01. 
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Results indicated that the relative activity of the mutant promoter is 3.2 -fold of that of 
pGL3basic, in contrast to the wild promoter activity which was 0.8 -fold of pGL3basic in this 
case (Figure 13). Hence, the mutation of three nucleotides in the reverted CCAAT binding 
motif resulted in significant derepression of PI. Since I have determined that the identified 
mutation can block the binding of NF-Y (Figure 12D), NF-Y interacting with the reverted 
CCAAT binding motif in EA acts as a repressor. Hence, mutation of the NF-Y binding motif 
alone, without altering the GLI attachment sites, relieves repression of PI in mammary 
epithelial cells. 
3.3.2.2 Delineation the factors binding to EC 
3.3.2.2.1 Element C is bound by C/EBP factors  
Subsequently, research is focused on the repressive motif and the repressor in EC. 
Computational analysis manifested a putative C/EBP binding motif (site1) in EC (Figure 14A). 
In order to confirm the possibility that C/EBP interacts with its binding motif in EC, EMSA 
analysis was performed using the labelled oligonucleotide of EC as a probe. Results 
demonstrated that two protein-DNA complexes were formed using the nuclear extracts 
prepared from HC11. These two complexes (Figure 14B ´a´ S) were competitively inhibited 
by unlabelled wild type oligonucleotide competitor (Figure 14B ´a´ C), but the unlabelled 
mutant competitor can not affect them (Figure 14B, ´a´ Cm). After adding 
anti-C/EBP198, shift bands formation was hindered in the extent, and retarded bands are 
visible (Figure 14B ´a´ SS). Hence, C/EBP factors can bind to the C/EBP binding motif in the 
repressive element (EC) of PI.  
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Figure 14 Determination of the C/EBP factors binding to the repressive element EC 
A) Diagram summarizing the sequences used as probes in EMSA assays; Putative wt DNA sequence for C/EBP 
binding is shown in black bold-face. The mutated DNA sequence is shown in white lower-case with black 
background.  
B) The probe was labelled with 32P-dCTP. Nuclear extracts are from HC11 cells of control or transiently 
transfected DN-C/EBP factors as indicated. FP: Free Probe; C: Competition with cold C/EBP site1-wt; Cm: 
Competition with cold C/EBP site1-mu. S: Shift; SS: Supershift with anti-C/EBP. S and SS with arrows 
indicate the shift and supershift bands. `a´, `b´, `c´ represent three independent experiments each from one gel.  
3.3.2.2.2 C/EBP and - can bind to the C/EBP binding site in EC 
It is uncertain which member directly binds to the C/EBP binding motif in EC, because there 
are many members in C/EBP family, and the epitope recognized by anti-C/EBP198 is the 
conserved C-terminus. Expression constructs were constructed, including C/EBP, -, - and 
–. However, since the factors are all of about the same molecular weight, it is hard to 
differentiate the shift bands. They were truncated by deleting the N-terminal transactivation 
domain resulting in so called trans-dominant (“DN”-) factors. Their binding to a relevant 
probe can easily be distinguished from binding of the native factor, due to their low molecular 
weight. Also, these DN-factors were engineered to carry tags, such as the six-His residue 
comprised His-tag. Application of anti-His-tag antibodies can permit identification of 
DN-factor binding to the probe in EMSA-supershift analyses, providing adequate binding 
exists between the probe and the DN-factor. 
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To differentiate which member of the C/EBP family bound to element EC, nuclear extracts 
were prepared from HC11 cells transiently transfected with DN-C/EBP, -, - or –. 
DN-C/EBP have only DNA binding and leucine zipper domains, thus the lower molecular 
weight results in the lower, or stronger shift band, differs from the native shift band. For 
DN-C/EBP, 154 amino acids were deleted, and a His-tag and a Strep-tag were fused into the 
protein resulting in a similar molecular weight as native full length C/EBP. Results derived 
from the nuclear extract of HC11 cells over-expressing DN-C/EBP indicated that a specific 
DNA-DN-C/EBP complex was formed at the C/EBP binding motif in EC. However, not 
DN-C/EBP or -
 The binding activity of DN-C/EBP and - were confirmed using the 
labelled C/EBP consensus binding motif (data now shown). Regarding C/EBP, the 
intensities of DNA-protein complexes formed by the nuclear extract of HC11 cells 
over-expressing DN-C/EBPwere much higher than by the control nuclear extract. Hence, 
C/EBP and - may directly bind to the C/EBP binding motif (site1) in EC (Figure 14B, gel 
`b´ and gel `c´).  
3.3.2.2.3 Mutation of C/EBP binding site (site1) in EC relieves repression 
The conserved core site (GNAA) in the conserved C/EBP binding motif (TT/GNNGNAAT/G) is 
very important for C/EBP binding (Ryden and Beemon, 1989). In order to examine the 
functional role of C/EBP factors binding to the C/EBP site1 of EC, the four core nucleotides: 
GCAA of the C/EBP site1, were substituted by tagt in a site1mu reporter construct by 
PCR-mediated site directed mutagenesis. The P2 and P3 used for C/EBP site1 mutation were 
PI_ec_CEBP_B_fm and PI_ec_CEBP_B_rm respectively. Results demonstrated that the 
mutation relieved the repression of PI (Figure 15), just similar to the role of NF-Y binding 
motif in EA. The promoter activity was significantly higher (3.7 fold) than that of the wild 
type reporter (1 fold). Hence, C/EBP interacting with the C/EBP site1 contributes to PI 
repression. 
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Figure 15 Derepression of PI promoter activity by mutation of the repressive C/EBP binding site 
in element C  
The C/EBP binding site in the mutated reporter was mutated from GCAA into tagt based on the reporter Nde. 
1.5 g of reporter construct was transfected into HC11 cells, the transfection efficiency was normalized by 
phRL-TK and the data were normalized with pGL3basic. Data shown were from ten independent experiments. 
Error bars: SEM. **:p<0.01. 
3.3.3 Functional analyses of NF-Y and C/EBP factors on regulation of PI 
EMSA and mutational techniques described so far have demonstrated that NF-Y and C/EBP 
factors may be the repressors of PI regulation. Hence, to further evaluate the function of 
candidate factors in regulation of PI, the relevant expression vectors of NF-Y factors and 
various C/EBP factors were cotransfected together with the wt PI promoter reporter construct 
(-1045) into HC11 cells. This resulted in intact NF-Y factors (NFYA+NFYB+NFYC) 
activating, but not repressing the PI promoter (-1045). In contrast, the single subunit of 
NF-YA had no effect (Figure 16A). Results also manifested that 100 ng of C/EBP and - 
expression vectors can significantly activate the PI promoter in HC11 cells (Figure 16B). 
Equal amounts of - and - expression vectors could only moderately activate the promoter PI. 
Taken together, NF-Y and C/EBP factors both activate PI promoter, playing no part in PI 
promoter repression.  
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Figure 16 Cotransfection analyses of NF-Y and C/EBP factors on the PI promoter 
The wild type reporter (-1045) was used for cotransfection analyses. A) 1.5 g of reporter construct was 
cotransfected with 200 ng of NF-YA, or 600 ng of NF-YABC (each 200ng) expression vector constructed in 
pcDNA3.1. B) 100 ng of C/EBPs expression vector was cotransfected as described in the methods, with 1.5 g 
of -1045 reporter in HC11 cells. Transfection efficiency was normalized by phRL-TK renilla luciferase. Activity 
was the fold change relative to mock transfection, in which only -1045 was transfected. Error bars: SEM. Data 
were from at least three independent experiments. Black columns represent transfection data in pbMEC. , ,  
and  are C/EBP, -, - and – respectively.  ** p<0.01 
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3.4 Genetic control elements in the proximal PI?
In order to understand the paradox that the addition of the factors previously presented 
repressing rather than activating the wt-PI promoter, systematic analyses were carried out on 
the functional elements relevant for activity of the short, proximal promoter segment. 
Computer analysis against databases indicated that there are several conserved attachment 
sites of transcription factors in the proximal PI promoter, including NF-Y & C/EBP (Figure 
17A).   
3.4.1 Cis-elements in the proximal PI are conserved among species 
The distal parts of ACC- PI are species-specific, being found in rodents and ruminants 
(Barber et al., 2001; Kim, 1997; Mao et al., 2001). However, sequence comparisons of 
proximal PI suggested that bovine PI (-127/+84) shows 93 % identity with ovine PI 
(-186/+29), and 75 % identity with murine PI in Figure 17B (-200/+26). In detail, bovine 
C/EBP site3 (TTGTGTAAT, -6/+3) motif is the same as the ovine C/EBP site (-65/-57). The 
rat C/EBP site (TTATGCAAT) which was reported as a repressive C/EBP binding site (Tae et 
al., 1994) is identical to the mouse C/EBP site (-71/-63). Upstream of the C/EBP binding site 
in different species, there are several conserved hormonal control elements, such as E-box, 
USF and ChoRF (Koo et al., 2001; O'Callaghan et al., 2001; Travers et al., 2001). Despite 
variability of the absolute positions of C/EBP binding sites between rodent and ruminant, the 
relative positions of the C/EBP and other factors in the proximal region are similar (Figure 
17).  
Interestingly, there is no TATA box in bovine ACC- PI (Mao et al., 2001), though a similar 
sequence motif is found in bovine (TAAAAA), ovine and mouse (TATAAA). The third 
nucleotide of bovine is ‘A’, but that of ovine and mouse is ‘T’. This substitution means the 
motif cannot bend to allow RNA polymerase complex binding. Thus, bovine ACC- PI does 
not contain a functional TATA-box (Keaveney et al., 1993), confirmed by the fact that the 
most 3´-TSS of bovine ACC- PI lies upstream (overlapping with the C/EBP binding motif) 
of the TAAAAA sequence motif (Mao et al., 2001). 
Moreover, one potential NF-Y binding site was found in bovine PI (-116/-102) and ovine PI 
(-175/-161). Due to the importance and the specificity of bovine proximal ACC- PI promoter, 
the relevance and contributions of NF-Y and C/EBP factors were examined in this study.  
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Figure 17 Multiple alignment of the proximal region of bovine, ovine and mouse PI 
A) Putative binding sites in the proximal PI promoter of the bovine ACC- gene. The black box represents the 
element EC region. The box filled gray represents the proximal PI promoter segment.  
B) The identity of the proximal PI sequence of bovine PI (b, –127/+84), of ovine PI (o, –186/–29) and of murine 
PI (m, –200/+26). 
C) The sequence comparison of the PIs of bovine, ovine and murine. The bold nucleotides represent the putative 
binding site as indicated. The underlined nucleotide is the transcriptional start site (+1) where relevant.  
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3.4.2 NF-Y activates proximal PI by binding to its proximal binding site in PI
3.4.2.1 Interaction of NF-Y with the its proximal binding site results in activation of PI  
The CCAAT binding motif is usually located approximately 60-100 bp upstream of the 
transcription start site in many eukaryotic genes, just as was found for the putative proximal 
NF-Y binding motif in PI between -127 to -91. In order to determine whether NF-Y activates 
the proximal PI promoter, HC11 cells were cotransfected with the expression vectors of all 
NF-Y subunits and the proximal PI promoter (-127). Results revealed that NF-Y could 
significantly activate the proximal PI promoter (Figure 18). Thus, the NF-Y activational 
binding motif lies in the proximal region. To confirm the proximal NF-Y binding site of PI, 
the key binding site of NF-Y (CAATTGGAT) was substituted with the sequence AAATACGGG 
resulting in the mutated construct, which was also cotransfected into HC11 cells. The results 
demonstrated that the mutation of the proximal NF-Y binding site significantly reduces the 
proximal PI activity in HC11 cells, and also significantly blocks the NF-Y mediated 
transactivation of proximal PI (Figure 18). Hence, NF-Y functions as an activator of proximal 
PI when it interacts with its binding motif in the proximal region. 
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Figure 18 The NF-Y binding site in the proximal PI is required for its basal activity and NF-Y 
mediated activitation  
600 ng of each NF-YA+B+C (each 200ng) were transiently cotransfected with 1.5 g of -127 or -127NFYm. In 
the mutated reporter (-127NFYm), the NF-Y binding site was disrupted by fusion PCR mediated site-directed 
mutagenesis from CAATTGGAT (wild type) into AAATACGGG. Error bars: SEM. Data shown are representative 
from three independent experiments assayed in triplicate. ** represents p<0.01. 
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3.4.2.2 NF-Y binds to proximal NF-Y binding motif 
To further determine whether NF-Y binds to the reverted CCAAT element (-127/-91) in 
proximal PI region, EMSA experiments were performed with the oligonucleotides 
corresponding to sequences -127 and -91 (Figure 19). The sequence of NF-Y consensus 
binding motif (Cicchillitti et al., 2004) was also used as a probe. Nuclear extracts from 
HEK293 cells expressing three recombinant NF-Y subunits (NF-YA, NF-YB and NF-YC) 
were incubated either with or without adding anti-NF-YA to the probes. The results 
demonstrated that the consensus NF-Y motif competes efficiently for the complex formed 
with the proximal NF-Y motif. The complexes formed with both probes are supershifted by 
the anti-NF-YA antibody (Figure 19). Taken together, the NF-Y complex binds to its proximal 
motif and contributes to activate the PI promoter.  
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Figure 19 EMSA analysis of NF-Y binding site in the proximal PI promoter.  
A) The NF-Y binding site of proximal PI and consensus. The bold letters represent the reverted CCAAT core site 
of NF-Y motif.  
B) NF-Y site in ACC- proximal PI were labelled and used for analyses. Nuclear extracts were prepared from 
HEK293 cells over-expressed with NF-Y[A +B +C]. FP: Free Probe; Cs: competition of itself cold probe; Cnfy: 
competition of NFY consensus probe; S: Shift; SS: Supershift with anti-NF-YA.  
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3.4.3 C/EBP factors activate the proximal PI promoter by interaction with the C/EBP 
site3 of proximal PI 
3.4.3.1 C/EBP factors bind to the C/EBP site3, but not site2 
Since the region -189/-166 in the PI promoter was identified as a C/EBP binding motif 
repressing PI activity, whilst C/EBP, -, - and - all up-regulated the PI promoter, I 
analyzed the proximal region (-127/+84) of PI and detected another two C/EBP binding 
motifs located at -74 bp and -6 bp. These are designated herein as C/EBP site2 and C/EBP 
site3 (Figure 20A). To identify nuclear factors that bind to this motif, again EMSA 
experiments were performed using nuclear extracts extracted from bovine and mouse cells or 
tissues. Incubation of a probe consisting of the C/EBP site3-wt with the nuclear extracts 
revealed three distinct protein-DNA complexes (‘S’ with three arrows, Figure 20C). Binding 
of the nuclear proteins to this probe was completely inhibited by an excess of unlabelled 
probe, while not affected by the addition of the mutated oligonucleotide C/EBP site3mu. 
Supershift assays further demonstrated the presence of the transcription factor C/EBP in the 
‘S’ protein-DNA complexes. The entire DNA-protein complexes bands seen in the absence of 
antibody were supershifted when anti-C/EBP (198) was included into the incubation. 
Comparable results were found by the addition of nuclear extracts from primary bovine 
mammary epithelial cells and mammary gland tissue. In contrast, incubation of a probe 
(C/EBP site2-wt) with nuclear extracts prepared from HC11 manifested no specific 
protein-DNA complexes (Figure 20C). Since the epitope recognized by the anti-C/EBP 
antibodies is conserved among C/EBP family members, these results indicate that members of 
the transcriptional factor C/EBP family can bind to the proximal C/EBP binding motif (C/EBP 
site3). However, it is unclear which ones.  
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Figure 20 Identification of the C/EBP site in the proximal PI promoter 
A) The putative C/EBP binding sites in the proximal PI and the repressive C/EBP binding motif (site1) are 
shown.  
B) The sequences of the relevant probes derived from the proximal PI sequence. For mutation of site3, the 
original sequences (bold) were mutated into the white with black background. The C/EBP consensus 
binding sequence was as described Wu et al, 2003. C) C/EBP site2 and site3 were labelled and were used 
for EMSA. Lane1-5 are for site2, and Lane 6-14 are for site3. Wt: wild type; Mu: mutant type. Nuclear 
extracts were prepared as described in method from HC11, primary bovine epithelial cells (pbMEC) and 
mammary gland (MG) tissue. ‘S’ with arrows indicates the shift bands. ‘SS’ with an arrow represents the 
retarded bands supershifted by antibody in the experiment.  
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3.4.3.2 C/EBP, - and - may interact with the C/EBP site3 
The C/EBP family members share a high degree of amino acid homology in the DNA binding 
and leucine zipper domains. In the family, four members (C/EBP, -, - and -) which have 
complete activation and repression domains, are regulated in different physiological 
conditions (Crosson et al., 1997; Matsuno et al., 1996; Ramji and Foka, 2002; Wu et al., 
1998). In order to determine which member directly interacts with the C/EBP binding motif in 
the proximal PI and potentially regulates bovine ACC- PI activity, HC11 nuclear extracts 
were isolated from control and DN-C/EBP vector-transfected cells. A labelled C/EBP site3-wt 
probe was incubated with each nuclear extract in the absence or presence of anti-C/EBP or 
anti-His-tag.  
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Figure 21 Identification of the members of the C/EBP family which directly bind to the proximal 
C/EBP binding site of PI 
The labelled probe of C/EBP site3 was used. Nuclear extracts prepared in HC11 cells were of control (HC11) or 
cells expressing DN-C/EBPs (DN-, DN- DN-, DN-). Antibody of SS1 is anti-C/EBP and that of SS2 is 
anti-His6. FP is free probe; C is competition of itself (the same sequence used for hot probe); Cm is competition 
of mutation; S is shift. Gel `a´ and `b´ were from one intact gel.  
 
Results revealed that nuclear extracts from transfected DN-C/EBP, - (Figure 21B gel -a and 
-b) and  cells (Figure 21B gel -c) formed one additional and prominent complex with the 
labelled C/EBP site3-wt probe. The additional protein-DNA complexes are competed by a 
molar excess of cold C/EBP site3-wt competitor, but are unaffected by a molar excess of 
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C/EBP site3-Mu competitor (Figure 21B gel-a, -b, -c). Hence, C/EBP, - and - may 
directly bind to the C/EBP site3 in the proximal PI. In contrast, weak protein-DNA complexes 
were detected in control (Figure 21B gel -a) and DN-C/EBP transfected cells extracts (data 
not shown).  
Antibodies were used to supershift the protein-DNA complexes in EMSA to further identify 
the specificity of direct binding of C/EBP, - and -. The results demonstrated that the 
retarded supershifted bands were visible by anti-C/EBP with nuclear extracts of control and 
DN-C/EBP, - and - transfected cells. However, the retarded complex could only be seen 
by anti-His-tag using the nuclear extracts prepared from DN-C/EBP and --transfected cells 
(Figure 21B gel `d´). For DN-C/EBP, all additional shifted bands are supershifted by 
anti-C/EBPantibodies (Figure 21B gel `c´). Taken together, C/EBP, - and - directly 
interact with the C/EBP site3 of proximal PI. 
3.4.3.3 Low amounts of C/EBP and -activate PI by dose dependent way 
The results described above establish C/EBP factors as possible positive regulators of bovine 
ACC- proximal PI activity. Transfection as little as 100 ng of C/EBP and - expression 
vectors into HC11 cells evidently stimulates the activity of long PI (Figure 16B). The amount 
of expression vector in these previous experiments was relatively low compared to the amount 
of PI reporter construct (1.5 g). To test whether low amounts of C/EBP and - factors could 
function as transcriptional activators of the proximal PI, the effect of increasing amounts of 
C/EBP and - expression vector on the proximal PI reporter construct was titrated. 
Increasing amounts (10, 40, 70, 100 ng) of C/EBPexpression vector were contransfected 
with a constant amount of the proximal promoter -127. The proximal promoter activity was 
increased from 15 to 42 -fold of pGL3basic (Figure 22A). A similar result was obtained for 
C/EBP. The proximal promoter activity was increased in this setting from 15 to 37 -fold that 
of pGL3basic. The extent of activation by C/EBP is slightly lower than that by C/EBP. 
These data indicate that already, low amounts of C/EBP and - transactivate the proximal 
bovine ACC- PI promoter in a dose-dependent manner in HC11 cells.  
In order to demonstrate which of the domains of C/EBP factors are relevant for PI activation, 
the C/EBP factor was divided into two parts. C-C/EBP contains the first 263 amino acid 
residues of C/EBP, carrying a Flag-tag and a strep-tag at its N-terminus and C-terminus 
respectively (Data not shown). N-C/EBP (named also DN-C/EBP) contains 89 residues 
from amino acid 265 to amino acid 353, and a His-tag and a Strep-tag were fused to its 
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N-terminus and C-terminus respectively. To examine the functions of the fusion proteins in 
regulating the proximal PI, these vectors were individually transiently transfected into HC11 
cells with the proximal PI reporter construct (-127). Overexpression of full length (FL) 
C/EBP evidently increased the proximal PI activity. However, the proximal PI activities 
were not altered in N- and C-C/EBP transfected cells (Figure 22B).  
Taken together, these results show that C-terminal binding of C/EBP to proximal PI is not 
sufficient for PI activation. The presence of the N-terminal domain is also required, 
highlighting the functional requirement of the N-terminus as a transcriptional activator. 
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Figure 22 The functional role of C/EBP and - on the proximal PI 
A) Various amounts (10, 40, 70, 100 ng) of C/EBP or -expression plasmid were transiently cotransfected into 
HC11 cells together with 1.5 g of the proximal PI reporter construct (-127). The total amount of transfected 
DNA was kept constant, by filling up accordingly with the empty pFLAG.cmv. Error bars: SEM. Data was from 
three independent experiments. 
B) 100 ng of full length (FL), N- terminus (C) and C-terminus (N) of C/EBP expression vectors 
(constructions as described in Figure 43: C=P2, N=DN) were cotransfected with -127 reporter construct 
into HC11 cells. Activity indicated was from three assays of one experiment. Error bars: SEM. **p<0.01. 
3.4.3.4 High amounts of C/EBP and - activate proximal PI  
Low amount of C/EBP and - did not activate the proximal PI promoter. To test the 
efficiency of larger amounts, different amounts of C/EBP and - were transiently transfected 
into HC11 cells with 1.5 g of proximal PI reporter construct (-127). The activity of proximal 
PI was significantly increased up to 75 -fold that of pGL3basic by expressing 1000 ng of 
C/EBP vector (relatively high amount of C/EBP expression vector). A similar result was 
acquired by C/EBP, but the extent of activation (20 –fold of pGL3basic) is quite lower than 
that by C/EBPFigure 23A.  
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Figure 23 High amounts of C/EBP and - transactivate the proximal PI in a dose-dependent 
manner
A) Different amounts of C/EBP factors were transiently cotransfected into HC11 cells with 1.5 g of proximal PI 
reporter (-127). The activity indicated was the fold change of mock in which the reporter was cotransfected with 
the empty plasmid pFLAG.cmv. Error bars: SEM. Data shown were the mean values of at least three independent 
experiments. **T-test against control: p<0.01.  
B) Various amounts (50, 100, 500, 1000, 1500 ng) of C/EBP or -expression plasmid were transiently 
transfected into HC11 cells with 1.5 g of proximal PI reporter construct (-127). The amount of expression 
vector was filled up to 1500 ng with pFLAG.cmv. Activity is the fold of pGL3basic. Error bars: SEM. Data were 
from three assays of one experiment. 
 
To test the specificities of the activation by C/EBP and - an ascending titration of C/EBP 
and - expression vectors (50, 100, 500, 1000, 1500 ng) were cotransfected into HC11 cells 
with 1.5 g of proximal PI reporter construct. Below 100 ng, C/EBP and - expression 
vectors had no effect on the activity of proximal PI. Above that, increasing amounts of 
C/EBP and - activate proximal PI activity, but the activation extent by C/EBP is evidently 
lower than that by C/EBP(Figure 23B). The extent of activation peaks at 1000 ng of 
C/EBP and 1500 ng of C/EBP. In contrast, the activation extent seems to slightly decrease 
when the amount of the expression vector of C/EBP and - increased from 100 ng to 300 ng 
(Figure 23A, B).  
Taken together, these data indicate that high amounts of C/EBP and - can transactivate the 
proximal PI promoter.  
3.4.3.5 Mutation of the C/EBP site blocks the activation by full length C/EBP proteins 
To examine further the function of the C/EBP binding motif (site3) in the proximal PI region, 
a mutation was introduced into the core sequence of C/EBP site3 in the context of proximal PI 
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reporter (-127), resulting in the construct -127site3mu1 reporter (Figure 24). The 
responsiveness of this reporter to the binding of C/EBP, - and - was then determined in 
HC11 cells by transient transfection assays. Mutation of the proximal C/EBP binding motif 
abolished the basal promoter activity of the reporter construct (-127site3mu1). Furthermore, 
the C/EBP, - and - mediated transactivations were significantly reduced (Figure 24).   
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Figure 24 Mutational analysis of C/EBP binding site3 in proximal PI region by cotransfection 
with C/EBP, - and -
100 ng (A) and 1 g (B) of expression C/EBP vectors was cotransfected with PI long (-1045, k609) and 
proximal (-127, k429) promoters. The C/EBP site3 in the proximal region was mutated from the wild type 
sequence TTGTGTAAT into TTGTagcca in m1 and gactagAAT in m2. The results show one representative 
from at least two independent experiments with assays in triplicate. Error bars: SEM.  
 
Previously, our lab reported that ACC- PI transcription starts at the first 'A' lying in the 
C/EBP site3. In site3mu1, the original sequence TTGTGTAAT (-6/+3) was mutated into 
TTGTagcca. Herein the TSS was blocked and the mutation should theoretically abolish the 
transcription start. In order to examine the role of the TSS in the regulation of PI when 
activated by C/EBP factors, the second mutation (site3mu2) was introduced keeping the TSS 
and converting the original sequence TTGTGTAA into gactagAAT. Results indicated that 
the second mutation also abolished the basal promoter activity of the reporter construct 
(-127site3mu2). Likewise, C/EBP, - and - mediated transactivations were evidently 
blocked (Figure 24).  
Subsequently, the same mutations were analyzed in their effect on the activity of the long PI 
reporter construct (-1045). Both mutations blocked the transactivations mediated by C/EBP, 
- and - in mutated reporter constructs (-1045site3mu1, -1045site3mu2) transfected cells. 
Taken together, these data indicated that the C/EBP binding motif (site3) of the bovine ACC- 
PI promoter is required not only for C/EBP, - and --mediated transactivation, but also for 
basal promoter activity in HC11 cells. 
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3.4.3.6 DN-C/EBPs block its activation by full length C/EBP and . 
To further investigate the contributions of C/EBP factors to the basal activity of PI in vivo, 
DN-C/EBP proteins were transiently transfected into HC11 cells with the proximal PI reporter 
construct. Theoretically, DN-C/EBP proteins harboring only the DNA binding domain and 
leucine zipper domain will bind to their binding motif compete for originally bound 
transcription factor, and eventually abolish its transactivation function. The inhibitory 
activities of DN-C/EBP and DN-C/EBP were first titrated in transient transfection assays 
with the C/EBP or C/EBP expression vectors and the proximal PI reporter (Figure 25A). 
2.7 g of various DN-C/EBP expression vectors was cotransfected into HC11 cells with 0.9 
g of proximal PI reporter construct. Over-expression of DN-C/EBP and C/EBP (CHOP), 
but not -, - and - significantly reduced the ACC- PI activity by (~40 %) in HC11 cells. 
These data show that DN-C/EBP and CHOP efficiently function as repressors of the basal 
activity of ACC- PI in HC11 cells (Figure 25B), whereas DN-C/EBP or DN-C/EBP 
sufficiently repress the activation by their respective full length proteins. 
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Figure 25 Inhibitional analysis for the basal activity of PI by DN-C/EBPs in HC11 cells 
A) 0.9 g of proximal PI reporter construct (-127) and a constant amount of C/EBP or - (0.3 g) was 
cotransfected into HC11 cells with no or increasing mounts of DN-C/EBP or - expression vectors (0.33, 1 and 
3 fold the amount of reporter construct -127). 
B) 2.7 g DN- expression vectors was contransfected into HC11 cells with 0.9 g of proximal PI reporter 
construct. C/EBP vector expressing human CHOP protein. Data shown were from two independent experiments. 
Error bars: SEM. *:p<0.05, **:p<0.01 
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3.5 The molecular mechanism of PI repression 
3.5.1 NF-Y synergistically represses C/EBP mediated activation of the proximal PI by 
specific protein-protein interaction 
So far it has been identified and characterized that both NF-Y and C/EBP,  and  directly 
bind to respective binding sites in the proximal PI region and contribute to activate PI. The 
center position of the NF-Y binding site is at -110 bp, while C/EBP binding site lies at -2 bp. 
There are 109 nucleotides, including 10  helixes, between these two binding sites. It is 
possible that one protein may interact with the other to regulate transcription initiation by 
DNA bending at transcription start site.  
3.5.1.1 NF-Y specifically represses C/EBP mediated activation on proximal PI 
To investigate the functional relationship between NF-Y and C/EBP factors in controlling the 
proximal PI activity, expression vectors of NF-Y [A+B+C] and/or respective C/EBP factors 
were cotransfected into HC11 cells with the proximal PI reporter construct. Consistent with 
the previous results, NF-Y (~1.5 -fold) and C/EBP (~5.3 -fold) separately and significantly 
transactivate the proximal PI activity (Figure 26A). Surprisingly, NF-Y[A+B+C] decreased 
the C/EBP mediated activation of proximal PI expression, from 45 –fold to 15 –fold of 
pGL3basic (Figure 26A). 
 
To confirm the specificity of this observation, increasing amounts (30, 90, 300, 900, & 1500 
ng) of NF-Y [A+B+C] expression vectors were cotransfected into HC11 together with 
constant amounts gof C/EBP. Increasing amounts of NF-Y [A+B+C] decreased the 
extent of C/EBP mediated activation, from 100 % down to 37 % (Figure 26B). These data 
showed that NF-Y represses the C/EBP mediated activation in ACC- PI in a 
dose-dependent manner. 
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Figure 26 NF-Y and C/EBP synergism repressing the proximal PI 
A) NF-Y significantly represses C/EBP-mediated activation. The ** on an empty column represents that the 
t-Test was performed against the control which was cotransfected with pFLAG.cmv, but without NF-Y[A+B+C]. 
Error bars: SEM. Data were from one experiment assayed in triplicate. **: p <0.01; *: p <0.05.  
B) The activation of C/EBP was inhibited by NF-Y in a dose-dependent manner. X-axis is in natural 
logarithmic scale. Data shown were representative from two independent experiments assayed in triplicate.  
 
Transfections were performed in HC11 cells. The total amount of DNA in each transfection was constant. 0.5 μg 
for each NF-Y subunit, C/EBP and –, 1 μg for C/EBP and  were used to attain maximal activation. These 
amounts were determined previously by titration. The transfection efficiency was normalized with phRL-TK 
renilla; data were normalized with pGL3basic. B) Similar as A), the amount of NF-Y[A+B+C] was titrated from 
30 ng till 1500 ng. NF-Y represses very significantly the C/EBP mediated PI activation. 
 
3.5.1.2 All subunits of NF-Y are indispensable for the repression of C/EBP activated 
proximal PI 
NF-Y regulates gene expression only if all three NF-Y factors (NF-YA, NF-YB, NF-YC) form 
a heterotrimer, known to constitute the active factor “NF-Y”. NF-Y can bind to its DNA 
binding motif by its NF-YA subunit, when NF-YA recognizes the NF-YB/NF-YC dimer. In 
order to identify if the inhibition is based on the entire NF-Y complex, NF-YA, -B, and/or -C 
were cotransfected either alone or together into HC11 cells with the C/EBP expression 
vector and proximal PI reporter construct. Moreover, to identify whether the inhibition is 
depended on the proximal NF-Y binding site of proximal PI, DNA binding function of NF-YA 
is devoid by substituting three amino acids (RGEAAA) at its C-terminus as described 
(Mantovani et al., 1994), resulting NF-YAm29. Analyses showed that the binding activity of 
the nuclear extract from HEK293 cells expressing NF-YAm29, -YB and -YC subunits 
(non-binding NF-Y) was decreased by 28 % of the control (Figure 27B). In contrast, the 
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nuclear extract of cells expressing NF-YA, -YB, -YC subunits possessed strong binding 
activity (100 %) when detected using labelled NF-Y consensus probes.  
Results indicated that the C/EBP mediated activation is repressed by NF-YA, -YB, -YC 
complex, and is also repressed by NF-YAm29, -YB, -YC complex (Figure 27A). But the 
C/EBP mediated activation can not be inhibited by any respective subunits of NF-Y 
including NF-YAm29. Hence, the inhibition of between NF-Y complex and C/EBP is 
independent from NF-Y binding to its proximal PI site. 
 
32P- NF-Y consensus motif
FP     C       S     SS C      S      SS
NE/HEK:     NFYA+B+C NFYAm29+B+C 
SS
S
10
20
30
40
50
60
70
80
90
100
NFYA + - + - - -
NFYB - + + - - + -
NFYC - + + - + - -
YAm29 - - + - - - + 
Fo
ld
 o
f p
G
L3
ba
si
c
A.
-127
B.
control C/EBP
-
-NFYA -NFYA
activity:  100%               28%
** **
 
Figure 27 Comprehensive analyses of the interaction of NF-Y and C/EBP by cotransfection in 
HC11 cells 
A) The inhibition of C/EBP activity is dependent of the intact NF-Y complex, but independent of the binding of 
NF-Y complex to its proximal binding site. 0.5 g each different subunit expression vectors or combinations of 
NF-YA, YB, YC YAm29 were examined for inhibition of C/EBP activity (by 1g of expression vector). 
Activity was normalized by pGL3basic. Data are representative of three independent experiments. Each assay is 
in triplicate. Error bars: SEM. ** represents p<0.01. 
B) Binding activity of recombinant `non-binding NF-Y´ was blocked by a three amino acid AAA substitution of 
the original RGE in the binding domain of NF-YA, resulted in NFYAm29. The nuclear extracts (NE) were 
prepared from HEK293 cells expressing recombinant NFYA+YB+YC and NFYAm29+YB+YC. S with an arrow 
is the DNA-protein complex, and SS indicates the retarded supershifted band. The consensus NF-Y binding 
motif was labelled for probe in the experiment.  
 
3.5.1.3 NF-Y and C/EBP bind to proximal PI by specific protein-protein interaction  
In order to analyze if the protein-protein interaction model between NF-Y and C/EBP is 
relevant to PI promoter activity in vivo, HEK293 cells were cotransfected with NF-YAm29, 
YB, YC and C/EBP vectors together with the proximal reporter construct. Inclusion of the 
expression construct NF-YAm29, ensured that the mutational NF-Y complex could not 
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directly bind to their cognate DNA-binding motif on the -127 reporter construct.  
Chromatin ImmunoPrecipitation (ChIP) technique was used to determine whether C/EBP 
and NF-Y interacted directly and occupied the proximal PI promoter binding site. The NFY 
antibody precipitated 5.1 fold of the amount of the PI promoter molecules than that of control 
IgG (Figure 28C). The C/EBP specific antibodies precipitated 3.4 fold the mount of PI 
molecules than the control IgG. Hence, both ‘non-binding NF-Y’ and C/EBP effectively 
interact with the proximal PI region.  
Because the binding domain of NF-Y was blocked using NF-YAm29, NF-Y interaction with 
the proximal PI promoter occurred via protein-protein interaction between NF-Y and C/EBP.  
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Figure 28 ChIP reveals that C/EBP binds to PI promoter and forms a complex with NF-Y in vivo.
A) Schematic representation of the proximal PI promoter on the reporter construct (-127) for ChIP. Arrows show 
the positions of the real-time PCR primers. B) Sonification of the transfected HEK293 cells. C) ChIP analysis 
using different antibodies. Data indicate the means of four qPCR quantifications from one precipitation. Error 
bars: SEM. ** represents p<0.01. 
Four g of proximal reporter construct (-127), 4 g of C/EBP and 4 g of NF-YC expression vector were 
cotransfected into HEK293 cells together with 8 g of NF-YAm29, 8 g of NF-YB expression vectors in a 
~90-mm cell culture plate. Crosslinked protein-DNA complexes were incubated with anti-NF-YA or 
anti-C/EBP antibodies and isolated by immunoprecipitation with protein A-Sepharose beads. DNA was 
immunoprecipitated and the amounts of the proximal C/EBP site3 were measured by qPCR, using primer pairs 
(chip_ f2, Luc_r) derived from this region of the reporter construct.  
3.5.2 Affinity comparison of the cis-elements in different region of PI 
It has been proven in this study that NF-Y as well as C/EBP binding elements in the distal 
promoter both represses PI activity, opposing their function on the proximal promoter. It could 
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be possible that the binding affinity of these two factors for the distal and proximal sites is 
different, and thus eventually contributing different functions, either repressor or activator, to 
the wt promoter.  
3.5.2.1 The NF-Y binding site in the proximal region has higher affinity than the 
repressive binding site in the distal region 
To evaluate the relative binding affinity of the distal and proximal binding sites, competition 
EMSA was performed with a labelled NF-Y consensus probe. Double stranded 
oligonucleotides with the original sequence of either the distal or the proximal NF-Y binding 
sites were included as unlabelled competitor molecules. Nuclear extracts were prepared from 
HEK293 cells expressing recombinant bovine NF-YA, -YB and -YC subunits. The 
dissociation of the specific NF-Y-DNA complexes was determined by analyzing the 
complexes in the presence of different molar excesses of competitor (Figure 29).  
The results manifested that an increasing molar excess of both competitors dissociate the 
NF-Y-DNA complexes formed by exogenous NF-Y consensus probes (Figure 29). However, 
25 –fold molar excess of the NF-Y proximal site competitor efficiently reduce the 
NF-Y-consensus DNA complexes by 80 % (20 % NF-Y-DNA complexes residual), whereas 
as much as 200 -fold molar excess of the NF-Y distal site competitor was required to reduce 
the amount of the shifted NF-Y-DNA complexes (Figure 29). Moreover, the labelled NF-Y 
proximal site and distal site probe was efficiently extinguished by the proximal site 
competitors, but inefficiently by the distal site competitors (data not shown). These results 
demonstrated that the NF-Y binding affinity for the proximal binding site (activator) is 
significantly greater than that of the distal binding site (repressor). 
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Figure 29 The affinity comparison of the NF-Y proximal and distal sites of PI 
HEK293 cells expressing recombinant bovine NF-Y[A+B+C] and oligonucleotide probes of NF-Y distal and 
proximal sites (corresponding to sequences -1052 to -1009 and -127 to -91, respectively) were used in EMSA. 
The NF-Y consensus oligonucleotide (AGACCGTACGTGATTGGTTAATCTCTT) probe was designed as 
described (Zhao et al., 2000). Amounts indicated are the molar excess of the corresponding competitor. The 
labelled probe is the NF-Y consensus binding motif. Densities of protein-DNA complexes were quantitated by 
phosphorimager analysis and the net value obtained for protein-DNA complexes in the absence of competitors 
was set to 100 %. The empty triangle represents the values obtained under competition with the NF-Y proximal 
binding site (-127 to -91), and the solid square represents the values generated by the NF-Y distal competitor 
(-1052 to -1009).  
 
3.5.2.2 The C/EBP site in the proximal region has a higher affinity than the repressive 
site in distal region 
The binding affinities of the distal and proximal C/EBP binding sites were evaluated in a 
similar experiment. The nuclear extracts were extracted from HC11 cells expressing 
recombinant bovine DN-C/EBP. In bovine DN-C/EBP, 154 amino acid residues of the 
N-terminus were deleted, but the DNA-binding domain and leucine zipper domain were kept. 
The C/EBP proximal binding site efficiently competes for the labelled consensus probe 
(Figure 30), as well as the labelled proximal or distal probe (data not shown). The distal 
C/EBP binding site, however, only ineffectively competes for the labelled probe.  
Taken together, the proximal sites of both factors have much higher binding affinities than the 
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respective distal sites. Hence, small amounts of either factor are sufficient to saturate the 
proximal binding site and activate the promoter. Much higher concentrations, however, are 
necessary to saturate the distal binding sites. Once these are occupied, then the distal factors 
can feed back to repress the activation potential of the either NF-Y and/or C/EBP bound 
proximal attachment site. 
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Figure 30 The affinity comparison of the C/EBP proximal and distal sites in PI 
HC11 cells expressing recombinant bovine DN-C/EBP and oligonucleotide probes of C/EBP distal and 
proximal sites (corresponding to sequences -198 to -166 and -26 to +9, respectively) were used in EMSA. The 
sequence of the C/EBP consensus oligonucleotide (TGCAGATTGCGCAATCTGCA) probe was as described 
(Wu et al., 2003). Amounts indicate the molar excess of corresponding competitor. The labelled probe was 
C/EBP consensus binding motif. Densities of protein-DNA complexes were quantitated by phosphorimager 
analysis and the net value obtained for protein-DNA complexes in the absence of competitors is set to 100 %. 
The empty triangle represents the values by the proximal C/EBP binding site competitor (-26 to +9), and the 
solid square represents the values by the distal C/EBP competitor (-198 to -166). 
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3.6 The associations of the levels of NF-Y and C/EBP factors with PI activity 
Data from this study indicate that in vitro, NF-Y and C/EBP factors play an essential role in 
the regulation of ACC- PI activity in the model cells. The investigation of their changes 
during different physiological conditions will contribute to unraveling the molecular 
mechanisms controlling ACC- PI activity.  
3.6.1 The proportion of NF-Y over C/EBP correlates with the tissue specific level of 
PI activity 
It was reported that the NF-YB and -YC heterodimer is ubiquitously expressed, being 
detectable in all tissues, whereas NF-YA is not ubiquitously expressed (Gurtner et al., 2003; 
Tomita and Kimura, 2008). Hence, the regulation of NF-YA expression controls levels of 
functional NF-Y complex in a tissue-specific manner (Farina et al., 1996). Since the current 
study revealed that NF-Y and C/EBP may control ACC- PI activity by protein-protein 
interaction, I hypothesized that in the cow the interplay of NF-Y and C/EBP may also 
regulate ACC- PI activity. Hence, the association between ACC- PI activity and the mRNA 
levels of NF-Y (by measuring NF-YA) and C/EBP factors was examined in bovine tissues.  
 
As has been examined, ACC- PI activity is dramatically down-regulated by starvation 
(Figure 8A), but the mRNA levels of NF-YA or C/EBP have not been changed (see appendix 
J). Considering that fatty acid synthesis is active in the mammary glands, the C/EBP and 
NF-YA mRNA levels were investigated in these tissues from different groups, with different 
diets. Results indicated that C/EBP is significantly up-regulated by starch-enriched diets, but 
transcripts of ACC- PI are insignificantly down-regulated. The mRNA levels of NF-YA are 
not changed.  
However, ACC- PI is maximally expressed in the mammary gland, while expression is 
moderate and minimal in the adipose tissue and liver respectively. Hence, ACC- PI 
transcripts are expressed in a tissue specific manner (Table 8). The difference of the maximal 
PI activity and the minimal PI activity is ~400 –fold between mammary gland and liver. 
Surprisingly, similar levels of NF-YA mRNA copies were found in all tissues, for the most 
part, this remained true for C/EBP expression except for very low expression in the mammary 
gland. Further analyses indicated that the difference of NF-YA over C/EBP between liver 
and adipose is ~2 –fold, and that between liver and mammary gland is about ~10 –fold. Hence, 
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the levels of NF-YA over C/EBP also change in a tissue-specific way. 
Table 8 mRNA copies of ACC- PI, NF-YA and C/EBP in various tissues under different 
nutritional conditions 
Copies/200 ng 
RNA Liver Adipose Mammary Gland 
 starveda feda fat-dietb starch-dietb starch-dietb fat-dietb 
ACC- PI (×104) 0.10 ± 0.02 0.52 ±0.18 6.81 ±2.24 8.49 ±4.86 21.64 ±4.8 40.57 ±12.3 
NF-YA (×103) 8.94 ±1.05 7.64 ±0.71 10.41 ±0.91 18.57 ±7.61 8.36 ±1.39 8.31 ±1.24 
C/EBP(×106) 43.71 ±2.49 37.06 ±7.98 24.50 ±3.53 30.83 ±10.99 6.12 ±0.81 3.78 ±0.60 
NFYA:C/EBP 2.06 ±0.24 2.44 ±0.64 4.69 ±0.66 6.45 ±0.90 14.26 ±1.76 26.25 ±4.76 
NEL [MJ] 18.0 ±1.1 110.2 ± 11.2 nd nd nd nd 
RNA from liver, fat and mammary gland tissues was reversely transcribed and measured by real-time PCR. 
NEL, Net Energy content for Lactation; nd, not determined. a: (n=6); b: (n=8). Each value represents the 
relative mRNA copies and is mean ± SEM.  
 
Intriguingly, high PI expression levels in lactating udder appear to be correlated with a high 
proportion of NF-YA mRNA over C/EBP mRNA molecules (Table 8). The intermediate PI 
activity measured in adipose tissue also demonstrates an apparent link with an intermediate 
ratio of NF-YA over C/EBP mRNA molecules. This trend continues in the liver, where PI 
activity is low and NF-YA mRNA abundance compared to that of C/EBP is also low. Hence, 
the proportion of NF-YA over C/EBP correlates with the tissue-specific PI activity (Figure 
31). 
Statistically, this correlation is highly significant. Thus, tissue and nutrition related alteration 
in the RNA abundance of those factors previously shown in vitro to contribute to the 
molecular controls of PI activity, may also be true in vivo.  
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Figure 31 The correlation of ACC- PI activity and the ratio of NF-YA/C/EBP
Data were from Table 8. Li, Fa and MG indicate liver, fat and mammary gland tissues respectively. Error 
bars are SEM. of 6 or 8 animals. 
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3.6.2 mRNA levels of NF-Y and C/EBP factors may not be regulated in the liver
To analyze the response of C/EBP factors to feeding, real-time PCR was performed to 
measure the mRNA levels of ACC- derived from PI, C/EBP, -, - –and NF-YA 
in the liver. However, different diets did not influence these factors in according to PI activity. 
Surprisingly, C/EBP and - appear to increase in tendency (p<0.1) response to starvation, in 
opposition to ACC- PI activity declining with starvation (appendix J). The mRNA level of 
beta-actin was not significantly altered by starvation. This measure was assessed for technical 
control.  
3.6.3 C/EBP and – may be repressors, but C/EBP and NF-YA may be activators in 
adipose tissues during the transition period (before and after calving) 
To know the association of PI activity with the expressions of C/EBP factors in adipose tissue, 
the same samples in which I know that PI expression is physiologically and nutritionally 
regulated, were used to measure the mRNA levels of C/EBP factors by real-time PCR (Table 
9). Results demonstrated that mRNA level of C/EBP has a tendency to decrease after 
calving (p<0.1) in the starch-enriched group, and also insignificantly in the fat-enriched group. 
The ratio of before to after calving was 2.16±0.45 in starch-diet group, or 1.78±0.38 in 
fat-diet group analyzing on individuals (Table 9). Accordingly, mRNA expression of NF-YA 
decreased in tendency (p<0.1) after calving in the fat-enriched diets group. The ratio of before 
to after is 1.53±0.25. Hence, C/EBP and NF-YA are positively correlated to PI activity 
before and after calving in adipose tissue by given diets.  
Surprisingly, mRNA expressions of C/EBPand increased after calving in both starch- and 
fat-enriched diet groups, and C/EBP decreased significantly in the fat-enriched group 
(p<0.05). The ratio of before calving to after calving of these genes is listed in Table 9. The 
trend shown by these two factors opposes that of PI activity, functioning as a repressor.  
 
Taken together, C/EBP and NF-YA may be the activators of PI expression in adipose tissue 
in the transition period (before and after calving), but C/EBP and - may function as 
repressors.  
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Table 9 mRNA expressions of relevant genes in adipose tissue before or after calving by 
different diets 
Copies (by diets) p_calving  
 Starch-diets Fat-diets Starch-enri. Fat-enri. 
p_diets 
Before Calving x103 5.44±1.34 9.09±2.83 0.36 
After calving x103 0.04±0.01 0.13±0.04 <0.01 <0.05 0.10 ACC PI 
Before: After  256±64 65±18   <0.05
Before Calving x105 1.43 ±0.25 1.38±0.33 0.92 
After calving x105 0.75 ±0.12 0.88±0.16 <0.1 0.29 0.61 C/EBP 
Before: After  2.16±0.45 1.78±0.38   0.60 
Before Calving x106 1.69±0.34 1.93±0.28 0.66 
After calving x106 1.32±0.22 1.79±0.41 0.44 0.83 0.42 C/EBP 
Before: After  1.51±0.40 1.34±0.22   0.76 
Before Calving x106 0.69±0.11 0.88±0.07 0.21 
After calving x106 1.38±0.32 1.39 ±1.52 <0.1 <0.05 0.99 C/EBP 
Before: After  0.56±0.09 0.75±0.18   0.45 
Before Calving x104 2.10±0.64 2.12±0.34 0.98 
After calving x104 2.29±0.47 3.38±0.63 0.84 0.18 0.26 C/EBP 
Before: After  1.10±0.28 0.75±0.11   0.35 
Before Calving x103 2.36±0.91 1.40±0.13 0.37 
After calving x103 1.43±0.34 1.06±0.11 0.44 <0.1 0.31 NF-YA 
Before: After  1.85±0.52 1.53±0.25   0.59 
Before Calving x105 2.50±0.50 2.29±0.26 0.87 
After calving x105 2.40±0.70 2.59±0.30 0.84 0.70 0.75 -actin 
Before: After  1.67±0.43 1.04±0.18   0.27 
Adipose samples were used for analyses (n=8). Each value represents the mean ± SEM. The highest and the 
lowest PI expression values were deleted for statistic analysis of t-test, accordingly the expression of the 
relevant genes.  
3.6.4 Bovine C/EBP-Thr269 (relative mouse Thr	) is phosphorylated in refed liver 
Considering the regulation of different transcription factors is tissue-specific, the mRNA 
levels of C/EBP remain constant during feeding changes in the liver (Figure 8A). Data in 
vitro have shown that C/EBP binds to and regulates the bovine ACC- PI promoter (Figure 
21B). Moreover, it is reported that Thr269 (relative to mouse Thr217) was phosphorylated to 
activate the proliferation of stellate cells. Examination of the phosphorylation of bovine 
C/EBP-Thr269 was performed using an antibody that recognizes the conserved mouse 
phosphorylated Thr217 of C/EBPby western blot. Results showed that the Thr269of C/EBP 
is greatly phosphorylated in the liver of refeeding cows (Figure 32). In contrast, the 
expression of LAP1, LAP2, LIP and alpha-actin prevails during diet changes. Hence, 
phosphorylation of bovine C/EBP Thr269 is increased by refeeding and may contribute to 
activate PI activity.  
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Figure 32 Refeeding robustly phosphorylates bovine C/EBP Thr269
Liver samples were obtained from cows fed normally, and starved for 43 h, and then refed for 29 h. Tissues 
were ground in liquid N2, and lysed with lysis buffer (0.1 M Tris-Cl pH8.0, 0.15 M NaCl, 1 mM EDTA, 
1Mm DTT, 1 mM PMSF, 0.5 % Sigma cocktail inhibitor, 1 % triton, 0.5 % NP-40, 20 mM NaF, 1 mM 
NaVO3) at a concentration of 0.5 mg/ml. Cell lysates were sonicated for 2 min in an ice-cold water bath to 
shear genomic DNA. Samples loaded were from different animals. lane1:J2067; lane2 J2069; lane3: J2055; 
lane 4:J2057; lane5: J1550; lane6: J1553. Equal amounts of protein (50 g) were loaded on 12 % 
SDS-PAGE for Coomassie brilliant blue staining and Western bloting. Phosphorylation of C/EBP Thr269 
was detected by anti-mouse-C/EBP p-Thr217; LAPs and LIP of C/EBP were probed by anti-C/EBP 
(sc-150); Anti-alpha-actin was used to probe for loading control. Detection antibody was conjugated with 
alkaline phosphatase. The ready membrane was developed with BCIP/NBT.  
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4 Discussion 
4.1 ACC- is the regulation target of lipid metabolism in cattle 
ACC- is the rate-limiting enzyme in long-chain fatty acid synthesis de novo (Kim, 1997). 
Malonyl-CoA, the product formed by ACC-, is the two-carbon donor in the elongation of 
fatty acid in the cytosol. In mouse liver, conditional knockout of the ACC- biotin binding site 
decreases both the level of malonyl-CoA and triglycerids, and the de novo synthesis of fatty 
acids (Mao et al., 2006). The results cited above support the role of ACC- in de novo lipid 
biosynthesis.  
ACC- contributes to biological membranes, lipid signaling and the accumulation of large 
amounts of lipids in lipogenic tissues, such as liver, adipose tissues and mammary glands. The 
fatty acid synthesis is vital for making up of cells. Fatty acids are the main structural 
components of biological membranes, including the cellular plasma membrane and the 
intracellular membranes of organelles. The diverse functions of eukaryotic cells are dependent 
on the well compartmentalized organelles. Meanwhile, the derivative of fatty acids are 
involved in a vital part of the cell signalling (Wang, 2004), such as sphingolipid, 
diacylglycerol, phosphatidylinositol phosphates (PIPs) and the steroid hormones (Eyster, 
2007). The fatty acids-formed triacylglycerols are a highly efficient form of energy storage in 
higher animals, whereas plants can afford to store energy in a less compact but more easily 
accessible form, carbohydrate. 
Research on human and mouse manifests that the dysregulation of lipid metabolism may 
result in metabolic diseases such as obesity and diabetes. In cattle, the dysregulation of lipid 
metabolism in dry standing may result in metabolic disorders (e.g. ketosis). It is also reported 
that dysregulation of lipid metabolism accompanies cancer. The silencing of the 
ACC--encoding gene inhibits cell proliferation and induces caspase-mediated apoptosis of 
highly lipogenic prostate cancer cells (Brusselmans et al., 2005). Hence, regulation on ACC- 
may contribute to the control of lipid metabolism.  
ACC- plays an essential role in cell activities. Thus, not surprisingly, ACC- KO is lethal 
for mouse embryo (Abu-Elheiga et al., 2005). In contrast, ACC- deficient mice can live 
normally, and it appears the lipid oxidation is not inhibited (Abu-Elheiga et al., 2003). 
Improved understanding of ACC- regulation may provide an insight into the therapy of 
Discussion 
90 
metabolic disease and the enhancement of beef or milk quality. In the study, I focus on the 
regulation of PI in bovine ACC-.  
4.2 PI is the nutritionally regulated promoter 
In cattle, four promoters (PIn, PI, PII, PIII) control ACC- expression. PI, PII and PIII have 
been reported previously (Mao et al., 2001; Mao et al., 2002; Mao and Seyfert, 2002; 
Molenaar et al., 2003). PIn was isolated and identified as one of the ACC- promoters in the 
current study. 
4.2.1 PIn is not the principle promoter in lipogenic tissues 
PIn is the most 5´ promoter of bovine ACC-. The identified PIn features characteristics 
similar as its homologs of other species. It is GC-rich (Figure 37), a bidirectional promoter, 
and locates faraway upstream (41 kb) of the next promoter (PI). The isolation of PIn extends 
the knowledge about the regulation of the bovine ACC-. A previously existing gap in the 
complete bovine genome DNA-sequence between the TADA2L gene and ACC- is filled in 
by the sequence of PIn as characterized here. The transcripts generated from PIn in different 
species are similar. They contain exons [1n:4:5] and [1n:5] forming the 5´-UTR of the ACC- 
mRNA in cattle (this work, Figure 35).  
PIn is a tissue-specific promoter of ACC- in brain. Functional analysis indicated that the 
bovine PIn has a very low activity in the murine mammary epithelial cells HC11. The activity 
of PIn is only ~3.3 –fold of pGL3basic (Figure 39). Hence, PIn barely drives the activity of 
this promoter-less vector. Expression profiles of PIn mRNA molecules demonstrate that PIn is 
highly expressed in the brain, but very low in liver, adipose tissues and mammary gland. 
These are the main lipogenic tissues (Figure 38). This highlights that bovine PIn is a 
brain-specific promoter, which is consistent with the homolog of sheep (Travers et al., 2005). 
Hence, bovine PIn may drive ACC- transcription initiation in brain and regulate the 
synthesis of fatty acids in the brain neural cells, but it is not the main promoter for ACC- 
expression in lipogenic tissues. 
The key issue to characterize PIn for this study was to examine if (i) such a 5´-located PIn 
might be expressed in cattle as well, and (ii) if such a “PIn” might eventually override the 
regulation of PI. 5´-RACE showed that transcripts from PIn do not contain exon1 (Figure 35). 
Hence transcripts containing exon1 start from PI. Characterization of PI derived transcripts 
allows characterizing the activity of PI. 
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4.2.2 PI is the key promoter relevant for the nutritional regulation of fatty acid 
synthesis in lipogenic tissues 
Previous work indicated that PI is the prominent promoter expressing ACC- in the lipogenic 
tissues (Mao et al., 2001). In the present study, I found that PI activity in bovine liver is 
dramatically decreased (~20-fold) by prolongated starvation, and that refeeding activates PI 
expression ~3 -fold afterwards (Figure 8A). This finding is consistent with reports from the 
rat PI promoter, showing that starvation decreases PI activity in the liver, and that refeeding 
increases it again (Bianchi et al., 1990; Iverson et al., 1990; Kim and Tae, 1994). In adipose 
tissues, PI activity decreases during the transition period from pregnancy to lactation (Figure 
8B). This finding is well supported by the fact that the rat PI activity is further diminished 
down to undetectable levels by the time of parturition in female white adipose tissue (Kim and 
Tae, 1994). Interestingly, the extent of decrease is slowed by fat-enriched diets, comparing to 
the standard carbohydrate diets (Figure 8B). No related results have been reported in other 
species. Hence, the observations of this study firmly establish that PI is the regulated 
promoter in the lipogenic tissues in the cattle.  
Regarding PII and PIII, the former is a house keeping promoter, and it is not nutritionally or 
physiologically regulated in the liver (Figure 8A) and adipose tissues (Duske et al., 2009, in 
press). The latter is a mammary gland specific promoter. Taken together, PI is the principally 
and nutritionally regulated promoter in the lipogenic tissues in the cattle. This study is to 
unravel the regulation mechanism of PI. 
4.3 Characterization of a master control unit for PI promoter 
4.3.1 NF-Y and C/EBP factors function as repressors via the distal PI promoter 
Previous work reported that the bovine PI is basically repressed (Mao et al., 2001). The long 
promoter (-1045) has a very low activity, while the proximal promoter is very active in 
reporter gene analysis. Hence, PI is basically repressed by an upstream located element. The 
repressors and the repressive mechanism are unknown.  
Primary investigation on bovine PI repressor was performed by Mao et al. 2001. But the 
detailed elements and repressors are unknown. In the study, serial deletions (Figure 10, 11), 
mutations (Figure 13, 15) and EMSA assays demonstrated that the upstream NF-Y (Figure 
12B, D) and the downstream C/EBP (Figure 14B) comprise the bipartite repressor. Hence, 
NF-Y and C/EBP factors interacting with their distal binding sites are the bipartite repressor 
of PI promoter (Figure 33). Similar results were reported that rat PI repressor is bipartite 
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(Figure 33). The upstream element is CA28 repeat, and the downstream component is also a 
repressive C/EBP (Tae et al., 1994). O´Callaghan and colleagues further found the distal 
repressive region of rat PI reduces the extent of the response to insulin (O'Callaghan et al., 
2001). Hence the elucidation of the repressive mechanism will contribute to understanding the 
regulation mechanism of fat metabolism in response to hormonal regulation, in cattle, rat and 
mouse. However, how do these repressors modulate PI activity in vivo? 
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Rat PI
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upstream downstream
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Art2-element
 
Figure 33 The bipartite repressor of ACC- PI 
4.3.2 NF-Y and C/EBP factors function as activators via the proximal PI promoter 
Cotransfection analyses manifested that both NF-Y and C/EBP factors () 
activate rather than repress the long PI promoter (Figure 16). Hence, I hypothesized that the 
two family factors can also regulate PI promoter by interacting with the proximal region. The 
fact that both factors activate the proximal PI promoter further supported this hypothesis 
(Figure 18 and Figure 23). Subsequently, point mutation of the putative NF-Y binding site 
indicated that NF-Y binding to the proximal PI promoter drives expression (Figure 18). 
EMSA analysis further established that NF-Y factors bind to this site (Figure 19). Likewise, 
EMSA and point mutations showed that C/EBP factors are the key factors interacting with the 
binding site of proximal PI promoter, overlapping with transcription start site (Figure 20 and 
Figure 24). Sequence comparisons indicated that C/EBP involved in PI is conserved in 
ruminant and rodent, while NF-Y site is only found in bovine or ovine proximal PI (Figure 
17). Taken together, the NF-Y and C/EBP factors interacting with their proximal binding site 
(-127/+84) are the drivers of PI promoter (Figure 34, green).  
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4.3.3 Both NF-Y and C/EBP factors are of key importance for PI regulation 
NF-Y vastly regulates gene transcription by interacting with CCAAT box, and may do so 
either positively or negatively. Bucher found that the CCAAT box is one of the most 
ubiquitous enhancer elements, being present in approximately 30 % of eukaryotic promoters 
(Bucher, 1990). Typically, the CCAAT box is found as a single copy element in either forward 
or reverse orientation at the 5´- of the transcription start site (TSS). This was shown for the 
osteoclast differentiation factor gene (Kabe et al., 2005), the human homeobox gene (TLX3) 
(Borghini et al., 2006), the human collagen COL11A1 gene (Matsuo et al., 2003) and the 
mouse adiponectin gene (Park et al., 2004). Despite the basal activation, NF-Y also mediates 
the transcriptional inhibition of genes, such as the mitotic cyclins and the cdc25C genes 
during p53-dependent G2 arrest induced by DNA damage (Manni et al., 2001), and the FGF-4 
(fibroblast growth factor-4) gene (Bernadt et al., 2005). FGF-4 is regulated positively by its 
NF-Y binding site in embryonal carcinoma (EC) cells where the distal enhancer of the FGF-4 
gene is active. However, the binding site functions as a negative cis-regulatory element when 
the FGF-4 enhancer elements are disrupted, or after the FGF-4 enhancer is inactivated during 
differentiation of EC cells. 
However, in the present study, dual CCAAT boxes of NF-Y are found in bovine ACC- PI 
promoter. The distal site extends from position -1040 to -1026 and the proximal site from 
position -116 to -102. The former site contributes to the repression of PI promoter, whereas 
the latter site is indispensable for NF-Y mediated activation and basal activity. Similarly, dual 
NF-Y binding sites have been reported in the human von willebrand factor (VWF) gene 
promoter (Peng and Jahroudi, 2002). In the VWF gene, the nonconsensus binding site (low 
affinity site) in exon1 contributes to repress VWF promoter activity, while the consensus 
NF-Y binding site (high affinity site) in the region from -30 to +1 functions as an activator. 
Peng et al further found that NF-Y interacts with histone deacetylases (HDACs) in a cell 
type-specific manner and recruits them to the VWF promoter to inhibit the promoter activity 
in non-endothelial cells through the repressive binding site (Peng and Jahroudi, 2003). 
Moreover, new evidence indicates that NF-Y can compact DNA (Guerra et al., 2007) and 
hence may repress the target gene promoter. 
The NF-Y transcription factor is a heteromeric protein complex that consists of 3 subunits, 
NF-YA, NF-YB and NF-YC. Each subunit contains an evolutionary conserved HAP domain 
that is critical for subunit interaction and DNA binding (Mantovani, 1999). The function of 
NF-Y in regulation of gene expression is ubiquitous and depends on the physiological 
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condition. Solid evidence has been reported documenting that NF-Y may function as both, a 
repressor or an activator of gene expression (Bernadt et al., 2005; Ceribelli et al., 2008; Peng 
and Jahroudi, 2002). The functional role of NF-Y depends on the certain physiological 
condition (Bernadt et al., 2005) or the exact binding site in promoter (Peng and Jahroudi, 
2002) and depends on other transcriptional factors which it may interact with. Hence, NF-Y is 
a bifunctional transcription factor and plays an important role in gene regulation. 
Likewise, C/EBP is essential in gene regulation. Two C/EBP binding sites have also been 
found in the bovine PI promoter: a distal C/EBP binding site (-183/-175) and a proximal 
binding site (+6/-3). The proximal binding site contributes to basal promoter activity and 
activation. This was found in many C/EBP-dependent genes (Reddy et al., 2003; Zhang et al., 
2003; Zhou and Snead, 2000). However, the distal binding site is relevant to the repression of 
bovine PI. This finding is consistent with the C/EBP binding motif of rat ACC- PI (Tae et al., 
1994). C/EBP cooperates with an unknown factor on upstream CA-28 repeat to repress rat 
ACC- PI activity (Tae et al., 1994). The C/EBP repressive factor is further supported by fact 
that tumor necrosis factor-alpha (TNF- inhibits transcription of the 2 chain of type I 
collagen (2(I) collagen) in cultured fibroblasts, by stimulating the synthesis and binding of 
repressive C/EBPs to a responsive element (Greenwel et al., 2000). It is known that there are 
several-members in the family of C/EBP factors. Each C/EBP member can be translated into 
an activator or a repressor isoform (Descombes and Schibler, 1991). Moreover, C/EBP factors 
regulate gene expression by interacting with other factors such as NF-Y and NF-B. It has 
recently been reported that different C/EBP members interacting with HDAC1 in various 
physiology conditions control promoter activity (Wang et al., 2008a; Wang et al., 2008b). 
Hence, C/EBP factors can also positively or negatively regulate gene expression.  
4.3.4 Both the driver sites have vastly different binding affinities from the repressor 
sites 
It seems a paradox that the PI promoter has both driver binding site and repressor binding site 
for both, NF-Y and C/EBP factors. However, further investigation showed that the proximal 
binding sites have much higher affinities than those of the distal NF-Y and C/EBP binding 
sites (Figure 29, 30). Hence, the proximal binding sites with high affinities are responsible for 
activation, while the distal binding sites with low affinities are relevant to repression. The 
proximal cis-elements are indispensable for the basal activity of PI. These results are in 
agreement with the finding that the activity of promoter elements correlates well with the 
relative affinity of their factors (Mauxion et al., 1991). Interactions by low affinity sites and 
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the binding proteins may be functionally relevant in vivo because the binding affinity can be 
greatly enhanced by cooperative interactions with other transcriptional factors that recognize 
the adjacent sites (Carey and Smale, 2000). Hence, the difference of affinity is also an 
important factor in the complicate regulation mechanism of eukaryotic genes. 
Therefore, a small amount of NF-Y and C/EBP factors are sufficient to saturate the proximal 
binding sites and activate the promoter. Much higher concentrations are necessary to saturate 
the distal binding sites. Once these are occupied, then the distal factors can feed-back repress 
the activation potential of the factors bound to the proximal attachment sites. Various affinity 
binding sites may cooperatively regulate ACC- PI activity depending on different 
concentration of C/EBP factors and their isoforms. 
4.3.5 NF-Y represses the activating capability of C/EBP 
Using series of cotransfections, I demonstrated that C/EBPand NF-Y all activate 
PI activity (Figure 26A). The PI activity responds to different concentrations of C/EBP factors. 
PI activity is greatly activated by C/EBP expressed in low concentrations (Figure 22). But 
C/EBP eventually is the strongest activator of the four members () of this 
factor family (Figure 23B). NF-Y significantly but moderately activates PI activity, as is 
consistent with the work of NF-Y (Xu et al., 2006). Combination of NF-Y and C/EBP factors 
indicated that NF-Y significantly represses the C/EBP-mediated activation (Figure 26A). In 
contrast, NF-Y represses the C/EBP-mediated activation moderately by the extent. No 
inhibition of C/EBP activity was found by NF-Y. Subsequently, the inhibition of C/EBP 
activity can be titrated by using increasing amount of NF-Y expression vectors (Figure 26B). 
However, separately the respective subunit of NF-Y (NF-YA, or NF-YB, or NF-YC) can not 
repress the C/EBP activity (Figure 27). I do not know whether the two subunits combination 
can repress the C/EBP-mediated activation, but the intact NF-Y complex can do.  
4.3.6 NF-Y and C/EBP may physically interact via protein-protein interaction 
The inhibition of C/EBP by NF-Y is independent of the proximal NF-Y binding site, because 
the `non-binding NF-Y´ still represses the C/EBP activity (Figure 27). The binding domain 
of NF-Y complex was mutated by 3-amino acid-substitution AAA for the original RGE in the 
binding domain of NF-YA  (Mantovani et al., 1994). Hence, I deduced that the inhibition of 
C/EBP activity by NF-Y is based on protein-protein interaction. 
The other potent evidences supporting the assumption that the interaction of NF-Y-C/EBP 
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synergistically regulates bovine ACC- PI promoter are the pull-down (not shown) and 
`ChIP´ experiments (Figure 28). C/EBP can be detected in immunoprecipitated protein by 
both anti-NF-YA and anti-C/EBP, though the amount of pulled down C/EBP proteins by 
anti-C/EBP exceeds that being pulled-down by anti-NF-YA. This fact manifests the protein 
interaction between C/EBP and NF-Y complex (data not shown). In `ChIP´ analysis, the 
proximal PI promoter both can be pulled down by respective antibodies recognizing either the 
over-expressed `non-binding NF-Y´ or C/EBPFigure 27. As discussed (Figure 27B), the 
`non-binding NF-Y´ can not bind to the NF-Y binding motif in the proximal PI promoter. The 
pulled down proximal PI fragment by anti-NF-YA indicates the interaction between the 
`non-binding NF-Y´ and C/EBP, which directly bind to the C/EBP binding site in proximal 
PI fragment.  
The interaction between NF-Y and C/EBP factors is constituently and functionally biased in a 
factor-specific manner. Functional evidence was provided that the interaction between NF-Y 
and C/EBP in bovine represses PI activity (Figure 26A). This interaction could also occur 
between NF-Y and C/EBP, rather than between NF-Y and C/EBPand – on the grounds of 
my cotransfection analyses (Figure 26A). However, it was found in mouse that the 
protein-protein interaction between NF-Y and C/EBP, but not C/EBP, positively regulates, 
rather than represses the C/EBP activity in the amelogenin gene promoter (Xu et al., 2006). 
A similar result was reported for the human microsomal epoxide hydrolase gene (EPHX) 
regulating through the direct interaction of C/EBPwith NF-Y (Zhu et al., 2004). 
Interestingly, this interaction could be substituted by the interaction of NF-Y and C/EBP. 
When C/EBP was knocked out in vivo, the interaction of C/EBP-NF-Y was blocked, but a 
new interaction complex of C/EBP-NF-Y substituted for the previous one (Xu et al., 2007).  
4.3.7 The mRNA proportion of NF-YA over C/EBP is greatly correlated in a 
tissue-specific manner with the ACC- PI activity 
Since above evidences indicate that NF-Y and C/EBP are crucial in regulating bovine ACC- 
PI, I examined in vivo the physiological relevance of the proposed regulation circuit 
controlling PI activity. To this end, I measured the mRNA concentrations of PI activity and 
the relevant transcription factors in the liver, mammary glands and adipose tissues. The 
correlation between ACC- PI activity and NF-Y, C/EBP factors is not evident considering 
the values from the individuals. However, the average proportion of NF-YA over average of 
C/EBP mRNA molecules correlates with ACC- PI activity from udder, adipose to liver 
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tissue respectively (Figure 31). This correlation of the factors and the PI activity explains the 
followed conditions.  
In the basal condition, both NF-Y and C/EBP factors are expressed at a relatively low level, 
and the proximal binding sites are saturated. Due to the low affinity of the distal sites, the 
repressor is barely occupied at low concentration of C/EBP, and the PI activity is high. Such a 
situation is seen in the mammary gland (Table 8). When the relative concentration of C/EBP 
factors is increased and with only a slight increase of NF-Y factors, the distal sites repressors 
feed back to repress PI activity, such as in adipose tissue (Table 8). However, a high level of 
C/EBP factors almost silence the expression of ACC- PI, just as in the liver (Table 8). Taken 
together, this suggests that both factors are important for the regulation of ACC- PI activity 
in a tissue-specific manner.  
Detailed analyses indicated, in the liver, the PI activity is nutritionally regulated (Figure 8A). 
The PI activity is inhibited by starvation (Figure 8A) or energy reduction (Table 8). However, 
the NF-YA and C/EBP factors are barely regulated at the mRNA level by starvation in the 
liver of the cows, which were reduced down to 16 % energy (appendix J). Subsequently, I 
found that more C/EBP factors bind to the repressive C/EBP binding site after refeeding in the 
liver, but no evident changes were found between feeding and starvation, as well as for NF-Y 
complex (data not shown). These investigation manifested NF-Y and C/EBP factors are not 
regulated at the mRNA level, but may be at the protein level in the liver in response to 
nutritional regulation.  
In adipose tissues, I found that calving greatly down-regulates the PI activity, but NF-YA and 
C/EBP,  and  repressors do not increase to inhibit the PI activity (Table 9). Though I 
found that C/EBP increases by fat-enriched diets after calving (Table 9), I can not explain 
why C/EBP activate, but not represses the proximal PI promoter in reporter gene analysis 
(Figure 23B). 
Afterwards, I found, in the udder, the lowest C/EBP is expressed compared to the liver and 
adipose tissues (Table 8). C/EBP is significantly down-regulated at the mRNA level by 
fat-enriched diets (p<0.05). No significant changes were found on NF-YA expression. These 
investigations indicated that C/EBP factors may be regulable in the udder under nutrition 
controls.  
Because the bifunctional nature of both factors depends on different cofactors (Caretti et al., 
2003; Peng et al., 2007; Peng and Jahroudi, 2003; Wang et al., 2008a), it is unknown how 
C/EBP factors and NF-Y positively or negatively regulate ACC- PI in a given condition. 
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Different isoforms (LAP1, LAP2 and LIP) may either activate or repress gene transcription 
resulting in a very comprehensive functional pattern of C/EBP factors. Hence, it is unclear at 
present how the different levels of NF-Y and C/EBP factors ultimately regulated PI activity.  
Taken together, the ratio of the concentration of NF-Y and C/EBP factors adjusts very 
different set points around which the activity of PI may be regulated by other factors of either 
acute or hormonal fatty acid synthesis regulation.  
4.3.8 All C/EBP family members potentially regulate ruminant and rodent ACC- PI 
In the study, two C/EBP binding sites have been characterized in bovine ACC- PI. C/EBP, 
- can directly bind to the distal site (Figure 14) and C/EBP, - and - can directly bind to 
the proximal binding site (Figure 21). Functionally, C/EBP, -, - and - all positively 
regulate bovine ACC- PI (Figure 16, 23). Hence, these C/EBP factors are directly or 
indirectly relevant to bovine PI activity. Due to the identity of bovine and ovine C/EBP 
binding motif in proximal promoter region (Figure 17), and it is reported that C/EBP and  
both activate rat PI promoter (Tae et al., 1995), I hypothesize that all C/EBP family members 
will contribute to control ACC- PI activity in ruminant and rodent.  
4.3.8.1 C/EBP is a tissues-specific regulable activator  
It is well known that C/EBPactivates differentiation of adipocyte resulting in adipogenesis 
(Millward et al., 2007) but inhibits proliferation of liver cell (Cao et al., 1991). In the study, I 
found the ACC- PI activity dramatically decreased in the transition period (before calving vs 
after calving, Figure 8). Accordingly, C/EBPlevels are down-regulated in tendency during 
the transition period (Table 9). In the liver, C/EBP does not change in response to starvation 
(Appendix J). Similarly, Robinson et al reported that C/EBP levels keep steady in the mouse 
mammary gland during starvation and refeeding (Robinson et al., 1998). Taken together, 
C/EBP may be an adipose tissue-specific activator for bovine ACC- PI promoter.  
 
4.3.8.2 C/EBP may regulate PI at different levels 
Several lines of evidence show that C/EBP is relevant for bovine ACC- PI regulation. First, 
anti-C/EBP supershifted both the distal and the proximal binding elements formed shift 
bands in EMSA (Figure 14, 20). Second, recombinant DN-C/EBP can specifically bind to 
the two binding elements of bovine ACC- PI promoter (Figure 14, Figure 21). Third, 
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increased C/EBP concentrations increased the bovine ACC- PI activity (Figure 23, 24). 
Likewise, Tae et al showed that C/EBP activates the rat ACC- PI activity (Tae et al., 1995), 
and adipogenesis can also be induced by ectopic expression of C/EBP (Ge et al., 2002; Yeh 
et al., 1995). Consistent with this conclusion, it is found that C/EBP knockout mice display 
decreasing of lipid accumulation and are protected from obesity (Millward et al., 2007; 
Rahman et al., 2007; Schroeder-Gloeckler et al., 2007). Hence, the present finding further 
provides novel evidence linking C/EBP expression to lipogenesis and energy balance, and 
important implications for the treatment of dysregulation of lipid metabolism.  
I did not find altered mRNA concentrations (Appendix J), and protein expression (Figure 32) 
of C/EBP in the liver caused by feeding changes. It is well known that C/EBP may regulate 
the target genes by changing the ratio of various isoforms, especially of LAP and LIP (Raught 
et al., 1995). However, the expressions of these isoforms are unaltered in bovine liver (Figure 
32). Subsequently, I examined the active C/EBP factors using the 32P-labelled distal binding 
sites, and more active C/EBP binds to C/EBP binding site from refed liver (data not shown). 
The increased active C/EBP may be incurred by phosphorylation. Phosphorylation of 
C/EBP at Thr269 (orthologous to Thr217 in mouse C/EBP) is increased in the livers from 
refed-cows (Figure 32), but not from normally feeding and starved cows. Taken together, 
C/EBP may regulate PI at different levels.  
4.3.9 The active NF-Y is regulated in a tissue-specific fashion at the protein level 
NF-Y is a ubiquitous factor controlling gene regulation. However, NF-YA Expression 
fluctuates during the cell cycle and is down-regulated in postmitotic cells (Bolognese et al., 
1999). In the study, I found that NF-YA levels decrease in tendency after calving in the 
adipose tissue, but the mRNA levels of NF-YA were relatively steady in the liver, adipose 
tissues and mammary glands (Table 8). This result is consistent with the finding by Bolognese 
and Farina, that NF-YA mRNA is relatively constant in growing and differentiated cells 
(Bolognese et al., 1999; Farina et al., 1999). However, I found high levels of NF-Y-DNA 
complex when examined the nuclear extracts from mammary gland using the EA-left side 
probe of NF-Y in EMSA experiment (Figure 12B `C2´). Small amounts of NF-Y complex 
were found in the livers of fed cows. NF-Y factors could not be detected in the liver of starved 
and refed cows. In contrast, high level of C/EBP factors was detected from all the three 
samples (data not shown). The functional NF-Y complex is controlled broadly in the protein 
level and post-translational level (Manni et al., 2008).  
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4.3.10 The master control unit controlling PI activity 
In conclusion, a master control unit repressing PI activity is proposed as described in Figure 
34 basing on the above results. The distal NF-Y (red) binding to element A represses the 
proximal C/EBP (green) activity by direct protein-protein interaction, while the distal C/EBP 
(red) binding to element C repress PI activity by interaction with the proximal NF-Y (green). 
Hence, the master control unit is composed of double protein-protein interactions between 
NF-Y and C/EBP.  
C/EBP
NF-Y
proximal region
driver
-1045
-127 +84
repressor
distal region
+1 PI activity
is repressed
 
Figure 34 A master control unit in PI promoter of the bovine ACC- gene 
The map is not drawn to scale. +1 represents the transcription start site. Repressive factors are in red, and 
these drivering expression are in green.  
 
The master control unit can be regulated by the mounts of the components (NF-Y and C/EBP) 
in a given tissue or in different physiology or nutritional conditions, or by competition of 
different family members, or by the posttranslational modification, and hence ACC- PI 
displays tissue-specific activity. By recruiting coactivitors or corepressors, or 
post-translational modification, the master control unit can be modulated finely in response to 
nutritional or hormonal changes.  
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5 Summary 
 PI of ACC- is confirmed as a nutritionally regulated promoter.  
 
 A repressive NF-Y binding site and a repressive C/EBP binding site (site1) have been 
identified in the distal PI promoter.  
 
 A NF-Y binding site and a C/EBP binding site (site3) have been also identified in the 
proximal PI promoter, as driver binding sites.  
 
 The affinities of the distal and proximal sites have been compared for NF-Y and 
C/EBP. The proximal sites have higher affinities for the respective binding factors than 
the distal site. 
 
 C/EBP factors and NF-Y separately activate PI activity. However, NF-Y can 
specifically inhibit C/EBP activity on ACC- PI by protein-protein interaction. 
 
 The proportion of NF-YA over C/EBP mean values correlates with the tissue-specific 
PI activity. The mRNA levels of NF-YA and C/EBP factors are not regulated 
significantly in a certain tissue under nutritional changes. 
 
 The phosphorylation of C/EBP Thr269 is up-regulated by refeeding in the liver, as 
indicates that a quick regulation by C/EBP phosporylaion may regulate PI activity. 
 
 Bovine new promoter (PIn) and its derived ACC- transcripts (5´-UTR) have been 
identified. The distance between PIn and PI is ~41 kb. The transcripts by PIn are 
composed of Exon [1n:4:5] and [1n:5], and are prominently expressed in the brain.  
 
 To establish these results, expression constructs of bovine NF-YA, -YB, -YC, 
C/EBP -- and -, have been cloned and constructed for expression both in 
bacterial and mammalian cells. And the derived Dominant Negative factors: 
DN-C/EBP, DN-C/EBP, DN-C/EBP and DN-C/EBP have been constructed. The 
bovine C/EBP mRNA has been isolated and first time characterized.  
 
 An indirect Avidin-Biotin Complex based sandwich ELISA (ABC-ELISA) has been 
developed for the measurement of bovine ACC-. The sensitivity is 1.6~3.2 ng /assay. 
To this end, the polyclonal antisera of rabbit and goat against a recombinantly 
expressed N-terminal segment of the bovine ACC- have been developed by 
immunizations with purified recombinant protein expressed in E.coli BL-21. The two 
antibodies were purified by affinity chromatography on antigen carrying sepharose 
columns. 
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8 Appendix 
A. Isolation and identification of PIn of bovine ACC- 
8.1 Isolation of exon1n and PIn 
8.1.1 Cloning of bovine ACC- exon1n 
Cloning exon1n (Ex1n) was achieved by a two-step procedure (Figure 35). Firstly, the 3´-terminus of 
Ex1n was isolated by RT-PCR; secondly, 5´-RACE was used to amplify the entire Ex1n sequence 
(Figure 35C). 
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Figure 35 Identification and cloning of bovine ACC- Ex1n by RT-PCR 
Step 1: A) Schematic representation of the partial Ex1 cloning. The size of the exon in mRNA is listed above the 
respective exon. Relative primer positions are indicated by arrows. B) RT-PCR products were resolved on 2 % 
agarose gel electrophoresis. 
Step 2: C) Schematic representation of the entire Ex1n cloning. The black frame represents the Gene Racer® 
RNA oligo (Invitrogen). The size of respective exon is listed above the according mRNA frame. Relative primer 
positions are indicated by arrows. D) PCR products of 5´-RACE were resolved on 2 % agarose gel 
electrophoresis.  
 
Step 1: 2 g of total RNA from brain was reversely transcribed into cDNA with primer Ac990r. The 
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II 
cDNA was used as a template to amplify the 3´-terminus of Ex1n (Figure 35A). The primers were the 
reverse primer bAcEx6rn and the forward primer PI_ex1n_f, which is an Ex1n universe primer 
devised on the Ex1n sequences of ovine, mouse and human (Travers et al., 2005). Two bands (Figure 
35B) were obtained, and subsequently cloned into pGEM-T easy vector for sequencing. The sequence 
alignments demonstrated the longer fragment contains a 53 bp unknown segment besides the known 
ex4, ex5 and partial ex6 of bovine ACC-. The shorter fragment, except for the absence of ex4, 
contains the same exons as the longer. Further analysis indicated that the 53 bp unknown sequence is 
conserved in the Ex1n of ovine, mouse and human. Hence, part of the Ex1n sequence of bovine 
ACC- was successfully achieved. The two transcripts [Ex1n:4:5:6] and [Ex1n:5:6] are derived from 
RNA-splicing.  
Step 2: In order to clone the entire Ex1n, 5´-rapid amplification of cDNA ends (5´-RACE) was 
performed by nested PCR as described in the methods (Figure 35C). Primary PCR was carried out 
using the 5´-primer and the ex6 specific primer bACex6rn. Subsequently, the secondary PCR was 
performed using the 5´-nested primer and the Ex1n specific primer PI_ex1n_r1 from the partial Ex1n 
sequence. A dominant and specific PCR fragment was obtained (Figure 35D). This product was cloned 
into pGEM-T easy vector. The final clone was sequenced with universe SP6 and T7 primers. The 263 
bp-Ex1n DNA sequence of bovine ACC- is listed in the appendix H, and demonstrated differences 
from the known exons in the 5´-UTR of the ACC-gene (Mao et al., 2001; Mao et al., 2002; Mao and 
Seyfert, 2002). The cDNA sequence of ACC- has been deposited in EMBL Nucleotide Sequence 
Database with the accession number FN185962. 
8.1.2 PIn is shared by ACC- and TADA2L  
In order to identify the PIn of bovine ACC-, I blasted the entire Ex1n sequence against the bovine 
genomic sequence. Ex1n has 100 % homogeneity with the genomic contig (Sequence ID 
NW_001493653.2) in bovine chromosome 19 from position 50,244 to 50,506 bp (Figure 36A). 
However, gap presents 528 bp upstream of Ex1n. Hence, it is necessary to isolate the entire sequence 
of PIn. 
To retrieve the sequence of the gap and to achieve the complete PIn, I analyzed our BAC478 clone 
which includes ACC- PI and ex1 (Mao et al., 2001). ACC- PI locates to the same genomic contig as 
mentioned above from position 6,261 to 9,179 bp as shown (Figure 36B). The sequence from BAC478 
sequenced down from the vector with SP6 (346 bp) accords with 57, 639 to 57,984 bp of this contig. 
This region belongs to the intron2 of the TADA2L gene. Taken together, bovine ACC- neighbors 
TADA2L. The finding is consistent with the previous report that ACC- and TADA2L are located in 
vicinity in sheep, mouse and human. These two genes are transcribed in different orientations (Travers 
et al., 2005). Hence, BAC478 harbors the PIn promoter. The PIn of bovine is also an intergenic 
promoter between ACC- and TADA2L. This conclusion was further confirmed by southern blot when 
probed with universe primer PI_ex1n_f (Figure 36C).  
8.1.3 Cloning of the bovine ACC- promoter PIn 
Genome Walking was carried out to retrieve the genomic sequence of PIn from BAC478. Primary 
PCR was performed with the outer adaptor primer (AP1) and PI_ex1n_r1 using BAC478 libraries as 
the templates (materials and methods). The PCR product was used as a template of the Secondary PCR 
with the nested adaptor primer (AP2) and PI_ex1n_r2. The secondary PCR products were analyzed 
with 2 % agarose electrophoresis (Figure 36D). A band (~530 bp) was visible from StuI libraries. 
Subsequently, the band was cloned into pGEM-T easy vector. Sequencing analysis indicated the partial 
PIn from Stu I libraries sequence was identical with the same genomic contig (Sequence ID 
NW_001493653.1) mentioned above.  
Due to the low efficiency in amplification of a GC-rich promoter by genome walking, I did not get a 
longer sequence possibly bridging the gap. Hence, GC-rich PCR was performed with the forward 
primer PIn_f2 from the TADA2L gene and the reverse primer PI_ex1n_r1 from Ex1n of the ACC- 
gene. Genomic DNA (genomic) and BAC478 DNA (BAC478) were used as templates separately 
(Figure 36D). The same size PCR product was generated from both templates. This PCR product was 
cloned into pGEM-T easy vector (k1336). Sequencing k1336 down from vector with SP6 showed 
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identity to the 5´- before the gap in the genomic contig. This region locates to the TADA2L gene. 
Whereas, sequencing with PIn_r2 indicated that a ~200 bp region showed identity to partial PIn 
sequence by genome walking of StuI library. Moreover, the two sequences are overlapped. Taken 
together, the entire PIn sequence (1.2 kb) of the bovine ACC- gene was achieved (Figure 37). This 
sequence has been deposited in EMBL Nucleotide Sequence Database with the accession number 
FN185963.  
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Figure 36 Isolation of PIn promoter of bovine ACC-
A) The 100 kb genomic contig is from gene bank (Sequence ID NW_001493653.2). Arrows directed towards 
TADA2L and ACC- represent the transcription orientation of the respective gene. The identity between 
5´-flanking region of BAC478 and genomic contig was confirmed by sequencing with SP6 and alignment.  
B) Genomic distributions of gap, ex1 of TADA2L and Ex1n of ACC- are indicated.  
C) Southern blot analysis of PIn on BAC478 DNA by EB staining (EB) and by Southern blot (SB) with Ex1n 
specific primer PI_ex1n_f. 
D) Isolation of PIn based on Genome walking or GC-rich from BAC478 DNA.  
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8.1.4 Sequence analysis of PIn 
-952    AGGTGCGTGA AGCAGAGGAC AGGGGCAGAC TTGGAAGAGA TTCGCAGACA AGATTCGAAG
PIn_f2
-892    CCTCACTTGG TCCCTCATTA ATTATATGAT CTTGGGCGTC ATTTTACTGG AGACTCAGAC
HOXF/HOMF               CREB
-832    AACCTCAGCT CTATAGATAC GAAATGTCTA CTTGGAAGGC CTATCTGAAA ACAAGGGGTC
StuI CREB(+)
-772    ACGTCAGTCC TTTGTTAACA ACGGGATTTC GCGCTCCGCC ACAGCAGCGA CAGGAATGCC       
-712    GAGGCGGGGA CCCAGCGGAC CGTTCAGGGG GCGGGGCGCG GCCCCAGGGC TCAGTCCCGG
SP1                     SP1(-)
-652    CCCGCGGCGC CCTCCCCCAC CGCGCGGCGT GGCCCGTGCC TCACGCCCGC CCGCCTGCCC
SP1(-)                            SP1(-)
-592    CTCTCGCCCC TGACGCCGCC GGGGCCCGCA GCCCGCCCGC AAACTGGCCG CCCTTCGCGG
CREB  SP1                  SP1(-)
-532    TCCCCGCCTC CCACCTAGTC CCGCGAGTGG GGCTCACGGC CGGCGACAAG CTCCCGGAGC
SP1(-)              SP1(-)       CREB          
-472    ACCTCGTGCC TAACTCAGCG CGTTCCCCCT CCTCCGCGCC GAGGAAACGC CAGCCGTGCG
NF-AT (+)/NF-B(-)           
-412    CGCGCCCGAG CTTTGCGTGC GCGCTCCCTG CGGGCGGCGC AGGCGCGTGC GGGCCGCGCG
SP1
-352    CCCGCCGCCT CCGCCCAGTC CCCGCCCCGG CCGTCGAAGC CCCGTCGCGG GTGGCGCGCC
SP1(-)
-292    TGCCGCCGCC GCCCCTGGCT CGGCCCCCGT CTGGGGCTCT CGCCGCGCGC CCGCCGCCGG
SP1(-)
-232    CCTCTTGCAG AGAGGCCTGA GAGGCTGGGA CTCTGAGCCG CCTGCCCGAG TTTTGAGTGG
StuI
-172    GACCAGTGAT TACTTTTTCC TGAGGGCGTG TTGCTGGTCG CCGCGGACCG GCCGGTGCCT       
-112    GATGCCGCCG TTTTATCCGC TCCAGAGTGC GCTGAGCCGG AGCGGGCCAG TATGCCCCGC
+1(exon1n)
-52    TTGTGTTTGT TTTCTGACAT TCCCACTCCC ACCCTTGTTA CCGCCTCGAA GGAGATCGAG
+9    GCTAAGCGCC TGGGCCCAAG GACGGCGAGC GGGGGTAGCC TCTCGAAGCC GTATCTTGCA
+69    GTGCCGCTGG TGGATTAATC AGACTGCCTG AATGGTTTAA GGGTACACGG GGTACGTTTG
+129    ATTCAGATGC TCCTGGAACG TCGAAGTTAT CATCTTTGGA AGGAACCATC CCCTCTTTGG
+189    GCTTCAGGGG CCCAGATTGA GGCGCAATGA TGAGAGGATG TGGTGGTCCA CTCTGATGTC
PI_ex1n_f                                       PI_ex1n_r1   
PI_ex1n_r2
+249    AATCTTGAGGG CTAG
 
Figure 37 The Nucleotide sequence of bovine ACC- PIn including partial Ex1n with exact 
position of cis-elements 
The ‘A’ base underlined with TSS (+1) was determined by 5´-RACE. +1 is the boundary of Ex1n (exon1n). The 
nucleotides underlined are the binding sites of the potential transcription factor. ‘-’ indicated as reverse strand of 
the sequence. CREB: The cAMP response element binding protein.  
 
The entire 952 bp PIn segment of the ACC- gene was sequenced (Figure 37). No TATA box, no 
CCAAT box, but containing GC-rich boxes, characteristic of house-keeping promoters or 
tissue-specifically regulated promoters. A set of repeated cis-acting elements and transcription factors, 
including eleven Sp1 binding sites and four CREB binding sites were found in the PIn promoter by 
computer analysis against database. Sequence comparison indicated bovine PIn sequence (from 
position -611 to -1) showed 94 % identity to the ovine genomic analogue (Sequence ID AJ56446), and 
86 % to that of human (NT_078100), but only 41 % to mouse ACC- PIn (Sequence ID AJ619665). 
Regarding the ex1n sequences, they are highly conserved at 3´ terminal. In detail, bovine Ex1n 
showed 98 % identity to that of ovine (Travers et al., 2005), and 84 % to that of human (determined by 
human ACC1 sequence # NM_198834 and genomic sequence # NT_078100.1) and 68 % to that of 
murine (determined by the cDNA sequence # NM_133360.2). Taken together, ex1n is highly 
conserved in all species mentioned above, whereas PIn is highly conserved in only cattle, sheep and 
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human.  
8.2 Expression profiles and functional analysis of PIn promoter 
8.2.1 Bovine PIn is prominently active in the brain 
In order to assess the tissue-specific activity of PIn, the abundance of ACC- transcripts derived from 
PIn were used as criteria, to which the transcripts from PI were compared.  
Li    Fa    Br    M     Mh Ms   ---
154
220
PIn expression PI expression
Lane: 1       2        3        4        5        6       7
bp
298
B.
154
220
bp
298
Li    Fa     Br     M    Mh Ms  ---
Lane: 1       2        3        4        5        6       7
1n:4:5
1n:5
1:4:5
1:5
ex1n 4 5Ex [1n:4:5]
Ex [1n:5] ex1n 5
PI_ex1n_f bcACex5rk
ex1 4 5Ex [1:4:5]
Ex [1:5] ex1 5
bcACex5rk
PIn
PI
263 bp 47 bp 253 bp
267 bp 47 bp 253 bp
A.
AC1c1f
 
Figure 38 Relative transcriptional level of PIn and PI in bovine tissues  
A) Represent of ACC- transcripts derived by PIn or PI. The length of the exon was showed above on box. 
B) Transcriptional profile of ACC- transcripts derived from PIn or PI by RT-PCR. 
Li: liver, Fa: fat, Br: brain, M: mammary gland, Mh: healthy mammary gland. Ms: sick mammary gland. 
Lane1-4 of were for animal 18009. Lane5: animal 755, and Lane 6: animal 757. Lane7: PCR negative 
control. 
 
To do so, I use Ac990_r as a common reverse primer for cDNA synthesis. Subsequently, PIn derived 
transcripts were amplified with PI_ex1n_f and the reverse primer bcACex5rk locating to exon5 of the 
known ACC- transcript, and PI derived transcripts were amplified with Ac1c1f and the same reverse 
primer. Results indicated that PIn derived transcripts were abundant in the brain tissue, but not in the 
liver, fat and mammary gland (Figure 38B). In contrast, in the brain the PI transcripts was very low, 
but high in the liver, fat or mammary gland (Figure 38B), which is consistent with previous results 
(Mao et al., 2001). Interestingly, the transcript of Ex1n:4:5 is more prominent in brain, indicating a 
brain-specific promoter.  
 
8.2.2 The basal activity of bovine ACC- PIn is very low in HC11 cells 
In oder to validate the promoter activity of PIn on ACC- transcription, the PIn promoter and partial 
Ex1n from position -952 to position +255 was cloned into the SmaI site of pGL3basic. The correct 
insertion (PI-luc) was screened by restriction analysis. In order to examine the fine regulation of PIn, 
two deletions were constructed. An internal segment of 577 bp was deleted, between the StuI sites at 
position -790 and -214 (Figure 39). The PIn promoter was truncated down to the proximal 214 bp, by 
deleting the distal 738 bp in the construct PIn-luc via KpnI (the upstream site of insertion in 
pGL3basic) and the proximal StuI site. Both subclones were confirmed by digestion and sequencing.  
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Figure 39 Mapping of cis relevant elements of PIn promoter in HC11 cells 
The filled circles indicate the putative binding sites of CREBs. The empty circles in PIn-luc reporter indicate the 
putative binding sites of transcription factor SP1. Data shown were representative of three independent 
experiments assayed in triplicate. Error bar: SEM. ** p<0.01.   
 
Subsequently, the wild type PIn reporter construct and the derived deletion series were transiently 
transfected into HC11 cells using cotransfected phRL-TK vector to normalize the transfection 
efficiency. Results indicated that the promoter activity of the wild type PIn is very low in HC11 cells 
(3.3 fold of pGL3b). The two deleted promoters dramatically decreased the promoter activity even 
further. Hence, the two regions of position -952 to -790 and -790 to -214 both contribute to increase 
the basal activity of PIn (Figure 39). Further analyses indicated that there are 11 potential SP1 and 3 
potential CREB binding motifs in the region -790 to -214, and one putative CREB binding motifs in 
the region -952 to -790.  
 
The data on PIn expression in the HC-11 mammary epithelial model cells show that PIn located far 
upstream does not encode many transcripts in these model cells.   
 
B. Cloning of bovine transcriptional factors 
Regarding Figure 7, I speculated that C/EBP and NF-Y factors may be relevant for PI regulation. 
Therefore, these factors are cloned as constructs for high yield expression in eukaryotes cells, to serve 
as valuable analytical tools.  
C/EBP factors are highly conserved at the C-terminus. It is difficult to discriminate them among 
family members, bovine specific antibodies being unavailable. No discriminating antibodies are 
available for these family members of bovine. Thus, the factors were cloned to characterize their 
corresponding roles in specific gene regulation.   
8.3 Cloning of four members (, ,  and ) of bovine C/EBP family 
Throughout this study, three tool vectors were used in the cloning, including pGEM-T easy (Promega), 
pASK-IBA43plus (IBA, Biotagnology) and pFLAG.CMV-1 (Sigma). 
The pGEM-T easy vector is a normal clone vector to retrieve PCR product. The single 3´-T overhangs 
at the insertion site match to the 3´-A of the amplified fragments. A successful insertion interrupts the 
coding sequence of -galactosidase in the pGEM-T easy vector. Recombinant clones can usually be 
identified by color screening on indicator plates.  
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pASK-IBA43plus vector is an expression vector in prokaryote such as E.coli. The expression cassette 
is under transcriptional control of the tetracycline promoter/operator. The recombinant protein has 
double tags. The His-tag is fused to N-terminus and the Strep-tag to C-terminus. The in-frame 
expression of recombinant protein can be confirmed by Western blot with antibody recognizing 
either/both tags.  
To express the target genes in mammalian cells, the respective genes were subcloned from 
pASK-IBA43plus into pFLAG.CMV-1 expression vector, which is for the expression of N-terminal 
FLAG tagged protein in mammalian cells. The promoter-regulatory region of the human 
cytomegalovirus (CMV) drives transcription of FLAG-fusion constructs. Hence, the recombinant 
protein comprises double tags. The Flag-tag lies in N-terminus, and the Strep-tag to C-terminus (from 
pASK-IBA43plus). Generally, attach 5´- overhang to sequence specific oligos to introduce any 
restriction sites suitable for subsequent clonings. The construction map of C/EBP factors in the 
expression vectors is list in Figure 40. 
C/EBPHis-tag EcoRI Sal I Strep-tagpASK-IBAplus-C/EBP
C/EBPFlag-tag EcoRI Sal I Strep-tagpFLAG-CMV-1-C/EBP
C/EBPFlag-tag EcoRI Sal I Strep-tagpFLAG-CMV-1-C/EBP
C/EBPFlag-tag EcoRI Sal I Strep-tagpLAG-CMV-1-C/EBP
C/EBPFlag-tag EcoRI Sal I Strep-tagpFLAG-CMV-1-C/EBP
Kpn I
Kpn I
ORF
1
1 1059
1059
1 1044
1 768
1 843
Kpn I
Kpn I
Start:bp End:bp
k1369
k1381
k1623
k1471
k1537
?
Figure 40 Schematic representations of the C/EBP expression vectors depicting the sequence 
of CDS and tags.  
8.3.1 Cloning of bovine C/EBP
A cDNA sequence of bovine C/EBP was obtained from the GeneBank database (Sequence ID 
AY634627). This sequence was used to blast assembled genomes of Bos taurus at 
http://blast.ncbi.nlm.nih.gov/Blast.cgi. The sequence file (Sequence ID NW_001493603.2) was 
retrieved. Alignment indicated that the cDNA sequence of bovine C/EBP completely matches its 
genomic sequence. Hence, bovine C/EBP is intronless, like the homolog in human.  
 
Because the GC% content in the C/EBP CDS is 73%, GC-rich PCR was applied with the forward 
primer bg_c_Paf and the reverse primer bg_c_Par. Bovine genomic DNA served as a template. The 
PCR product was cloned into pGEM-T easy. The positive C/EBP clone in pGEM-T easy (clone 
k1338) was confirmed by restriction analysis and sequencing.  
 
Subsequently, the coding region of C/EBP was generated by PCR. The forward and the reverse 
primers (CEBPa_f1, CEBPa_r2) were respectively introduced EcoRI and SalI site. The amplified 
fragment was cloned into EcoRI/SalI site of pASK-IBA43plus (clone k1369). The recombinant 
C/EBP by pASK-BIBA43plus comprises the N-terminal His-tag and the C-terminal Strep-tag. The 
correct expression vector was validated by sequencing and Western blot for C-terminus Strep-tag.  
 
Finally, the coding region was subcloned from pASK-IBA43plus to pFLAG.CMV-1 by PCR, for the 
expression in mammalian cells. The forward and reverse primers (CEBPa_f2, Strep_Kpn_r) were 
added the restriction sites of EcoRI and KpnI respectively. The amplified fragment was cloned into 
EcoRI/KpnI site of pFLAG.CMV-1, in which the SalI site was previously disrupted. The recombinant 
C/EBP will be also expressed with two tags: N-terminal Flag-tag and C-terminal Strep-tag. The 
correct construct was finally confirmed by sequencing and western blot with anti-flag antibody (Figure 
43B). 
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8.3.2 Cloning of bovine C/EBP
Bovine C/EBP is also GC-rich (73 %) and intron-less (Yamaoka et al., 1997). Its sequence was 
retrieved from gene bank database (Sequence ID D82985).  
 
To establish C/EBP expression vector, the gene was first amplified with the forward primer 
CE_Pbf1b and the reverse primer CEBPb_r5b by GC-rich PCR, using bovine genomic DNA as the 
template. The PCR product was cloned into pGEM-T easy vector. This clone (clone k1614) was 
confirmed by restriction analysis and sequencing.  
Subsequently, the coding region of C/EBP was obtained by PCR. The forward and the reverse 
primers with added restriction sites were used (EcoRI: CEBPb_f7, SalI: CEBPb_r5). The amplified 
fragment was cloned into EcoRI/SalI site of the pFLAG.CMV-1 backbone, which was prepared by 
double digestion of K1381 with EcoRI and SalI. The recombinant C/EBP was expressed with the 
same two tags as the recombinant C/EBP in pFLAG.CMV-1. The correct construct (k1623) was 
finally confirmed by sequencing and western blot with anti-flag antibody (Figure 43B). 
8.3.3 Cloning of bovine C/EBP
Regarding C/EBP, because there is no complete cDNA sequence, the full length cDNA of C/EBP 
was established by PCR-based rapid amplification of cDNA ends (RACE) and fusion PCR as 
indicated in Figure 41. GC-rich PCR was applied due to the high GC content (75%) of the coding 
region. 
5´- and 3´- RACE experiments were conducted using total RNA derived from liver (Figure 41). Gene 
specific primers were designed on the CDS sequence of C/EBP from Gene Bank database (sequence 
ID NP_776692.1). The 1st PCR of 5´RACE was performed with the 5´-primer and the reverse primer 
CE_Pdr1, whereas the 1st PCR for 3´-RACE was conducted with the forward primer CE_Pdf1 and the 
3´-primer. The 2nd PCR of 5´RACE was carried out with the 5´-nested primer and the reverse primer 
CE_Pdr2, while the 2nd PCR of 3´RACE was performed with the reverse primer CE_Pdf2 and the 
3´-nested primer.  
In order to achieve the intact cDNA fragment, fusion PCR was performed with the 2nd PCR products 
of 5´- and 3´- RACE.  The final product was amplified by 5´- and 3´- nested primers and was cloned 
into pGEM-T easy vector for sequencing.  
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..AAA…
3´TTT 5´
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Figure 41 Cloning of C/EBP by 5´-, 3´- RACE and fusion PCR 
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1032 bp of entire cDNA sequence of C/EBP was successfully achieved. Alignments indicated that 
the cDNA sequence shows 98 % identity to the genome contig (Sequence ID NW_001493203). 
Hence, bovine C/EBP is also intron-less. Further sequence analyses demonstrated the bovine C/EBP 
cDNA is composed of 29 bp of entire 5´- untranslated region (UTR), 771 bp of an open reading frame, 
and 232 bp of entire 3´-UTR. This cDNA sequence has been deposited in EMBL Nucleotide Sequence 
Database (accession number AM980827, appendix G).  
 
To construct the eukaryote expression vector of C/EBP, amplification was performed using forward 
and reverse primers with incorporated restriction sites (EcoRI: CE_Pdf3, SalI: CE_Pdr3). The 
amplified product was cloned into EcoRI/SalI site of the same pFLAG.CMV-1 backbone as 
above-mentioned for C/EBPb expression. Thus, recombinant bovine C/EBP also has the N-terminal 
FLAG-tag and the C-terminal Strep-tag. The final clone (clone k1471) was confirmed by sequencing 
as well as western blot with anti-FLAG antibody (Figure 43B).  
8.3.4 Cloning of bovine C/EBP
Expression vector of C/EBP was constructed by fusion PCR as indicated in Figure 42. 
First, the C/EBP cDNA sequence (870 bp) was retrieved from Gene Bank database (Sequence ID 
XM_614092.2). It comprises 24 bp 5´- UTR and 846 bp of ORF. This sequence was used to blast 
bovine genome database. Alignment showed that it matches a genomic contig (Sequence ID 
NW_928095.1). Alignment also showed the genomic region of C/EBP has an intron (Figure 42). 
Hence 5´- and 3´- RACEs were tried to clone the entire C/EBP gene using total RNA derived from 
liver. Successful 3´-RACE fragment was obtained. However, 5´-RACE was failed to be acquired.  
To clone the 5´-exon of the C/EBP gene, GC-rich PCR was carried out with the forward primer 
CE_Pef5 and the reverse CE_Per5, and followed by the nested PCR using the forward primer 
CE_Pef3 (induced an EcoRI site) and the reverse primer CE_Per6 (introduced ~10 bp of 3´-exon 
sequence).  
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ATG TGAintron
5´-Exon 3´-Exon
CE_Pef3 CE_Per6 
CE_Pef4CE_Pef1
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Figure 42 Cloning of C/EBP by fusion PCR 
Black box indicates the 5´- of C/EBP expression region. Grey box represents the 3´- of C/EBP 
expression region. ATG and TGA are the start and stop codon of C/EBP. Primers CE_Per6 and 
CE_Pef4 include a part sequence of ex1 (black region) and a part sequence of ex2 (grey region). The 
other primers matter the according region as indicated. 
 
For the 3´-RACE, primer pairs CE_Pef1 and the 3´-Primer were used in the primary PCR. The 
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secondary PCR was carried out with the forward primer CE_Pef4 and the 3´-nested primer. The 
obtained 3´-RACE product contains the entire 3´-exon and 3´-UTR of the C/EBP gene. The fusion 
fragment of 3´-exon was amplified with the forward primer CE_Pef4 (introduced ~10 bp of 5´-exon 
sequence) and the reverse primer CE_Per3 (induced a Sal I site) in the 3rd PCR 
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Figure 43 Expression of C/EBP and DN-C/EBP fusion proteins in HEK293 or HC11 
A) Schematic representations of full length C/EBP and DN-C/EBP factors with flag, His or strep tags. P2: 
C-C/EBPin which the c-terminal of C/EBP will be deleted; DBD: DNA binding domain; Leu: leucine zipper 
domain. B) Western blot with anti-Flag-tag antibody (Sigma). M: protein ladder; , ,  and  represent C/EBP, 
-, - and -. C) Western blot with Strep-tactin (IBA). M: protein ladder; DN, -, - and - represent 
DN-C/EBP, -, - and -. 
 
For experiment B), 20g of expression construct was transfected into HEK293 grown in a 10 cm plate. 48 h after 
transfection, cells were collected and washed with 1x cold PBS. Suspended the cells in 1x PBS containing 0.5 % 
(v:v) cocktail inhibitor (Sigma), and sonicated for 5 min to shear genomic DNA. 50 g of protein was for 
Laemmli gel (left), 20 g of protein for WB (right). Anti-flag recognize the FLAG-tag attached at N-terminus of 
C/EBP factors. The secondary antibody is anti-mouse IgG-HRP. Membrane was developed by ECL. For 
experiment C), 3 g of expression construct was used to transfect HC11 in 6-Well-plate. 24 h after transfection, 
cells were split into 3 wells of 24-well-plate. Addtional 24 h later, cells were collected and washed with 1x cold 
PBS. Then were treated with in 1× lysis buffer for 30 min under RT with gentle shaking, and the protein of the 
lysate was determined by Bradford method. Lysate was condensed by cold acetone. 50 g of lysate protein was 
loaded onto SDS-PAGE for Laemmli gel (left), and 100 g was loaded for WB with Strep-tactin AP (right). The 
membrane was developed with BCIP/NBT.  
 
In order to obtain the entire ORF segment of the C/EBP gene, fusion PCR was performed using the 
5´-exon and 3´-exon, and the product was amplified with the forward primer CE_Pef3 and the reverse 
primer CE_Per3. The fusion PCR product was cloned into EcoRI/SalI site of the pFLAG.CMV-1 
backbone as above-mentioned. Thus, recombinant bovine C/EBP also has the N-terminal FLAG-tag 
and the C-terminal Strep-tag. The final clone (k1537) was confirmed by sequencing and western blot 
with anti-FLAG antibody (Figure 43B). 
The results show that the C/EBP factors , -, - and - have been successfully cloned as expression 
constructs. The bovine respective factors are faithfully translated, since the N-terminal tag is expressed 
(Figure 43), and the C-terminally in-frame tag is recognized by antibody.  
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8.4 Cloning of the DN-C/EBP series 
Dominant negative (DN)-C/EBP harbors the DNA binding domain and leucine zipper domain of 
C/EBP. DN-C/EBP may be used to detect the direct and specific binding activity of C/EBP factors, 
providing information about the functional importance of a C/EBP-DNA interaction. The dominant 
negative proteins will compete with the wild-type endogenous protein, thereby preventing the 
wild-type protein from activating reporter gene transcription. Inhibition of transcription with this type 
of dominant negative protein is often used to examine if the wild-type protein is a functional activator 
of the respective control region fused to a reporter gene.  
The constructions of DN-C/EBPs were completed in two-step procedures. Firstly, the full length 
proteins were truncated by PCR or restriction digestion in pASK-IBA43plus. Secondly, the encoding 
fragment was cloned from pASK-IBA43plus into pcDNA3.1 by PCR. The schematic protein size was 
presented in Figure 43A.  
In the first step, amplification was performed using the gene specific primer pairs: CEBPa_f3_IBA 
and CEBPa_r2 for DN-C/EBP; the primer pairs CE_Pdf4_IBA and CE_Pdr3 for DN-C/EBP; the 
primer pairs CE_Pef7 and CE_Per3 for DN-C/EBP. The templates were the according full length 
expression vectors in pFLAG.CMV-1. The amplified PCR products were cloned into EcoRI/SalI site 
of pASK-IBA43plus.  
The truncation of C/EBP was based on restriction digestion. The full length coding region of C/EBP 
was cloned from pFLAG.CMV-1(k1623) into pASK-IBA43plus by EcoRI and SalI. The resulted clone 
was digested with EcoRI and SmaI, followed blunting by Klenow enzyme, and religated to result in 
DN-C/EBP in pASK-IBA43plus. All DN-C/EBP clones in pASK-IBA43plus were confirmed by 
sequencing and western blot by Strep-tactin (data not shown). 
 
In the second step, the according DN-C/EBP fragments were cloned from pASK-IBA43plus into 
pcDNA3.1 (Invitrogen) by PCR. Two universal primers (IBA_Hind_Xho_f and IBA_Strep_BamHI_r) 
were used for amplification. The obtained respective DN-C/EBP fragments were cloned into 
HindIII/BamHI site of pcDNA3.1+. The final DN-C/EBPs proteins have the His-tag at the N-terminus 
and the Strep-tag at the C-terminus (see Figure 43A). The final clones were verified by sequencing and 
Western blot with Strep-tactin (Figure 43C).  
8.5 Cloning of the three subunits of NF-Y 
All three subunits of the NF-Y family of transcription factors (NF-YA, -YB, -YC) are indispensable in 
NF-Y-dependent regulation. In order to know how bovine NF-Y complex regulate ACC- PI activity, 
the three subunits were cloned. Liver RNA was used for RNA ligase-mediated 5´-RACE. cDNA was 
synthesized using GeneRacer® oligo-(dT)18 as the primer. Subsequently, three PCR reactions were 
performed to obtain the entire coding region of NF-YA (see Figure 44A), or NF-YB (see Figure 44B), 
or NF-YC (see Figure 44C).  
 
The 3rd PCR products were cloned into EcoRI/SalI site of pASK-IBA43plus. The final constructs were 
confirmed by sequencing. The scheme of the NF-Y factors and their tags for expression is indicated in 
Figure 45A. To know if the insertions were in the proper frame in pASK-IBA43plus, western blots 
were performed with Strep-tactin to detect the C-terminal Strep-tag. Taken together, the cDNA 
fragments of NF-Y factors were successfully retrieved, and they properly cloned into the prokaryotic 
expression vector pASK-IBA43plus (Figure 45B). Hence, the recombinant NF-Y factors harbor 
His-tag in N-terminal and Strep-tag in the C-terminal. 
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Figure 44 Schematics of cloning for NF-Y factors by 5´-RACE 
A) NF-YA; B) NF-YB; C) NF-YC. The black boxes represent RNA oligo and oligo-(dT)18 from RACE kit 
(Invitrogen). Primers used are listed below the cDNA sequence with their names.  
  
To express NF-Y factors in mammalian cells, the coding region from the start codon to the stop codon 
was amplified using primers (IBA_Hind_Xho_f and IBA_Strep_BamHI_r). The restriction sites 
HindIII and BamHI were introduced into the forward primer and the reverse primer respectively. The 
procedures of subcloning are similar, but that for NF-YB has small changes. The amplified product of 
NF-YB was cloned into HindIII/BamHI site of pcDNA3.1+. The others amplified products were 
blunted and cloned into HindIII/EcoRV site of pcDNA3.1+. To mutate the binding domain of NF-YA, 
fusion PCR was performed as materials and methods using four primers (P1: NFYA-f1a, P2: 
NFYA-r4m, P3: NFYA-f2m, P4: NFYA-r3a). The 2nd PCR product of NF-YA was a template. The 
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amplified product was blunted and subsequently cloned into HindIII/EcoRV site of pcDNA3.1+. All 
final clones were sequenced and confirmed by western blot (Figure 45C).  
 
Results indicated that all factors were properly expressed in mammalian cells, because their 
C-terminal Strep-tags were in-frame expressed, or the specific antibody can recognize the recombinant 
proteins (Figure 45B,C). Three amino acids (RGE) in the DNA binding domain of NF-YA was 
successfully mutated into AAA, as was supported by sequencing and the western blot with anti-NF-YA 
(Figure 45C).  
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Figure 45 Expression of the recombinant NF-YA, YB or YC in E. coli XL1-blue and in HEK293 
cells.
A Schematic representations of the tagged bovine NF-Y factors.  
B The expressions of the recombinant NF-Y proteins in prokaryotes. -1): NF-YA; -2): NF-YB; -3): NF-YC; 
Laemmli gel (left) and Western blot (right) probed with Strep-tactin. U: uninduced, I: induced with 
anhydrotetracycline. 
C. The expressions of the recombinant NF-Y proteins in mammalian cells. -1) NF-YA with anti-NF-YA; -2) 
NF-YAm29 with anti-NF-YA; -3) NF-YB with Strep-tactin; -4) NF-YC with Strep-tactin. Ct: the control cell 
lysate of HEK293. NF-YA: YA, YAm29, YB and YC indicated the cells were transfected with respective 
expression vectors.  
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C. Establish an ELISA 
8.6 Establishment of an ELISA to measure the expression of bovine ACC-  
Measurements of ACC mass heavily rely on determination of its enzyme activity, or the mRNA 
concentration. The first method reflects ACC mass indirectly but not on the actual amount of enzyme. 
Since mRNA is regulated at different levels, the result by the second method would be affected by the 
decay and preparation of mRNA. Hence, it is necessary to develop ELISA, an efficient method, to 
directly measure the ACC mass. Moreover, the protein mass together with the enzymatic activity will 
give an insight into the post-translational regulation of ACC-.  
An Avidin-Biotin Complex indirect sandwich ELISA (ABC-ELISA) was developed to measure the 
bovine ACC mass. Several procedures are required, including the preparation and purification of the 
recombinant ACC- as an antigen, and the preparation and purification of specific anti-ACC- from 
two different species. The recombinant technique was used to prepare the antigen for two main 
advantages. Firstly, specific antigen of ACC- can be specifically and easily prepared. It is quite clear 
that both ACC- and ACC- have the conserved biotinylation sites in the domain of biotin 
carboxyl-carrier protein. Hence, the raised antibody based on the antigen of full length ACC- cannot 
effectively differentiate between ACC- and ACC-. Secondly, the low molecular weight and the 
affinity tag (His-tag was used in the study) will facilitate the preparation and purification of the 
antigen. Because the molecular weight of the native ACC- is ~265 kDa, the purification and analysis 
of such antigen of native ACC- will be problematic and laborious. Hence, the cloning and expression 
of truncated ACC- is necessary and important for the preparation of ACC- antibodies.  
8.6.1 Cloning and expression of truncated ACC- 
Cloning of the truncated bovine ACC- was based on RT-PCR. The reverse transcription of liver total 
RNA was primed with a specific primer ACC1R:GA264. The DNA segment encoding the region of 
the 2nd~313th aa of the bovine ACC- was amplified by nested PCR. The first primer pairs were 
bAcex5f and Ac1320_r. A secondary PCR was carried out using the forward primer (EcoRI: ACC_f) 
and 2 different reverse primers (SalI: ACC_r1, HindIII: ACC_r2). Restriction sites were introduced by 
the primers. Both the PCR products were cloned into the pGEM–T easy vector for sequencing.  
To construct the expression vectors of the truncated ACC-, the coding region was retrieved from the 
two pGEM-T easy vectors by subcloning. Subsequently the obtained fragments were respectively 
cloned into EcoRI/SalI site, or EcoRI/HindIII site of pASK-IBA43plus. The recombinant ACC- 
expressed by clone K1214 only has the N-terminal His-tag, and that by  clone K1215 has both tags: 
the N-terminal His-tag and the C-terminal Strep-tag.  
Results indicated that both the recombinant ACC- expression vectors with the Strep-tag and without 
the Strep-tag in C-terminus were highly expressed in E.coli BL-21. Figure 46A shows the expression 
of k1214 without the Strep-tag by Coomassie brilliant blue staining and Western blot with the 
anti-His-tag. The expression of k1215 with the Strep-tag was confirmed in Figure 46B. 
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Figure 46 Performance of vectors expressing an N-terminal segment of the bovine ACC- in 
E.coli
A) The expression of the His-tagged recombinant ACC- by k1214 in E.coli BL-21.  
B) The expression of the His and Strep-tagged recombinant ACC- by k1215 in E.coli BL-21. 
Laemmli gel (left), Western blot probed by Strep-tactin (right). U: uninduced, I: induced with 
anhydrotetracycline. 
8.6.2 Two-step purification of antigen: His-tag affinity chromatography and gel 
purification 
To raise specific antibodies for bovine ACC-, the antigen was purified for immunization in the study. 
Furthermore, two specific antibodies were raised in the rabbit and goat to avoid the crosstalk signal 
interference for the indirect sandwich ELISA. The antigen was purified by two steps: affinity 
purification by His-tag and gel purification.  
Firstly, insoluble expression of the recombinant ACC- was confirmed and the induced cells were 
lyzed by sonication. The soluble and insoluble fractions were then separated by centrifugation. Results 
showed that the recombinant ACC- was expressed as an inclusion body in the insoluble fraction 
(Figure 47A). The inclusion body of the recombinant ACC- was soluble by sodium phosphate buffer 
(PBS) pH8.0 containing 8 M urea (Figure 47A).  
The insoluble fraction of cell lysate from 1 L of cultured E.coli cells was dissolved in Equilibration 
buffer (PBS buffer pH8.0 with 8 M urea). Subsequently the solublized precipitate was applied to a 
Ni-NTA sepharose column. After washing (PBS buffer pH5.9 containing 8 M urea), the recombinant 
ACC- was specifically eluted by PBS pH4.5 containing 8 M urea (Figure 47B).  
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Figure 47 His-tag affinity chromatography and gel purification of the recombinant ACC- 
A) The solubility analysis of the recombinant ACC- from k1214. Su: Soluble fraction of the induced cell lysate 
after centrifugation; Pr: the insoluble fraction dissolved in sodium phosphate buffer pH8.0 containing 8M urea. 
B) Purification of the recombinant ACC- by Ni-NTA sepharose. Laemmli gel (left), Western blot (right). 5.9: 
eluate by elution buffer pH5.9 containing 8M urea; 4.5: eluate by elution buffer pH4.5 containing 8M urea. 
C) Gel purification for the recombinant ACC-. UV, Slice1: partly labelled with Dansyl Chloride before 
excising from gel; UV, Slice2: The excised gel before injection was analyzed by SDS-PAGE, by staining; WB: 
Western blot probed with anti-His-tag.  
 
To further purify the antigen and to visualize the desired protein bands of antigen in SDS-PAGE 
without staining, the purified proteins (by Ni-NTA sepharose) were solublized and partially dansylated 
for visibility under UV-light (Figure 47C, UV). The strongest band was excised from the gel column. 
Before injection, the antigen in the homogenized gel was confirmed by Coomassie brilliant blue 
staining and Western blot with anti-His-tag (Figure 47C, Laemmli, WB). Results showed that the 
technique to prepare the antigen was specific and efficient. 
8.6.3 Preparation and purification of polyclonal antibodies against bovine ACC- 
The antigen was injected into animals as described in the methods and specific antisera were harvested. 
In order to obtain concentrated antibodies, antisera were purified by affinity chromatography whose 
resin is CNBr-activated sepharose coupled with antigen as described in methods. The affinity column 
was washed with strong detergent of 1 % triton, 8 M Urea and 2 % SDS in order to remove uncoupled 
antigen, because any trace amount of antigen in affinity purification will affect the accuracy of 
subsequent Western blots and especially ELISA.  
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Figure 48 Evaluation of anti-bovine ACC- antibodies origined from rabbit and goat by Western 
blot 
A) The recombinant ACC- expressed by K1215 as the detection subject. U: Uninduced crude protein; I: 
induced crude protein;  
B) The whole cell lysate from bovine mammary gland as the detection subject.  
Arrows indicate the expected the recombinant ACC- and the endogenous bovine ACC- bands.  
 
Finally the purified antibodies from two origins were validated by Western blot. The whole cell lysates 
were from bovine mammary gland and a bacterial recombinant ACC- with a strep-tag at the 
C-terminus. The rabbit and goat antibodies raised in the study all recognize the truncated recombinant 
ACC-(Figure 48A). They also recognized the native bovine ACC- (Figure 48B). In bovine 
mammary gland, two major bands may possibly be translated from various ACC- transcripts 
containing different ATG. 265 kDa-isoform may be translated from ACC- transcripts derived from 
promoter I and II, while the 259 kDa-isoform may be translated from mRNA molecules derived from 
promoter III, the mammary gland specific promoter. 
Taken together, the purified antibodies against bovine ACC-, which were raised from rabbit and goat, 
are suitable for ELISA assay.  
8.6.4 The measurement sensitivity of ACC was greatly enhanced by ABC-ELISA 
In order to examine the efficiency of the present system for ELISA, increasing concentrations (0.2, 1, 
5 g/ml) of rabbit anti-ACC-and goat anti-ACC- were coated onto the plates respectively. 
Constant amount of recombinant antigen (30 ng/well) were then added. After additional washing, 
secondary anti-ACC- (2 g/ml) from a different species was then added into the plates. Afterwards, 
species-specific detection antibody with HRP conjugate was added into the plate. Finally, the color 
reaction was performed with TMB for suitable time, and stopped with 2 M sulphuric acid. A450 was 
then measured. Blank well contains only the substrate and was stopped with the same stopping buffer. 
Results showed that the increasing of both coating antibodies resulted in linearly increased 
absorbability (Figure 49A), indicating the system conditions were feasible.  
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Figure 49 Establishment of standard curves for the measurement of bovine ACC-
A) Test of antibodies by indirect sandwich ELISA. The solid line represents that goat anti-ACC-was coated 
antibody. The dashed line represents the coated antibody as rabbit anti-ACC-. 
B) A standard curve allowing measuring ACC- by ABC-ELISA. The solid line represents the standard curve by 
ABC-ELISA, and the variable concentrations of the recombinant ACC- (standard) were assayed from 1 to 64 
ng/ml (0.1 ng-6.4 ng/assay). The dashed line represents that by conventional ELISA, and the concentrations of 
the recombinant ACC- were from 10-80 ng/ml (1-8 ng/assay).  
 
For quantification of ACC-, the Avidin-Biotin-Complex indirect sandwich ELISA (ABC-ELISA) 
was performed for standard curve. 5 g/ml of goat anti-ACC- was coated onto the plate. Serial 
concentrations of recombinant purified ACC- (1, 2, 4, 8, 16, 32, 64 ng/ml) were then added to the 
coated plate. The secondary anti-ACC- antibody (rabbit anti-ACC-) was then added (2 g/ml). 
Subsequently, anti-rabbit IgG-biotin conjugate was added and was incubated with avidin-biotin 
mixture (Pierce). Results revealed that the slope of ABC-ELISA was 0.257 (R2=0.994), the sensitivity 
being 16-32 ng/ml (1.6-3.2 ng/assay, Figure 49B). In contrast, a similar experiment was performed by 
conventional ELISA (w/o ABC). The slope of the curve was very low (Figure 49B, dashed line). 
Hence, the ABC-ELISA evidently enhanced the sensitivity of measurement for ACC- compared with 
the conventional ELISA (w/o ABC). 
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D. List of Primers 
No. Name Sequence 
72 5_Lucr GCCTTATGCAGTTGCTCTCCA
92 BASENDf GTACTAACATACGCTCTCCATC
101 bAcEx6rn CAAATTCTGCTGGAGAGGCTACA
170 Acex7f GTTCTCATTGCCAACAATGGCA
171 Ac990r TTTCAAGAGAAGTTCTGGGAGCT
236 bAcex5f CTCTGAGAGCTCATTTTGAAG
328 bAcex5rk GAAGAAGGTTCATCCATTGCTTC
329 Ac5Aex6r GCCAGACATGCTGGATCTTTG
330 Acex2f3’ CGCCGCCGCCGCCTTGAG
497 pAIBA3f GTTATTTTACCACTCCCTATCAG
909 mActin_LCr ACGTCACACTTCATGATGGAAT
944 PI_ec_1f ATTCGCATATGCCACACGCTGCAAGGAAGAC
945 PI_ec_2f ATTCGCATATGTACTGGAGGTGTCATGCAAGAG
946 PI_ec_3f ATTCGCATATGAGCCAAGTTTTGGTGACTGCCA
947 PI_eb_r ATTCGCATATGCCTCCCTGTCCATCACCAACT
948 ACCPf ATCTGAATTCGATGAACCTTCTTCCTTGGCCA
949 ACCPr1 ATCTGTCGACTGAGGCCTTGATCATTACTGGA
950 ACCPr2 ATCTAAGCTTATGAGGCCTTGATCATTACTGGA
1000 PI_A_f4 GATGCTGAGGCTGAAACTCCAGTAC
1027 PI_ex1n_f GCCCAGATTGAGGCGCAATGA
1048 PI_ex1n_r1 TTGACATCAGAGTGGACC
1049 PI_ex1n_r2 CTCATCATTGCGCCTCAATC
1062 BT_Fib_f1 AAACCGGACCATGACCATCC
1063 BT_Fib_r1 TGCCAGTTCATCCACACCAC
1064 BT_Fib_r2 TCTTCATGGACATCTTCTTCATTGAG
1101 PI_ec_CEBP_B_rm CTGCCTCACTAATGACACCTCCAGTATCT
1102 PI_ec_CEBP_B_fm GTGTCATTAGTGAGGCAGCCAAGTTTTGG
1126 PIn_f2 AGGTGCGTGAAGCAGAGG
1137 bg_c_Paf CATGCCGGGAGGACTTTAGCT
1138 bg_c_Par CGGTGAGTTTGCGTTTCCAAG
1185 PI_ea_df GGAAGGACTTTTGGCCACCTCATGCGAAG
1186 PI_ea_dr GTGGCCAAAAGTCCTTCCAATGAACAC
1187 CEBPb_r5 AGTCGTCGACGCAGTGGCCGGAGGAGG
1191 CEBPa_r2 AGTCGTCGACCGCGCAGTTGCCCATGGC
1192 CEBPa_f2 CAGTGAATTCAATGGAGTCGGCCGACTTCT
1193 CEBPa_r1 AGTCGTCGACGCCGCCCGCACGGAGGTC
1194 CEBPa_f1 AGTCGAATTCATGGAGTCGGCCGACTTCT
1221 pFLAG-f GGGCGGTAGGCGTGTACG
1242 PI_CEBP2_r CTTGAGTTTT
1243 PI_CEBP2_f GGAGAATCTGAAATGCCTTGTGAAAACTCAAG
1244 PI_CEBP3_r GGCAAGATTA
1245 PI_CEBP3_f GGCGAACTCTGTCTTTCTTGTTGTGTAATCTTGCC
1286 PI_eA_m6r GTCCTTCGTCTGAACACCCAGGTACCTATC
1287 PI_eA_m6f GGTGTTCAGACGAAGGACTGATGCTGAGGC
1293 NFYA-r1 TGGCGTCACCAGTCAACAC
1294 NFYA-r2 AGTGGGAAACTGTGAGGAAT
1295 NFYA-f1 CAGTGAATTCAATGGTCCAGGCTGTTCCTG
1296 NFYA-r3 AGTCGTCGACTTAGGACACTCGGATGATCTG
1297 NFYA-f2m GGAAGGCTGCTGCAGGCGGACGATTTTTCTCTCC
1298 NFYA-r4m CCGCCTGCAGCAGCCTTCCGTGCCATGGCATGA
1299 NFYA-r3a AGTCGTCGACGGACACTCGGATGATCTGTG
1314 CE_Pef1 CCCAGGGCTGTGGCTGTGAA
1314 CE_Pef1 CCCAGGGCTGTGGCTGTGAA
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1315 CE_Per1 GCGCACCGCGATGTTGTTC
1319 CE_Per3 AGTCGTCGACGCTGCAGCCCCCCACG
1320 CE_Pdf1 AACCCGCTGCCTTCTACGA
1321 CE_Pdr1 GCATCTCCTGGTTGCGTC
1322 CE_Pdf2 GCCGACCTCTTCAACAGCAAC
1323 CE_Pdr2 CCCGCTTTGTGGTTGCTGT
1324 CE_Pdf3 CAGTGAATTCATGAGCGCCGCGCTCTTCAGC
1325 CE_Pdr3 AGTCGTCGACCCGCGCGTCCGCCGCC
1326 PI_ce3_rm AGGCAAGTGGCTACAACAAGAAAGACAGAGTTCG
1327 PI_ce3_fm CTTGTTGTAGCCACTTGCCTTTCATCACCAGGA
1344 CE_Pef4 GCGTCCTCAAGGCCCCTT
1345 CE_Per4 AAGGGGCCTTGAGGACGC
1346 PI_CEBP3_f2m GGCGAACTCTGTCTTTCTTGTTGTAGCCACTTGCC
1369 CBF_Ef AGACCGTACGTGATTGGTTAATCTCTT
1371 CBF_Er2 AAGAGATTAA
1372 FAST1_con_r ATTTCCATGG
1373 FAST1_con_f GCTGCCCTAAAATGTGTATTCCATGGAAAT
1374 hGLI_con_r GAACCATCAT
1375 hGLI_con_f TCGACTCCCGAAGACCACCCACAATGATGGTTC
1395 PI_A_r6 TCAGCCTCAGC
1396 PI_A_f6 GACCAGTCCTGGGTGTTCATTGGAAGGACTGATGCTGAGGCTGA
1397 PI_A_f6mu1 GACCAGTAAGGGGTGTTCATTGGAAGGACTGATGCTGAGGCTGA
1398 PI_A_f6mu3 GACCAGTCCTTTTTGTTCATTGGAAGGACTGATGCTGAGGCTGA
1399 PI_A_f6mu4 GACCAGTCCTGGGGAGTCATTGGAAGGACTGATGCTGAGGCTGA
1400 PI_A_f6mu5 GACCAGTCCTGGGTGTGACTTGGAAGGACTGATGCTGAGGCTGA
1401 PI_A_f6mu6 GACCAGTCCTGGGTGTTCAGACGAAGGACTGATGCTGAGGCTGA
1402 PI_A_f6mu7 GACCAGTCCTGGGTGTTCATTGTCCGGACTGATGCTGAGGCTGA
1403 PI_A_f6mu8 GACCAGTCCTGGGTGTTCATTGGAATTGCTGATGCTGAGGCTGA
1404 PI_A_f6mu9 GACCAGTCCTGGGTGTTCATTGGAAGGAAGCATGCTGAGGCTGA
1408 NFYA-f1a CAGTGAATTCATGGTCCAGGCTGTTCCTG
1418 PI_ec_Cc_r2 TGGCTGCCT
1419 PI_ec_Cc_f2 GAGGTGTCATGCAAGAGGCAGCCA
1420 PI_ec_Cc_f2m GAGGTGGACTAGTCAAGGCAGCCA
1426 CE_Per6 AAGGGGCCTTGAGGACGCGCAGTGGCT
1427 CE_Pef3 CAGTGAATTCATGTCCCACGGGACCTACT
1439 CE_Pef7 CAGTGAATTCTGCAGCCCGCTCCTCAAG
1450 STAT5/6_f GTATTTCCCAGAAAAGGAAC
1451 STAT5/6_r GTTCCTTTTC
1460 Pich_ba_r1 AAAAAAGACAAGAAGACCTGAT
1462 IBA_Hind_Xho_f ATGCAAGCTTCTCGAGATGGCTAGCAGAGGATCGC
1463 IBA_Strep_BamHI_r ATGCGGATCCTTATTATTTTTCGAACTGCGG
1486 CEBP_con_r TGCAGATTG
1487 CEBP_con_f TGCAGATTGCGCAATCTGCA
1488 CEBP_con_rm TGCAGAGAC
1489 CEBP_con_fm TGCAGAGACTAGTCTCTGCA
1490 CEBPa_f3_IBA CAGTGAATTCGGCGGCGGCAAAGCCAAG
1492 CE_Pdf4_IBA CAGTGAATTCGACAAGGCGGCAGGCAAG
1502 NFYB_f1 GAGGGTGAAATTGGGCAG
1503 NFYB_r1 TTAGTCAAGCATTGGGAAGC
1504 NFYB_f2 CAGTGAATTCATGACAATGGATGGTGACAGT
1506 NFYC_r1 CAGGAGGCGTGGAGGTCG
1507 NFYC_r2 CTGAGGAGGGAGGCGGTG
1508 NFYC_f CAGTGAATTCATGTCCACAGAAGGAGGGTT
1509 NFYC_r3 AGTCGTCGACGTCGCCGGTCACCTGGG
1550 NFYB_r3 AGTCGTCGACTGAAAACTGAATTTGCTGAACAC
1557 pcDNA3,1_f ACCCACTGCTTACTGGCTTA
1558 pcDNA3,1_r GGGGGAGGGGCAAACAAC
1559 chip_ba_f2 TGAAAACTCAAGTGTCCACG
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1570 PI_ce3_rm2 GGCAAGATTCTAGTCCAAGAAAGACAGAGTTCGCC
1571 PI_ce3_fm2 TTTCTTGGACTAGAATCTTGCCTTTCATCACCAGG
1572 PI_ec_Cc_f2mu3 GAGGTGTCATTATGAGGCAGCCA
1574 PI_CEBP3_r3m GGCAAGATTC
1575 PI_CEBP3_f3m GGCGAACTCTGTCTTTCTTGGACTAGAATCTTGCC
1576 IBA_r AGATCCGTGACGCAGTAGC
1592 CE_Pbf1b  CCGTGTTTCATGCAACGCC
1593 CEBPb_r5b GCAGTGGCCGGAGGAGG
1595 CEBPb_f7    AGTCGAATTCAATGCAACGCCTGGTGGTCT
1599 bActin_LCf GGAGAAGAGCTACGAGCTTC
1615 NFYA_f3 AGGCGGACGATTTTTCTCT
1633 PI_NFY5_Ef CCTTGGCAGTGTCTGCAATTGGATAATAAGGAGGGAG
1634 PI_NFY5_Er CTCCCTCC
1635 PI_NFY5_mf GTCTGAAATACGGGAATAAGGAGGGAGGAGAATCT
1636 PI_NFY5_mr CCTTATTCCCGTATTTCAGACACTGCCAAGGAAGG
1654 CEBPb_f8 AGTCGAATTCATGCAACGCCTGGTGGTCT
1703 CEBPaLC_f GCAAGAGCCGGGACAAGG
1704 CEBPaLC_r TCGGGCAGCTGACGGAAG
1739 CEBPB_r9 CGACAGTTGCTCCACCTTCTTC
1740 CEBPb_f8 GACAAGCACAGCGACGAGTACA
1884 bCEBPg_ex1-2_f GAGGGGCCAGGTACATGTGAA
1883 bCEBPg_ex2_r TATGGATGACACTTATTC
1882 bCHOP_ex2-3_f ACCTGAAAGCAGAGCCTGATC
1881 bCHOP_ex3-4_r GATTCTTCCTCCTTGTTTCCAG
GA264 ACC1R ACTCGCTGCCACCTGACGA
GA324 Ac1cx1f GTCTGTCCATCTGTGAAGTATC
GA387 Ac1320 r CTGTCGGAAGAGGTTAGGGAAG
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ACCGCGCTCGCCGCCGGCCCGACGCCGCCATGAGCACCGCGCTCCTCAGCCTGGACGGCCCAGCGCGCGGCGCGC
CCTGGACGGCGGAACCCGCTGCCTTCTACGAGCCCGGCCGCGCGGGGAAACCGGGTCGGGGAGCCGAGCCCGCCG
CGTCCGCCATGTACGACGACGAGAGCGCCATCGACTTCAGCGCCTACACCGACTCCATGGCCGCCGTGCCCACCC
TGGAGCTGTGCCACGATGAGCTCTTCGCCGGCCTCTTCAACAGCAACCACAAAGCGGGCGCCCTGGAGCCACTGC
CCGGGGGCCCCGCGCGCCTCGGGGGCCCTGGCCCGGCGCCGCGACCCCCCAAGCGCGAGCCCGACTGGGGCGACG
GCGACGCGCCCGGGCCCCTGCTGCCCGCGCAGGTGGCCGCGTGCGCGCAGACGGTGGTGAGCCTCGCGGCCGCTG
CGCAACCCACACCGCCCGCGTCGCCAGAGCCGCCGCGCCGGAGCCCCGCGCCCCCAGCGCCCGGGCCCGCGCGAG
ACAAGGCGGCAGGCAAGCGGGGCCCGGACCGCGGCAGCCCCGAGTACCGGCAGCGACGCGAGCGCAACGACATCG
CTGTGCGCAAGAGCCGCGACAAGGCCAAGCGACGCAACCAGGAGATGCAGCAGAAGCTGGTGGAGCTTTCGGCCG
AGAACGAGAAGCTGCAGCAGCGCGTGGAGCAGCTCACGCGGGACCTGGCCGGACTGCGGCGGTTCTTCAAGCAGC
TGCCCGGCGCGCCCTTCCTGCCCGGCGCGGGGGCGGCGGACGCGCGGTGACGCGGGGGCCGCGCGGGCTGCGGCC
GCACTGCCTGGAGCCGCCGGGCCGGACTCCCGCGCTTGGCCGGGACTCGGACAGCTGCCGCGTGGACCCTAAGTT
ACTGTGACGGCAGCTTCTCCTACATCCTACGCCTAGGATGCAGCTAAGGTACTTTCGTAAAAGAGACTTTTCCGA
CAAGCCTTTGTACTGTAGATACGAGGGAAAGACTGAGAAAAAAAAAAAAAAAAAAAA
The underlined `ATG´ is the start codon. The `TGA´ is the stop codon.  
Accesssion number: AM980827 
 
 
H. Exon1n Sequence of bovine ACC-  
AGATCGAGGCTAAGCGCCTGGGCCCAAGGACGGCGAGCGGGGGTGGCCTCTCGAAGCCGTATCTTGCAGTGCCGC
TGGTGGATTAATCAGACTGCCTGAATGGTTTAAGGGTACACGGGGTACGTTTGATTCAGATGCTCCTGGAACGTC
GAAATTATCATCTTTGGAAAGAACCATCCCCTCTTTGGGCTTCAGGGGCCCAGATTGAGGCGCAATGATGAGAGG
ATGTGGTGGTCCACTCTGATGTCAATCTTGAGGGCTAG
Included in the submitted gene bank sequence (accession number FN185962).
I. PIn sequence 
AGGTGCGTGAAGCAGAGGACAGGGGCAGACTTGGAAGAGATTCGCAGACAAGATTCGAAGCCTCACTTGGTCCCT
CATTAATTATATGATCTTGGGCGTCATTTTACTGGAGACTCAGACAACCTCAGCTCTATAGATACGAAATGTCTA
CTTGGAAGGCCTATCTGAAAACAAGGGGTCACGTCAGTCCTTTGTTAACAACGGGATTTCGCGCTCCGCCACAGC
AGCGACAGGAATGCCGAGGCGGGGACCCAGCGGACCGTTCAGGGGGCGGGGCGCGGCCCCAGGGCTCAGTCCCGG
CCCGCGGCGCCCTCCCCCACCGCGCGGCGTGGCCCGTGCCTCACGCCCGCCCGCCTGCCCCTCTCGCCCCTGACG
CCGCCGGGGCCCGCAGCCCGCCCGCAAACTGGCCGCCCTTCGCGGTCCCCGCCTCCCACCTAGTCCCGCGAGTGG
GGCTCACGGCCGGCGACAAGCTCCCGGAGCACCTCGTGCCTAACTCAGCGCGTTCCCCCTCCTCCGCGCCGAGGA
AACGCCAGCCGTGCGCGCGCCCGAGCTTTGCGTGCGCGCTCCCTGCGGGCGGCGCAGGCGCGTGCGGGCCGCGCG
CCCGCCGCCTCCGCCCAGTCCCCGCCCCGGCCGTCGAAGCCCCGTCGCGGGTGGCGCGCCTGCCGCCGCCGCCCC
TGGCTCGGCCCCCGTCTGGGGCTCTCGCCGCGCGCCCGCCGCCGGCCTCTTGCAGAGAGGCCTGAGAGGCTGGGA
CTCTGAGCCGCCTGCCCGAGTTTTGAGTGGGACCAGTGATTACTTTTTCCTGAGGGCGTGTTGCTGGTCGCCGCG
GACCGGCCGGTGCCTGATGCCGCCGTTTTATCCGCTCCAGAGTGCGCTGAGCCGGAGCGGGCCAGTATGCCCCGC
TTGTGTTTGTTTTCTGACATTCCCACTCCCACCCTTGTTACCGCCTCGAAGG
Accession number FN185963
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J. mRNA copies of relevant genes in the livers from fed and starved cows 
 copies Fed Starveda Fed/starved P_fed vs starved 
ACC- PI x103 5.22±2.22 1.00±0.15 5.24 0.06 
C/EBP x105 6.89±1.11 8.84±0.94 0.78 0.23 
C/EBP x107 2.22±0.44 2.62±1.49 0.85 0.41 
C/EBP x106 5.27±0.56 6.34±0.12 0.83 0.09 
C/EBP x104 1.85±0.40 3.39±0.56 0.55 0.05 
C/EBP    1.07 0.89 
C/EBP    0.90 0.46 
NF-YA x103 7.64±0.65 8.93±0.98 0.86 0.33 
-actin x106 1.85±0.10 2.46±0.37 0.75 0.17 
Total RNA was prepared from tissues and reverse transcribed with CE_Per1 (S1315) and oligo-dT (S792). cDNA 
was measured with CE_Pef1 (S1314) and CE_Per4 (S1345). Beta-actin was measured with bActin_LCf (S1599) 
and mActin_LCr (S909) to normalize different samples. Copy number was determined with serial concentration 
of standard expression vector k1357 linearized with EcoRI. ‘a’ represents the cows fed with 16 % energy of 
normally diets, n=6. 
 
Abbreviation list 
°C centigrade or Grade Celsius 
g microgram 
l micro liter 
M micro molar 
aa amino acid 
Ab antibody 
ABC avidin-biotin complex 
ACC acetyl-coA carboxylase 
ACC acetyl-coA carboxylase encoding gene 
Acc NO. accession number 
Acetyl-CoA acetyl-coenzyme A 
ADP adenosine diphosphate 
Ag antigen 
Amp Ampicillin 
AMP-PK AMP-dependent protein kinase 
AMV avian myeoblastosis virus 
AP alkaline phosphatase 
AP1 activator protein1, or adaptor primer1 
AP2 activator protein2, or adaptor primer2 
ATP adenosine triphosphate 
BAC bacterial artificial chromosome 
BAT brown adipose tissue 
BC biotin carboxylase 
BCCP biotin carboxyl carrier protein 
BCIP 5-bromo-4chloro-3-indolyl-phosphate (disodium salt) 
-Gal -galactosidase 
BiFC bimolecular fluorescence complementary 
bp base pair 
BSA bovine serum albumin 
C/EBP CCAAT/enhance-binding protein 
CaCl2 Calcium chloride 
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cAMP adenosine-3',5'-cyclophosphate 
cAMP-PK cAMP-dependent protein kinase 
cDNA complementary DNA 
ChIP chromatin immuno-precipitation 
CHOP C/EBP homologous protein 
ChoRE carbohydrate response element 
Ci Curie 
CIAP calf intestine alkaline phosphatase 
CMV cytomeglovirus 
CoA coenzyme A 
cpm counts per minute 
CPT-1 carnitine palmitoyl transferase-I 
CRE cAMP-respose element 
CREB cAMP-respose element binding protein 
CsCl cesium chloride 
CT carboxyl transferase 
Da Dalton 
DN Dominant negative 
DNA deoxyribonucleic acid 
dATP 2'-deoxyadenosine-5'-triphosphate 
dCTP 2'-deoxy-cytidine-5'-triphosphate 
DEPC diethylprocarbonate 
Dex dexamethasone 
dGTP 2'-deoxyguanosine-5'-triphosphate 
DIG digoxigenin 
DMEM dulbecco's modified Eagle' medium 
DMSO dimethyl sulfoxide 
DNase deoxyribonulase 
dNTPs deoxyribonucleoside triphosphate 
ds double-stranded (DANN) 
DTT dithiothreitol 
dTTP thymidine-5'-triphosphate 
E.coli Escherichia coli 
EA element A 
EB element B 
EC element C 
ECL enhanced chemiluminescent 
EDTA ethylenediaminetetraacetic acid (disodium salt) 
EGF epidermal growth factor 
ELISA enzyme-linked immunosorbent assay 
EMSA electrophoretic mobility shift assay 
EtBr ethidium bromide 
Ex exon 
Ex1n exon1 new 
FA formaldehyde 
FAS fatty acid synthase 
FCS fetal calf serum 
FP free probe 
g gram 
G guanosine 
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G418 geneticin 
GFP green florescent protein 
GH growth hormone 
GLI Glioma associated oncogene 
GSP gene-specific primer 
h hour 
H2O water 
HC11 murine mammary epithelial cell 
HEK293 human embryonic kidney 
HEPES 4-(-2hydroxyethyl)-1-piperazineethane sulfonic acid 
HepG2 Human hepatocellular liver carcinoma cell 
HRP horseradish peroxidase 
IBMX 3-isobutyl-1-methylxanthine 
IP Immuno-precipitation 
IPTG isopropyl--D-thiogalctopyranoside 
kb kilo base pairs 
kDa kilo Dalton 
KO Knock out 
L liter 
LAP Liver activator protein 
LIP Liver inhibitory protein 
LB Luria-Bertani Medium 
M molar 
MEC mammary epithelial cells 
Mg magnesium 
MG mammary gland 
mg milligram 
MgSO4 magnesium sulfate 
min minute 
ml milliliter 
mM milimolar 
MOPS 3-(N-morpholino) propanesulfonic acid 
mRNA messenger RNA 
mu mutant 
NaCl sodium chloride 
NaOAC sodium acetate 
NBT nitroblue tetrazolium 
NE Nuclear extracts 
NF1 nuclear factor1 
NF-B nuclear factor-B 
NF-Y/CBF nuclear factor-Y 
ng nanogram 
nm nanometer 
nt nucleotide 
OD optical density 
PBS phosphate buffered saline 
PCR polymerase Chain reaction 
PEG polyethylene glycol 
Pi phosphate 
PI promoter I 
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PII promoter II 
PIII Promoter III 
PIn Promoter I new 
pmol picomole 
PMSF phenylmethylsulfonyl fluoride 
poly [d(I-C)] poly-deoly-insosinic-deoxy-cytidylic acid 
PPAR peroxisome proliferator-activated receptor 
PUFA polyunsaturated fatty acid 
RACE rapid amplification of cDNA ends 
RL Renilla luciferase gene
RNA ribonucleic acid 
Rnase ribonuclease 
rpm revolution per minute 
RT-PCR reverse transcription-polymerase chain reaction 
s second 
SEM The standard error of the mean 
SDS sodium dodecyl sulfate 
SRE sterol regulatory element 
SREBP-1 sterol regulatory element binding protein-1 
SSC saline-sodium citrate 
STAT signal transducers and activators of transcription 
T thymidine 
T3 tri-iodothyronine 
TADA2L a component of chromatin-modifying complexes 
TBE tris-borate-EDTA 
TE Tris-EDTA buffer 
TEMED N,N,N',N'-tetramethylenediamine 
Tet tetracycline 
Thr Threonine 
TK thymidine kinase 
Tm melting temperature 
TMB  3, 3, ‘5, 5’-tetramentylbenzidine 
TNF tumor necrosis factor 
Tris tris (hydroxymethyl)-amino-methane 
tss transcriptional start site 
USF upstream stimulating factor 
UTR untranslated region 
UV ultraviolet 
V voltage 
WB western blot 
wt Wild type 
X-gal 5-bromo-4-chloro-3-indolyl--D-galactoside 
X-phosphate 5-bromo-4-chloro-3-indolyl-phosphate (BCIP) 
YFP yellow fluorescence protein 
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